# EDGAR Filing Document

**Accession Number:** 0001834868
**File Stem:** 0001493152-25-016376
**Filing Date:** 2025-9
**Character Count:** 473295
**Document Hash:** 15f9b9e0bdd5907b2e9341b33077473a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-016376.hdr.sgml**: 20250930

**ACCESSION NUMBER**: 0001493152-25-016376

**CONFORMED SUBMISSION TYPE**: 1-SA

**PUBLIC DOCUMENT COUNT**: 22

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250930

**DATE AS OF CHANGE**: 20250930

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Alternative Ballistics Corp
- **CENTRAL INDEX KEY:** 0001834868
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORDNANCE & ACCESSORIES, (NO VEHICLES/GUIDED MISSILES) [3480]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 852764555
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 1-SA
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 24R-00945
- **FILM NUMBER:** 251361447

**BUSINESS ADDRESS:**
- **STREET 1:** 5940 S. RAINBOW BLVD
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89118
- **BUSINESS PHONE:** 619-326-4411

**MAIL ADDRESS:**
- **STREET 1:** 5940 S. RAINBOW BLVD
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89118

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Alternative Ballisitics Corp
- **DATE OF NAME CHANGE:** 20201203

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 1-SA**

**☒ SEMIANNUAL REPORT PURSUANT TO REGULATION A**

**or**

**☐ SPECIAL FINANCIAL REPORT PURSUANT TO REGULATION A**

For the fiscal semiannual period ended <u>June 30, 2025</u>

**Alternative Ballistics Corporation**

(Exact name of issuer as specified in its charter)

---

| | |
|:---|:---|
| **Nevada** | **85-2764555** |
| State or other jurisdiction | (I.R.S. Employer |
| of incorporation or organization | Identification No.) |

---

5940 S. Rainbow Blvd., Las Vegas, Nevada 89118

(Full mailing address of principal executive offices)

(619) 326-4411

(Issuer's telephone number, including area code)

**Item 1.** **Management's Discussion and Analysis of Financial Condition and Results of Operations**

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes. The information contained herein contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed. Except as otherwise required by federal securities laws, we do not expect to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

**Overview** 

Alternative Ballistics Corporation, a Nevada corporation ("ABC" or the "Company") was formed on August 27, 2020 for the purpose of acquiring Alternative Ballistics, L.P. ("LP"), a California limited partnership. Our corporate offices are in Las Vegas, Nevada, and San Diego, California.

We are in the Less Lethal Ammunition ("LLA") market of the law enforcement industry. This is a niche market with multiple tools and options available to law enforcement personnel for the deployment of various types of ammunition designed to temporarily incapacitate, stun, or cause temporary discomfort to a person without penetrating the body. Less-lethal technologies are continuously evolving, and law enforcement agencies are generally open to reviewing data, scheduling demonstrations, or procuring ammunition samples to conduct their own internal testing, which is influencing the growth of the LLA global market.

Our immediate plan of operations includes additional rounds of ballistics testing, the launch of domestic pilot programs, securing our first international contracts, and research and development on the consumer version of our current product for the commercial market. We intend to penetrate domestic and foreign professional markets by continuing to introduce The Alternative® to law enforcement agencies and private security companies and other federal agencies. We hope to expand our presence in the professional markets and introduce our consumer version to the commercial market and continue to expand operations domestically and internationally. We anticipate that our training program will constitute our largest and most complex operation, as it will entail sending training teams throughout the country and eventually the globe on multiple day trips to conduct presentations, demonstrations, and training programs. This will involve traveling with weapons, inventory, and custom gear including custom targets and stands. Our training program will likely be the area where we will most need to expand our operations by bringing on new trainers who are professionals in the field of law enforcement. We can make no assurances that our plan of operation will succeed according to projections and expectations.

**Recent Developments**

The Company effected a one-for-five (1:5) reverse stock split (the "<u>Reverse Stock Split</u>") of its issued and outstanding shares of its common stock and preferred stock. As a result, every five (5) shares of each class or series of the Company's issued and outstanding common stock and preferred stock were automatically reclassified and combined into one (1) validly issued, fully paid, and non-assessable share of the same class or series, without increasing or decreasing the par value per share.

Pursuant to the Nevada Revised Statutes Section 78.207, the Company also decreased the number of each class or series of the shares of common stock and preferred stock it is authorized to issue proportionally with the Reverse Stock Split, so that the number of authorized shares of common stock and preferred stock following the Reverse Stock Split is one fifth of that before the Reverse Stock Split. Effective as of the close of business on August 8, 2025 and as of the date of this report, the Company is authorized to issue up to 50,000,000 shares of common stock, par value $0.001 per share, and 2,000,000 shares of preferred stock, par value $0.001 per share, all of which were designated as Series A Preferred Stock.

Following the Reverse Stock Split, no fractional shares will be issued. Stockholders who would otherwise be entitled to receive fractional shares will instead have their holdings rounded up to one whole share of stock of the applicable class of common stock or series of preferred stock.

Stockholders are not required to take any action in connection with the Reverse Stock Split. Stockholders holding their shares in book-entry form or through a brokerage account will see the adjustments automatically reflected in their accounts. Stockholders are encouraged to contact their bank, broker, or custodian with any procedural questions.

The foregoing is a summary of the Certificate of Charter Amendment and the Certificate of the Designation Amendment and is qualified in its entirety by reference to the full text of the Certificate of Charter Amendment and the Certificate of the Designation Amendment as Exhibit Nos. 2.7 and 2.8, respectively.

**<u>Results of Operations for the Six Months Ended June 30, 2025 Compared to the Six Months Ended June 30, 2024</u>**

*General and Administrative Expenses*

General and administrative expenses for the six months ended June 30, 2025 and June 30, 2024 were approximately $38.7 million and $13.8 million, respectively. The increase of approximately $25 million in general and administrative expenses primarily relates to stock-based compensation.

*Sales and Marketing Expenses*

Sales and marketing expenses for the six months ended June 30, 2025 and June 30, 2024 were approximately $0.3 million and $0.2 million, respectively. Sales and marketing expenses primarily relate to media campaigns, trade shows, and demonstrations.

*Professional Fees* 

Professional fees for the six months ended June 30, 2025 and June 30, 2024 were approximately $0.3 million and $0.2 million, respectively. Professional fees primarily relate to corporate consulting and corporate initiatives.

*Research and Development Expenses*

Research and development expenses for the six months ended June 30, 2025 and June 30, 2024 were approximately $700 and $7,500, respectively. Research and development expenses primarily relate to ballistics testing.

*Interest Expense*

Interest expense for the six months ended June 30, 2025 and June 30, 2024 was approximately $0.2 million and $0.1 million, respectively. The increase of approximately $0.1 million was primarily related to interest on the additional convertible debt issued in the latter part of 2024 and during the first six months of 2025. Going forward, we expect an increase in our interest expense because of the compounding interest on existing debt.

*Operating Activities*

During the six months ended June 30, 2025, operating activities used approximately $0.8 million of cash, primarily due to our net loss of approximately $39.3 million, partially offset by approximately $37.6 million of stock-based compensation for shares issued to related and third parties for services, the extension of a related party convertible note, and the conversion of deferred compensation to related parties.

During the six months ended June 30, 2024, operating activities used approximately $0.7 million of cash, primarily due to our net loss of approximately 14.4 million, partially offset by approximately $13.3 million of stock-based compensation for shares and warrants issued to related and third parties for services.

*Financing Activities*

During the six months ended June 30, 2025, net cash provided by financing activities was approximately $0.5 million, consisting of proceeds from the issuance of convertible notes and sale of common stock.

During the six months ended June 30, 2024, net cash provided by financing activities was approximately $0.3 million, consisting of proceeds from the sale of common stock.

*Funding Requirements*

We expect our expenses to increase substantially in connection with our ongoing activities, particularly as we advance our management team and sales and marketing, and research and development.

Until such time, if ever, as we can generate substantial product revenue, we expect to finance our operations through a combination of equity offerings and debt financings. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interests of our existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of such stockholders. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures, or declaring dividends.

**Liquidity and Capital Resources**

As indicated in the accompanying financial statements, we had an accumulated deficit of approximately $97.8 million as of June 30, 2025. We incurred a net loss of approximately $39.3 million and cash outflows from operations of approximately $0.8 million for the six months ended June 30, 2025. For the six months ended June 30, 2024, we had an accumulated deficit of approximately $57.6 million, incurred a net loss of approximately $14.4 million, and cash outflows from operations of approximately $0.7 million. Further, we expect to continue to incur significant costs in the pursuit of our business plans. We cannot assure you that our plans to raise capital, commercialize our products or to complete our research and development activities will be successful. These factors, among others, raise substantial doubt about our ability to continue as a going concern.

Since our inception, we have incurred significant operating losses. We expect to incur significant expenses and operating losses for the foreseeable future. To date, we have funded our operations with proceeds from sales of common stock and borrowings under convertible promissory notes. As of June 30, 2025, we had cash and cash equivalents of approximately $14,777.

Our short-and-long-term material cash requirements are expected to come from public and private offerings.

We have a total debt of $2.45 million in principal in the form of convertible notes comprised of the following:

- $1 million convertible promissory note issued on March 29, 2022, and is convertible into 1,000,000 shares of our common stock at a conversion rate of $1.00 per share. The conversion of the note is at the election of the holder, and the maturity date of the note is March 29, 2027.

- $1 million convertible note issued on August 2, 2024, which is accruing interest, as amended, at 18% per annum, and is convertible into shares of our common stock at a 50% discount of a "Qualified Offering" price. Prior to the maturity date of December 31, 2025, the conversion of the note is at the election of the Company.

- $500,000 convertible note (of which $450,000 was issued by June 30, 2025) issued on January 28, 2025, which is accruing interest, as amended, at 18% per annum and is convertible into shares of our common stock at a 50% discount of a "Qualified Offering" price. Prior to the maturity date of December 31, 2025, the conversion of the note is at the election of the Company

**Critical Accounting Policies**

See Note 2 in our Financial Statements for our Significant Accounting Policies.

**Revenue Recognition**

We generate revenue through the distribution of our products and accessories to dealers/distributors, security companies, and law enforcement agencies. Revenue is recognized upon transfer of control of goods to the customer, which generally occurs when title to goods is passed and risk of loss transfers to the customer. Depending on the contract terms, transfer of control is upon shipment of goods to or upon the customer's pick-up of the goods.

We recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers, which requires that five basic criteria be met before revenue can be recognized: (i) identify the contract with the customer; (ii) identity the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price; and (v) recognize revenue when or as the entity satisfied a performance obligation.

**Off-Balance Sheet Arrangements**

During the periods presented, we did not have and we do not currently have any off-balance sheet arrangements, as defined in the rules and regulations of the Commission.

**Working Capital Loans**

On August 2, 2024, January 28, 2025 and July 21, 2025, we borrowed $1 million, $500,000 and $300,000, respectively, to fund our working capital needs pursuant to a Loan Agreement and related Convertible Note by and between us, as the borrower, and Solyco CAC LLC ("Solyco") as lender (the "Working Capital Loan"). The Convertible Notes, as amended, have an interest rate of 18%. The Working Capital Loans issued on August 2, 2024 and January 28, 2025 mature, as amended, on December 31, 2025 and the Working Capital Loan issued on July 21, 2025 matures on April 21, 2026 (collectively, the "Maturity Dates"). In the event we close a public offering prior to the Maturity Dates, then Solyco has the option (a) to be repaid from the proceeds of our public offering within five days from the closing of a public offering; or (b) in the event that Solyco does not exercise such option for repayment, then the Convertible Notes shall automatically convert into shares of common stock 30 days following the closing of a public offering. If the Convertible Notes are converted, it will be converted at the "Conversion Price" equal to a 50% discount to the public offering price.

In connection with the Working Capital Loans, we also issued to Solyco warrants to purchase the number of shares that Solyco would receive assuming full conversion of the Note (the "Warrant"). The Warrants, as amended, have an exercise price equal to the lower of: (i) $5.00 or (ii) a 50% discount to the public offering price, and a term of five years from the date of issuance.

**Changes In And Disagreements With Accountants On Accounting And Financial Disclosure**

None.

**Item 2.** **Other Information**

None.

**Item 3.** **Financial Statements**

Alternative Ballistics Corporation <br> Balance Sheets

---

| | | |
|:---|:---|:---|
|  | June 30,<br>2025 <br>(Unaudited) | December 31,<br>2024 <br>(Audited) |
| ASSETS |  |  |
| Current assets |  |  |
| &nbsp;&nbsp;&nbsp;Cash | $14777 | $234907 |
| &nbsp;&nbsp;&nbsp;Inventory | 23121 | 25058 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses & Other current assets | 19961 | 21006 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 57859 | 280971 |
| Other Assets |  |  |
| &nbsp;&nbsp;&nbsp;Fixed Assets, net | 7352 | 7645 |
| &nbsp;&nbsp;&nbsp;ROU Asset, net | 31733 | 62812 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other assets | 39085 | 70457 |
| Total assets | $96944 | $351428 |
| LIABILITIES AND STOCKHOLDERS' DEFICIT |  |  |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | 664950 | 918142 |
| &nbsp;&nbsp;&nbsp;Lease liability | 32480 | 64306 |
| &nbsp;&nbsp;&nbsp;Interest payable | 126190 | 38530 |
| &nbsp;&nbsp;&nbsp;Convertible notes payable - short term, net of debt discount | 1324958 | 751268 |
| &nbsp;&nbsp;&nbsp;Related party convertible notes payable | - | 1000000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 2148578 | 2772246 |
| &nbsp;&nbsp;&nbsp;Related party convertible notes payable - long term | 1000000 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term liabilities | 1000000 | - |
| Total liabilities | 3148578 | 2772246 |
| Stockholders' deficit |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock, $0.001 par value, 2,000,000 shares authorized, 400,000 and 400,000 shares issued and outstanding as of June 30, 2025 and December 31, 2023, respectively | 400 | 400 |
| &nbsp;&nbsp;&nbsp;Common stock, $0.001 par value, 50,000,000 shares authorized, 31,776,036 and 27,942,799 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 31776 | 27943 |
| &nbsp;&nbsp;&nbsp;Additional paid in capital | 94879186 | 56077960 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (97962996) | (58527121) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' deficit | (3051634) | (2420818) |
| Total liabilities and stockholders' deficit | $96944 | $351428 |

---

Alternative Ballistics Corporation

Statements of Operations

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | For the six months ended | For the six months ended |
|  | June 30, 2025 | June 30 2024 |
| Revenue | $2750 | $4375 |
| Less: Cost of Sales | 746 | 720 |
| Gross Margin | 2004 | 3655 |
| Operating expenses |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and Administrative | 38671190 | 13871968 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 292970 | 242247 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Professional fees | 268798 | 188305 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development | 666 | 7510 |
| Total operating expenses | 39233624 | 14310030 |
| &nbsp;&nbsp;&nbsp;Loss from operations | (39231620) | (14306375) |
| &nbsp;&nbsp;&nbsp;Other expenses |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (204255) | (100448) |
| Total other expenses | (204255) | (100448) |
| Net loss before tax provision | (39435875) | (14406823) |
| Tax provision | - | - |
| Net loss | $(39435875) | $(14406823) |
| Net loss per common share - basic and diluted | $(1.36) | $(0.53) |
| Weighted average number of common shares outstanding - basic and diluted | 28962684 | 26974757 |

---

Alternative Ballistics Corporation

Statements of Cash flows

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | For the six months ended | For the six months ended |
|  | June 30, 2025 | June 30, 2024 |
| Cash Flows from Operating Activities |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $(39435875) | $(14406823) |
| &nbsp;&nbsp;&nbsp;Stock based compensation | 716846 | 7300000 |
| &nbsp;&nbsp;&nbsp;Stock based compensation, related party | 8110000 | 3750000 |
| &nbsp;&nbsp;&nbsp;Stock based compensation for extension of convertible note payable, related party | 24000000 |  |
| &nbsp;&nbsp;&nbsp;Stock based compensation, loss on conversion of deferred compensation | 4820937 |  |
| &nbsp;&nbsp;&nbsp;Amortization of debt issuance costs | 419935 |  |
| &nbsp;&nbsp;&nbsp;Stock based compensation - warrants |  | 2259997 |
| &nbsp;&nbsp;&nbsp;Gain on forgiveness on stock payable |  | (83334) |
| &nbsp;&nbsp;&nbsp;ROU asset | 31079 | 29855 |
| &nbsp;&nbsp;&nbsp;ROU liability | (31826) | (29108) |
| &nbsp;&nbsp;&nbsp;Depreciation | 1918 | 6106 |
| &nbsp;&nbsp;&nbsp;Imputed interest | 116596 |  |
| Changes in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 1045 | (49622) |
| &nbsp;&nbsp;&nbsp;Inventory | 1937 | 5825 |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | 492403 | 387786 |
| &nbsp;&nbsp;&nbsp;Related party interest payable | - | 100448 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in operating activities | (755005) | (728870) |
| Cash Flows from Investing Activities: |  |  |
| &nbsp;&nbsp;&nbsp;Purchase of fixed assets | (1625) | (1797) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (1625) | (1797) |
| Cash Flows from Financing Activities: |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from convertible notes payable | 450000 |  |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of common stock | 86500 | 299000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 536500 | 299000 |
| Net (decrease) increase in cash | (220130) | (431667) |
| Cash, beginning of period | 234907 | 561645 |
| Cash, end of period | $14777 | $129977 |
| Supplemental disclosure of cash flow information |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for interest | $11567 | $- |
| **SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:** |  |  |
| Deferred compensation exchanged for stock | $657935 | $- |
| Forgiveness of stock payable – related party | $- | $40000 |
| ROU Asset exchanged for ROU Liability | $- | $123122 |
| Warrant issued on convertible note payable (debt discount) | $282118 | $- |

---

**Alternative Ballistics Corporation**

**Statements of Stockholders' Deficit**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Series A Preferred Stock** | **Series A Preferred Stock** | **Common Stock** | **Common Stock** | | | | |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Additional<br> Paid-in**<br> **Capital** | **Subscriptions**<br>**Payable** | <br>**Accumulated**<br>**Deficit** | **Stockholder's**<br>**Deficit** |
| **Balance, December 31, 2023** | 400000 | $400 | 26545149 | $26545 | $41984610 | $123334 | $(43203417) | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1068528) |
| Shares issued for cash, net of offering cost |  |  | 18650 | 19 | 186481 | 112500 |  | 299000 |
| Shares issued for services |  |  | 619000 | 619 | 6106047 | 1110000 |  | 7216666 |
| Shares issued for services, Related Party |  |  | 375000 | 375 | 3749625 |  |  | 3750000 |
| Fair Value of Warrants issued for service |  |  |  |  | 2259997 |  |  | 2259997 |
| Forgiveness of stock payable, related party |  |  |  |  | 40000 | (40000) |  |  |
| Forgiveness of stock payable |  |  |  |  | 83334 | (83334) |  |  |
| Net loss | - | - | - | - | - | - | (14406823) | (14406823) |
| **Balance, June 30, 2024** | 400000 | $400 | 27557799 | $27558 | $54410094 | $1222500 | $(57610240) | $(1949688) |
| **Balance, December 31, 2024** | 400000 | 400 | 27942799 | 27943 | 56077960 |  | (58527121) | (2420818) |
| Shares issued for cash, net of offering cost |  |  | 8650 | 9 | 86491 |  |  | 86500 |
| Shares issued for services |  |  | 65700 | 66 | 656934 |  |  | 657000 |
| Shares issued for conversion of deferred compensation |  |  | 547887 | 548 | 5478324 |  |  | 5478872 |
| Shares issued for services, related party |  |  | 811000 | 811 | 8109189 |  |  | 8110000 |
| Shares issued for extension of note payable-related party |  |  | 2400000 | 2400 | 23997600 |  |  | 24000000 |
| Imputed interest on notes payable - related party |  |  |  |  | 116596 |  |  | 116596 |
| Stock compensation for stock options |  |  |  |  | 59846 |  |  | 59846 |
| Fair value of warrants issued on debt discount |  |  |  |  | 296246 |  |  | 296246 |
| Net loss | - | - | - | - | - | - | (39435875) | (39435875) |
| **Balance, June 30, 2025** | 400000 | $400 | 31776036 | $31776 | $94879186 | $- | $(97962996) | $(3051634) |

---

**1.** **ORGANIZATION AND BUSINESS OPERATIONS** 

Alternative Ballistics Corporation (the "Company") was incorporated in the State of Nevada on August 27, 2020. Our offices are located at 5940 S. Rainbow Blvd, Las Vegas, NV 89118.

Alternative Ballistics Corporation is a next generation less-lethal technology company. It is a new venture, which specializes in the production and distribution of a less-lethal impact munition known as "The Alternative® - to Lethal Force" designed for the law enforcement industry.

*Basis of Presentation*

The accompanying financial statements represent the results of operations, financial position and cash flows of Alternative Ballistics Corporation. prepared on the accrual basis of accounting and conform to accounting principles generally accepted in the United States of America.

 

*Going Concern*

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Management evaluated all relevant conditions and events that are reasonably known or reasonably knowable, in the aggregate, as of the date the financial statements are issued and determined that substantial doubt exists about the Company's ability to continue as a going concern. The Company's ability to continue as a going concern is dependent on the Company's ability to generate revenues and raise capital. The Company has not generated sufficient revenues to provide sufficient cash flows to enable the Company to finance its operations internally. As of June 30, 2025 and December 31, 2024, the Company had $14,777 and $234,907 cash on hand, respectively. At June 30, 2025 and December 31, 2024, the Company has an accumulated deficit of $97,962,996 and $58,527,121, respectively. For the six months ended June 30, 2025, the Company had a net loss and cash used in operations of $39,435,875 and $755,004, respectively. For the six months ended June 30, 2024, the Company had a net loss and cash used in operations of $14,406,823 and $728,870, respectively. These factors raise substantial doubt about the Company's ability to continue as a going concern.

Over the next twelve months management intends to raise additional capital through debt and equity financing in order to promote and sell its products. If the Company fails to obtain additional capital the Company may be forced to scale back or discontinue its operations. However, there is no guarantee the Company will raise capital to continue operations. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

**2.** **SIGNIFICANT ACCOUNTING POLICIES** 

*Basis of Presentation*

The accompanying financial statements represent the results of operations, financial position and cash flows of Alternative Ballistics Corporation. prepared on the accrual basis of accounting and conform to accounting principles generally accepted in the United States of America.

*Reclassifications*

 

Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.

*Use of Estimates*

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and also requires disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.

*Fair Value of Financial Instruments*

 

The Company measures fair value in accordance with Accounting Standards Codification ("ASC") 820 – Fair Value Measurements. ASC 820 defines fair value and establishes a three-level valuation hierarchy for disclosures of fair value measurements. ASC 820 establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by ASC 820 are:

Level 1 — Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.

Level 2 — Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument's anticipated life.

Level 3 — Inputs reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. Valuation of instruments includes unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

As defined by ASC 820, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale, which was further clarified as the price that would be received to sell an asset or paid to transfer a liability ("an exit price") in an orderly transaction between market participants at the measurement date.

The reported fair values for financial instruments that use Level 2 and Level 3 inputs to determine fair value are based on a variety of factors and assumptions. Accordingly, certain fair values may not represent actual values of the Company's financial instruments that could have been realized as of June 30, 2025 and December 31, 2024 or that will be recognized in the future, and do not include expenses that could be incurred in an actual settlement. The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, inventory, accounts payable and accrued liabilities, and related party and third-party notes payables approximate fair value due to their relatively short maturities. The Company's notes payable to related parties approximates the fair value of such instrument based upon management's best estimate of terms that would be available to the Company for similar financial arrangements at June 30, 2025 and December 31, 2024.

The carrying value of financial assets and liabilities recorded at fair value is measured on a recurring or nonrecurring basis. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs.

 

*Related parties*

 

The Company follows ASC 850, "Related Party Disclosures" for reporting activities with related parties. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.

*Impairment of Long-Lived Assets*

 

Long-lived assets, including intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. In such situations, long-lived assets are considered impaired when future undiscounted cash flows resulting the use of the asset and its eventual disposition are less than the asset's carrying amount. In such situations, the asset is written down to the present value of the estimated future cash flows. Factors that are considered when evaluating long-lived assets for impairment include a current expectation that it is more likely than not that the long-lived asset will be sold significantly before the end of its useful life, a significant decrease in the market price of the long-lived asset, and a change in the extent of manner in which the long-lived asset is being used. Based on management's assessment there were no impairments to its long-lived assets at June 30, 2025 and December 31, 2024.

 

*Property and Equipment*

 

Property and equipment are recorded at cost for purchases over $500 and depreciated using the straight-line method over the estimated useful lives ranging from three to ten years. The Company capitalizes direct costs associated with property and equipment in accordance with ASC 360 – Property, Plant, and Equipment. Leasehold improvements are amortized on a straight-line basis over the shorter of their useful life or the term of the related lease. Expenditures for ordinary repairs and maintenance are expensed as incurred.

 

*Advertising*

 

The Company expenses the cost of advertising, including promotional expenses, as incurred. Advertising expenses for the six months ended June 30, 2025, and 2024 were $93 023 and $164,370, respectively.

*Research and Development*

 

Costs related to the conceptual formulation and design of products and processes are charged to Research and Development as incurred. Development of a product is deemed complete when it is qualified through reviews and tests for performance and reliability. Subsequent to product qualification, product costs are included in cost of goods sold. Research and Development expenses for the six months ended June 30, 2025, and 2024 were $666 and $7,510, respectively.

 

*Stock-based Compensation*

 

The Company recognizes stock-based compensation issued to employees in accordance with ASC 718 – Compensation: Stock Compensation, based on the fair value of the equity instrument in exchange for employee or consulting services and the resulting recognition of compensation expense.

*Income Taxes*

 

The Company accounts for its income taxes in accordance with FASB Codification Topic ASC 740-10, "Income Taxes", which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

*Concentrations of Credit Risk and Financial Instruments*

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash.

The Company's cash balances are placed at financial institutions, which at times, may exceed federally insured limits. Generally, these deposits may be redeemed upon demand and, therefore, bear minimal risk. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk on cash

*Basic and Diluted Loss per Share*

 

The Company follows ASC Topic 260 to account for the earnings per share. Basic earnings per common share ("EPS") calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.

The Company reports earnings (loss) per share in accordance with FASB Codification Topic ASC 260-10 "Earnings Per Share", Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted average number of common shares available. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted earnings (loss) per share has not been presented for the six months ending June 30, 2025 and 2024, respectively, since the effect of the assumed exercise of options and warrants to purchase common shares (common stock equivalents) would have an anti-dilutive effect. There are 320,000 and 3,402,000 additional shares issuable in connection with outstanding options, warrants, stock payable and convertible debts as of June 30, 2025 and 2024, respectively.

*Recent Accounting Pronouncements*

In November 2024, the FASB issued Accounting Standard Update No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03"). This standard requires additional disclosures over certain expenses, including purchases of inventory, employee compensation, depreciation, intangible asset amortization, and other specific expense categories. This standard also requires disclosure of the total amount of selling expenses and the Company's definition of selling expenses. This update is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. We are evaluating the impact this update will have on our annual disclosures; however, there was no impact our financial condition, results of operations, or cash flows.

*Reclassifications of Prior Period Amounts*

 

Certain prior period amounts have been reclassified within operating expenses to conform to the current period presentation. These changes were made to better reflect the Company's cost structure and improve consistency in financial reporting. The reclassifications had no effect on previously reported total operating expenses, net income (loss), total assets, or shareholders' equity.

**3.** **BUSINESS SEGMENT INFORMATION** 

Our flagship product, The Alternative®, is currently the only offering in our reportable segment focused on less-lethal technologies. This segment encompasses all of the Company's global efforts in promoting and selling The Alternative® to domestic and international professional markets, including law enforcement, military, and private security end users.

This is a niche market that offers various tools and options for law enforcement, military, and security personnel to deploy types of ammunition designed to temporarily incapacitate, stun, or cause temporary discomfort without penetrating the body. Our product stands out as the only less-lethal technology available that can be carried by officers, allowing them to instantly and temporarily convert their service weapon into a less-lethal kinetic device without the need to transition to a completely separate platform.

The accounting policies for the less-lethal technologies segment align with those outlined in the summary of significant accounting policies. The Chief Executive Officer is the Chief Operating Decision Maker ("CODM") and assesses the performance of this segment and allocates resources based on net income, which is reflected in the income statement as total income. The measure of segment assets is represented as total assets on the balance sheet.

The CODM evaluates the income generated from segment assets, known as return on assets, using net income. This information assists the CODM in deciding whether to reinvest profits into the less lethal technologies segment or allocate resources to other areas of the business, such as acquisitions or dividend payments.

Net income is also utilized to monitor the difference between budgeted and actual results, offering insights into financial performance and guiding any necessary corrective actions. Additionally, the CODM employs net income for competitive analysis by comparing the performance of the less lethal technologies segment against competitors.

This combination of competitive analysis and budget-to-actual monitoring is crucial for assessing the segment's performance and determining management compensation.

The company does not engage in any intra-entity sales or transfers.

The Company has identified one reportable segment: the less lethal technologies segment. The less lethal technologies segment primarily generates revenue in North America, and the company manages its sole product sales and associated expenses on a total basis.

**4.** **PREPAID EXPENSES AND OTHER CURRENT ASSETS** 

As of June 30, 2025, prepaid expenses and other current assets consist of prepaid insurance of $9,005 and a lease deposit of $10,956.

**5.** **PROPERTY AND EQUIPMENT, NET** 

Property and equipment as of June 30, 2025 and December 31, 2024 comprise of the following:

---

| | | | |
|:---|:---|:---|:---|
|  | **June 30,** | **December 31,** | **Estimated <br> Useful Lives** |
|  | **2025** | **2024** |  |
| Tooling and molds | $86711 | $86711 | 10 years |
| Computer equipment | 10890 | 9265 | 3 years |
| Furniture and fixtures | 3964 | 3964 | 5 years |
|  | 101565 | 99940 |  |
| Less accumulated deprecation | (94213) | (92295) |  |
| Total property and equipment, net | $7352 | $7645 |  |

---

Depreciation expense for the six months ended June 30, 2025 and the year ended December 31 2024 was $1,918 and $11,771, respectively.

**6.** **LEASES** 

On January 1, 2024, the Company entered into a two-year non-cancellable property lease, for 996 square feet of office space, at a monthly lease term of $5,229 with a second year monthly escalation to $5,478. Included in the lease are utilities and property taxes.

The Company entered into a lease for office space under a month-to-month cancellable lease agreement that commenced on January 1, 2024 and was set to expire on December 31, 2024, at a monthly lease term of $1,700 a month. On July 9, 2024 the company entered into a one-year lease for a larger office space at the same location, at $1,952 a month.

Supplemental balance sheet information related to leases was as follows:

---

| | | |
|:---|:---|:---|
|  | For the Six Months Ended | For the Six Months Ended |
|  | June 30, | June 30, |
| Operating lease: | 2025 | 2024 |
| Operating lease assets | $31733 | $93267 |
| Current portion of operating lease liabilities | $32480 | $64076 |
| Noncurrent operating lease liabilities | - | 29938 |
| Total operating lease liability | $32480 | $94014 |
| Weighted average remaining lease term |  |  |
| Operating leases (years) | 0.5 |  |
| Weighted average discount rate: | 4.08% |  |

---

Supplemental cash flow and other information related to operating leases was as follows:

---

| | | |
|:---|:---|:---|
|  | For the Six Months Ended | For the Six Months Ended |
|  | June 30, | June 30, |
|  | 2025 | 2024 |
| Cash paid for amounts included in the measurement of lease liabilities: |  |  |
| Operating cash flows used for operating leases | $32868 | $32131 |
| Total operating lease liabilities | $32480 | $94014 |

---

Our anticipated future lease commitments on a calendar year basis in US dollars, under non-cancellable operating leases are as follows:

---

| | |
|:---|:---|
|  | Minimum |
| Year Ending | Lease |
| December 31, | Commitments |
| 2025 | 64306 |
| Total future minimum lease liabilities | $64306 |

---

**7.** **CONVERTIBLE NOTES** 

The Company has the following notes outstanding:

---

| | | |
|:---|:---|:---|
|  | **June 30,**<br>**2024** | **December 31,<br> 2024** |
| Note payable, secured, 14% interest, due May, 2025 | $1450000 | $1000000 |
| Discount on Note Payable | (125042) | (248732) |
| Note Payable (Net of Discount) | $1324958 | $751268 |

---

On August 2, 2024, the Company issued a convertible promissory note with a principal amount of $1,000,000. The notes bear interest at a rate of 14% per annum and matures on May 2, 2025. The proceeds received were allocated between the convertible note and warrants on a relative fair value basis. The aggregate estimated value of the warrants using the Black-Scholes Pricing Model, based on a weighted average volatility rate of 76.3% and a weighted average call option value of $1.282, was $1,281,653. The warrants resulted in a debt discount of $561,721. The aggregate debt discounts of $248,732 as of the year ended December 31, 2024 was fully amortized during the first six months of 2025 using the straight-line method, which approximates the effective interest method.

On January 21, 2025, the warrant was amended extending the term to January 21, 2030. In order to determine if there was incremental value to the warrant from this amendment, the aggregate estimated value of the warrants was re-calculated using the Black-Scholes Pricing Model, based on a weighted average volatility rate of 76.2% and a weighted average call option value of $1.2957, which resulted in an incremental value and additional debt discount of $14,126. This incremental value was fully amortized during the first six months of 2025 using the straight-line method, which approximates the effective interest method.

On January 28, 2025 the Company issued a convertible promissory note with a principal amount of $500,000, of which $450,000 was issued as of June 30, 2025. The notes bear interest at a rate of 14% per annum and matures on October 28, 2025. The proceeds received were allocated between the convertible note and warrants on a relative fair value basis. The aggregate estimated value of the warrants using the Black-Scholes Pricing Model, based on a weighted average volatility rate of 76.25% and a weighted average call option value of $1.2948, was $647,408. The warrants resulted in a debt discount of $282,118. The aggregate debt discounts of $125,041, as of June 30, 2025, are being amortized over the life of the loan using the straight-line method, which approximates the effective interest method.

Interest expense and accrued interest associated with these convertible notes for the six months ended June 30, 2025 was $87,659 and $126,190, respectively. Interest expense and accrued interest associated with convertible notes for the year ended December 31, 2024 was $38,530 and $38,350, respectively.

**8.** **CONVERTIBLE NOTES PAYABLE TO RELATED PARTIES** 

The company had the following convertible notes payable related party outstanding:

---

| | | |
|:---|:---|:---|
|  | **June 30,** <br> **2024** | **December 31, 2024** |
| Related Party convertible Note payable, secured, 15% interest, due March 2027 | $1000000 | $1000000 |

---

On August 13, 2021, the Company issued a convertible promissory note with a principal amount of $250,000. The note bore an interest at 15% per annum and matured on August, 2022. The note and accrued interest are convertible at the option of the noteholder at $0.10 per share but would mandatorily convert to common stock at the same price upon an up list to a national exchange and will have piggyback registration rights to register the shares of common stock underlying the conversion of the notes. In August, 2022, upon maturity of the $250,000 convertible promissory note, the Company paid the accrued interest to its holder and extended the term of the promissory note until August 13, 2023. In August, 2023, upon maturity of the $250,000 convertible promissory note, the company converted the principal balance on the note into 1,000,000 shares of common stock and paid the accrued interest on the note, pursuant to the terms in the agreement.

On December 31, 2021, the Company issued a convertible promissory note with a principal amount of $350,000. The note bore an interest at a rate of 15% per annum, matured on December 31, 2022. On December 31, 2022 upon maturity of the $350,000 convertible promissory note, the Company extended the term of the promissory note until December 31, 2024 at the same rate of interest. The notes and accrued interest are convertible at the option of the noteholder at $0.10 per share but will mandatorily convert to common stock at the same price upon an up list to a national exchange and will have piggyback registration rights to register the shares of common stock underlying the conversion of the notes. In October, 2023 the company paid $200,000 of principal and accrued interest and converted the remaining principal of the $350,000 convertible promissory into 513,040 shares of common stock, pursuant to the terms in the agreement.

On March 29, 2022, the Company issued a convertible promissory note with a principal amount of $1,000,000. The note bore an interest at a rate of 15% per annum and matured on March 29, 2024. In 2023, the company agreed to extend the term of the promissory note until March 29, 2025, at the same rate of interest. As consideration for the extension, the Company issued 2,000,000 shares on 17-month warrants exercisable at $0.125 per share. On March 29, 2024, the Company extended the term of the $1,000,000 promissory note until March 29, 2025, at the same rate of interest. In August, 2024, the Company issued 300 000 shares of its common stock valued at $3,000,000 to settle interest on the debt payable in the amount of $300,000.

On May 21, 2025, the Company extended the term of the $1,000,000 promissory note until March 29, 2027. In exchange for the extension and for no interest to accrue over the extended term, the Company issued 2,400,000 shares of common stock valued at $24,000,000, which is recorded as related party stock compensation expense in general and administrative expenses

Related Party interest expense and accrued interest for the six months ended June 30, 2025 were $0 and $0, respectively. Related Party interest expense and accrued interest in connection with these notes for the year ended December 31, 2024 was $117,930 and $0, respectively.

As the Related Party convertible promissory note does not accrue interest, imputed interest was calculated and for the six months ended June 30, 2025 was $116,596. Imputed interest for the year ended December 31, 2024 was $90,740.

**9.** **STOCKHOLDERS' EQUITY** 

*<u>Overview</u>*

The Company is authorized to issue up to 50,000,000 shares of common stock with a par value of $0.001.

The Company is also authorized to issue 2,000,000 and 2,000,000 shares of preferred stock and Series A preferred stock with a par value of $0.001, respectively.

As of June 30, 2025 and December 31, 2024, there were 31,776,036 and 27,942,799 shares of common stock issued and outstanding, respectively.

As of June 30, 2025 and December 31, 2024, there were 400,000 and 400,000 shares of Series A Preferred stock issued and outstanding, respectively.

*<u>Stock Warrants</u>*

 

On April 1, 2024, the company issued 300,000 shares on three month warrants exercisable at $2.50 per share.

On July 1, 2024, warrants were partially exercised into shares 45,000 shares of common stock at $2.50 per share. The remaining 255,000 warrants were forfeited.

On April 4, 2024, the company extended 400,000 share terms on the 1-year warrants issued on October 3, 2023, to December 31, 2024. On December 31, 2024, the warrant terms were further extended to February 15, 2025 at $1.25 per share.

On July 1, 2024, the company issued 50,000 shares on nine month warrants exercisable at $2.50 per share for services rendered.

On July 11, 2024, warrants were partially exercised into shares 20,000 shares of common stock at $1.25 per share. The remaining 60,000 warrants were forfeited.

On August 2, 2024, the company issued 200,000 shares on 5-year warrants exercisable at $10.00 per share as consideration for a note payable of $1,000,000.

On January 21, 2025, the company extended 200, 0000 share terms on the 5-year warrants issued on August 2, 2024 to January 21, 2030.

On January 28, 2025, the company issued 100,000 shares on 5-year warrants exercisable at $10.00 per share as consideration for a note payable of $500,000.

The fair value of each warrant grant is estimated on the date of grant recognizing share-based compensation expense over the vesting period based on the estimated number of equity instruments expected to vest and uses Plain Vanilla for calculating the expected terms of options, using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan:

---

| | | |
|:---|:---|:---|
|  | June 30, 2025 | December 31, 2024 |
| Average risk-free interest rates | 4.33-4.40% | 3.62 – 5.15% |
| Average expected life (in years) | 5.0 | 0.4 - 5.0 |
| Volatility | 76.22-76.25% | 62.9 - 68.2% |

---

<u>The following is a summary of activity of outstanding common stock warrants:</u>

---

| | | |
|:---|:---|:---|
|  | Number of Shares | Weighted Average Exercise Price |
| Balance, December 31, 2023 | 2880000 | $0.469 |
| Warrants expired | (715000) | $1.696 |
| Warrants Converted into stock | (65000) | $2.115 |
| Warrants granted and assumed | 550000 | $5.23 |
| Balance, December 31, 2024 | 2650000 | $1.085 |
| Warrants expired | (2450000) | $0.357 |
| Warrants granted and assumed | 100000 | $10.000 |
| Balance, June 30, 2025 | 300.000 | $10.000 |

---

*<u>Stock Options</u>*

On September 20, 2024, the Company granted options to four members of the board of directors. The options expire ten years following issuance and have an exercise price of $10.00. The options vest quarterly and have a total fair value of $94,728. The Company valued the options using the Black-Scholes model with the following key assumptions: fair value stock price, $10.00, Exercise price, $10.00, Term 10 years, Expected term 5 years, Volatility 87%, and Discount rate 3.48% and a dividend yield of 0%.

On September 20, 2024, the Company granted options to a member of the board of directors. The options expire five years following issuance and have an exercise price of $11.00. The options vest quarterly and have a total fair value of $16,823. The Company valued the options using the Black-Scholes model with the following key assumptions: fair value stock price, $10.00, Exercise price, $11.00, Term 5 years, Expected term 2.5 years, Volatility 68%, and Discount rate 5.31% and a dividend yield of 0%.

The following is a summary of activity of common stock options:

---

| | | |
|:---|:---|:---|
|  | Number of Shares | Weighted Average Exercise Price |
| Balance, December 31, 2023 |  | $- |
| Options expired |  | $- |
| Options granted | 20000 | $10.20 |
| Balance, December 31, 2024 | 20000 | $10.20 |
| Options expired |  | $- |
| Options granted | - | $- |
| Balance, June 30, 2025 | 20000 | $10.20 |

---

*<u>Series A Preferred Stock</u>*

On September 10, 2020, the Board of Directors approved the designation of a class of preferred stock "Series A Preferred Stock" consisting of 2,000,000 shares, par value $0.001.

On September 10, 2020, the Company issued 400,000 shares of Preferred Stock to its CEO as founder shares.

Under the Certificate of Designation, holders of the Series A Preferred Stock are entitled to vote together with the holders of the Company's common stock on all matters submitted to shareholders at a rate of one hundred (100) votes for each share held. The formal designation was filed on September 30, 2022.

As of June 30, 2025 and December 31, 2024, there were 400,000 and 400,000 shares of preferred stock issued and outstanding, respectively.

*<u>Common Stock</u>*

During the year ended December 31, 2024, the Company issued 24,550 shares for cash proceeds of $245,500.

During the year ended December 31, 2024, the Company issued 300,000 shares to settle accrued interest on convertible promissory notes of $300,000.

During the year ended December 31, 2024, stock warrants were exercised, resulting in an increase of 65,000 shares, valued at $137,500.

During the year ended December 31, 2024, the Company issued 1,008,100 shares valued at $10,081,000 for service, which is based on the price the Company raised capital during the year.

During the year ended December 31, 2024, the Company forgave stock payable in the amount of $83,334 which was recorded to APIC.

During the six months ended June 30, 2025, the Company issued 8,650 shares for cash proceeds of $86,500.

During the six months ended June 30, 2025, the Company issued 2,400,000 shares valued at $24,000,000 to a related party to extend the maturity date on convertible promissory notes of $1,000,000.

During the six months ended June 30, 2025, the Company issued 876,700 shares valued at $8,767,000 for service, which is based on the price the Company raised capital during the year.

During the six months ended June 30, 2025, the Company issued 547,887 shares valued at $5,478,872 for conversion of deferred compensation, which is based on the price the Company raised capital during the year.

**10.** **SUBSEQUENT EVENTS** 

On August 8, 2025, the Company effected a 1-for-5 reverse stock split of its common and preferred stock. As a result, every 5 shares of issued and outstanding common and preferred stock were automatically combined into 1 share of common or preferred stock. All share and per-share amounts in the financial statements and accompanying notes have been retroactively adjusted to reflect the reverse stock split.

On July 2, 2025 the Company issued a convertible note in the amount of $25,000 to a related party. The note bears interest at 15%.

On July 22, 2025 the Company issued a convertible note in the amount of $300,000. The note bears interest at 18%. In connection with the note the company will issue warrants convertible to 60,000 shares of common stock.

On July 22, 2025, the Company amended the convertible notes issued on August 2, 2024 and January 28, 2025 to increase the interest rate to 18% per annum and modify the conversion rate to 50% discount of a Qualified Offering Price. Also, modified the exercise price of the warrants issued with these convertible notes to the lower of (i) $5.00 or (ii) 50% discount to the Qualified Offering Price.

On September 2, 2025, the Company amended (with an effective date of May 1, 2025) the convertible notes issued on August 2, 2024 to extend the maturity date to December 31, 2025.

On September 2, 2025, the Company amended the convertible notes issued on January 28, 2025 to extend the maturity date to December 31, 2025.

**Item 4.** **Exhibits**

---

| | | |
|:---|:---|:---|
| ***Exhibit*** |  | ***Description*** |
| 2.1 | \* | [Articles of Incorporation of the Registrant filed with the Nevada Secretary of State on August 27, 2020](https://www.sec.gov/Archives/edgar/data/1834868/000149315223039034/ex2-1.htm) |
| 2.2 | \* | [Certificate of Amendment to Articles of Incorporation of the Registrant filed with the Nevada Secretary of State on July 8, 2021](https://www.sec.gov/Archives/edgar/data/1834868/000149315223039034/ex2-2.htm) |
| 2.3 | \* | [Certificate of Designation of the Registrant filed with the Nevada Secretary of State on July 12, 2021](https://www.sec.gov/Archives/edgar/data/1834868/000149315223039034/ex2-3.htm) |
| 2.4 | \* | [Certificate of Amendment to Articles of Incorporation of the Registrant filed with the Nevada Secretary of State on July 18, 2022](https://www.sec.gov/Archives/edgar/data/1834868/000149315223039034/ex2-4.htm) |
| 2.5 | \* | [Certificate of Amendment to Certificate of Designation of the Registrant filed with the Nevada Secretary of State on September 30, 2022](https://www.sec.gov/Archives/edgar/data/1834868/000149315223039034/ex2-5.htm) |
| 2.6 | \* | [Bylaws of the Registrant](https://www.sec.gov/Archives/edgar/data/1834868/000149315223039034/ex2-6.htm) |
| 2.7 | \* | Certificate of Charter Amendment |
| 2.8 | \* | Certificate of Designation Amendment |
| 3.1 | †\* | [2021 Omnibus Equity Compensation Plan of the Registrant](https://www.sec.gov/Archives/edgar/data/1834868/000149315223039034/ex3-1.htm) |
| 6.1 | †\* | [A&R Executive Employment Agreement between the Registrant and Steven Luna dated August 24, 2021](https://www.sec.gov/Archives/edgar/data/1834868/000149315223039034/ex6-1.htm) |
| 6.2 | †\* | [A&R Executive Employment Agreement between the Registrant and Jason LeBlanc dated August 24, 2021](https://www.sec.gov/Archives/edgar/data/1834868/000149315223039034/ex6-2.htm) |
| 6.3 | †\* | [A&R Executive Employment Agreement between the Registrant and Richard Nagle dated August 24, 2022](https://www.sec.gov/Archives/edgar/data/1834868/000149315223039034/ex6-3.htm) |
| 6.4 | †\* | [A&R Executive Employment Agreement between the Registrant and Vanessa Luna dated August 24, 2022](https://www.sec.gov/Archives/edgar/data/1834868/000149315223039034/ex6-4.htm) |
| 6.5 | \* | [Form of Advisory Agreement](https://www.sec.gov/Archives/edgar/data/1834868/000164117225001778/ex6-9.htm) |
| 6.6 | \* | [Lease Agreement between the Registrant and Premier Workspaces dated May 17, 2023](https://www.sec.gov/Archives/edgar/data/1834868/000164117225001778/ex6-10.htm) |
| 6.7 | \* | [Agreement with Issuance, Inc. dated November 17, 2023](https://www.sec.gov/Archives/edgar/data/1834868/000164117225001778/ex6-11.htm) |
| 6.8 | \* | [Agreement with GrowthTurbine dated January 30, 2024](https://www.sec.gov/Archives/edgar/data/1834868/000164117225001778/ex6-12.htm) |
| 6.9 | \*\* | [2025 Executive Employment Agreement with Steven Luna, dated May 1, 2025](ex6-9.htm) |
| 6.10 | \*\* | [2025 Executive Employment Agreement with Vanessa Luna, dated May 1, 2025](ex6-10.htm) |
| 6.11 | \*\* | [2025 Executive Employment Agreement with Jason LeBlanc, dated May 1, 2025](ex6-11.htm) |
| 6.12 | \*\* | [Addendum To Director Agreement with Bruce Culver, dated June 25, 2025](ex6-12.htm) |
| 6.13 | \*\* | [Addendum To Director Agreement with Bruce Amaro, dated June 25, 2025](ex6-13.htm) |
| 6.14 | \*\* | [Restricted Common Stock Award Agreement with Cuento LLC, dated January 1, 2025](ex6-14.htm) |
| 6.15 | \*\* | [Amended And Restated Warrant Agreement with Solyco CAC LLC, dated January 21, 2025](ex6-15.htm) |
| 6.16 | \*\* | [Third Amendment To Convertible Promissory Note Sky Financial & Intelligence, LLC, dated May 21, 2025](ex6-16.htm) |
| 6.17 | \*\* | [Bridge Loan Offering Documents with Vanessa Luna, dated July 2, 2025](ex6-17.htm) |
| 6.18 | \*\* | [Bridge Loan Offering Documents with Solyco CAC LLC, dated July 22, 2025](ex6-18.htm) |
| 6.19 | \*\* | [Omnibus Amendment No. 1 to Bridge Loan Documents with Solyco CAC LLC, dated July 22, 2025](ex6-19.htm) |
| 6.20 | \*\* | [Omnibus Amendment No. 2 to Bridge Loan Documents with Solyco CAC LLC, dated July 22, 2025](ex6-20.htm) |
| 6.21 | \*\* | [Omnibus Amendment No. 1 to Bridge Loan Documents with Solyco CAC LLC, dated September 2, 2025](ex6-21.htm) |
| 6.22 | \*\* | [Omnibus Amendment No. 2 to Bridge Loan Documents with Solyco CAC LLC, dated September 2, 2025](ex6-22.htm) |

---

† Indicates management contract or compensatory plan <br> \* Previously filed <br> \*\* Filed herewith

**SIGNATURES**

Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| **ALTERNATIVE BALLISTICS CORPORATION** | **ALTERNATIVE BALLISTICS CORPORATION** |
| By: | */s/ Steven Luna* |
|  | Steven Luna |
|  | Chief Executive Officer (Principal Executive Officer) |

---

Pursuant to the requirements of Regulation A, this report has been signed below by the following persons on behalf of the issuer and in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| */s/ Steven Luna* | Chief Executive Officer | September 30, 2025 |
| Steven Luna | (Principal Executive Officer) |  |
| */s/ John Lomoro* | Chief Financial Officer | September 30, 2025 |
| John Lomoro | (Principal Financial Officer and Principal Accounting Officer) |  |
| */s/ Jason LeBlanc* | Chief Operations Officer and Director | September 30, 2025 |
| Jason LeBlanc |  |  |
| */s/ Vanessa Luna* | Executive Vice President and Chairman of the | September 30, 2025 |
| Vanessa Luna | Board |  |
| */s/ Bruce Culver* |  |  |
| Bruce Culver | Director | September 30, 2025 |
| */s/ Bruce Amaro* |  |  |
| Bruce Amaro | Director | September 30, 2025 |

---

## Add

**Exhibit 6.9**

**2025 Executive Employment Agreement**

This EXECUTIVE EMPLOYMENT AGREEMENT (this "**Agreement**") is made as of signing on May 3, 2025 with an effective date of May 1, 2025 (the "**Effective Date**"), by and between Alternative Ballistics Corporation, a Nevada corporation (together with its successors and assigns, the "**Company**"), and Steven Luna ("**Executive**"). This agreement is made new for the calendar year 2025 and supersedes all prior agreements.

**RECITALS**

WHEREAS, the Company and Executive entered into that certain Executive Employment Agreement, dated December 1, 2021 and Company and Executive later amended and restated the Agreement as of August 23, 2024 (the "Prior Agreement"). This new agreement will immediately take effect and supersede the Prior Agreements in its entirety as set forth in this Agreement; and

WHEREAS, the Company desires to employ Executive, and Executive desires to be employed by the Company, as the Company's **Chief Executive Officer**.

NOW, THEREFORE, in consideration of the foregoing recitals, the mutual covenants, and conditions herein, and other good and valuable considerations, the receipt and adequacy of which are hereby acknowledged, the parties hereby agree as follows:

**AGREEMENT**

**1.** **Employment and Term**. The Company hereby agrees to employ Executive, and Executive hereby accepts
 employment by the Company, on the terms and conditions hereinafter set forth. Executive's
 term of employment by the Company under this Agreement (the "**Term**") shall
 commence on the Effective Date and end on December 31, 2025, subject to automatic renewal
 of the Term for additional one-year periods unless either the Company or Executive gives
 the other party written notice of intent not to renew the Term not less than 60 days before
 the date on which the Term otherwise would automatically renew. Notwithstanding the foregoing,
 the Term may be terminated earlier in accordance with Section 5.

**2.** **Position, Duties, and Responsibilities**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Position and Duties**. During the Term, the Company shall employ Executive as **Chief Executive Officer**. Executive shall have, subject to the general direction of the Company's
 Board of Directors (the "**Board** "), such duties, powers, and authority as
 are commensurate with their position as **Chief Executive Officer** and such other duties
 and responsibilities that are commensurate with their positions as reasonably delegated to
 them from time to time by the Board. In this position, Executive shall report directly to
 the Board.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Exclusive Services and Efforts**. Executive agrees to devote their efforts, energies, and skill to
 the discharge of the duties and responsibilities attributable to their position and, except
 as set forth herein, agrees to devote substantially all of their professional time and attention
 to the business and affairs of the Company. Notwithstanding the foregoing, Executive shall
 be entitled to engage in (a) service on the board of directors of two for-profit companies,
 businesses, or trade organizations at any time during the Term; provided that he shall not
 serve on the board of any entity that materially competes with the Company, (b) service on
 the board of directors of not-for-profit organizations, (c) other charitable activities and
 community affairs, and (d) management of their personal and family investments and affairs,
 in each case to the extent such activities do not, either individually or in the aggregate,
 materially interfere with the performance of their duties and responsibilities to the Company.
 Executive may only engage in other employment or business activities not covered by the aforementioned
 with the prior written consent of the Board.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Compliance with Company Policies**. To the extent not inconsistent with the terms and conditions of
 this Agreement and with due regard for their position, Executive shall be subject to the
 Bylaws, policies, practices, procedures, and rules of the Company, including those policies
 and procedures set forth in the Company's Code of Conduct and Ethics, but in no event
 shall anything in such documents be construed to expand the definition of Cause hereunder.

**3.** **Compensation**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Base Salary**. During the first year of the Term, the Company shall pay to the Executive an
 annual salary of $190,000 ()"**Base Salary** "). Thereafter, the Board or Compensation
 Committee of the Board if and when enacted (the "**Committee**") shall consider
 increases in Base Salary for subsequent years in connection with performance and a review
 of compensation provided at peer companies, which companies shall be subject to review on
 a continuing basis (the "**Peer Group** "), taking into account Company and
 individual performance objectives. Executive shall have the option to defer Executive's
 Base Salary, subject to applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Annual Cash Bonus**. The Board or Committee shall award Executive's annual cash bonus based
 on an evaluation of performance and Peer Group compensation practices, taking into account
 Company and individual performance objectives. Notwithstanding the foregoing, the Board or
 Committee may grant a special bonus at any time. Annual cash bonuses shall be deemed "earned"
 if Executive is employed on the last day of the year to which the bonus relates and shall
 be paid no later than March 15 of the year immediately following the year to which the annual
 bonus relates. For each complete fiscal year of the Company (each such fiscal year, a "Bonus
 Year") during the Employment Period, Executive shall be eligible for discretionary
 bonus compensation with a target amount equal to eighty percent (80%) of Executive's
 Base Salary (The **"Annual Bonus")** 

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Incentive Plan Participation**. During the Term, Executive shall be eligible to participate in Company
 equity incentive plans according to the recommendation of the Committee, if any, and approval
 of the Board.

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Stock Award**. The Company shall pay to the Executive a restricted stock award of $750,000 worth
 of shares of common stock pursuant to the Company's then existing equity incentive
 plan (the "Stock Award"). Thereafter, the Board or Committee shall consider stock
 awards for subsequent years. The Stock Award shall begin on May 1, 2025 and be granted on
 the last day of each quarter ending thereafter. The number of shares of the Company's
 common stock awarded will be calculated at the then current "Fair Market Value,"
 which shall be determined by the Board or, if the shares are traded or quoted in an exchange
 or an over the counter marketplace, by the average of the last sale price of the shares for
 the ten trading days preceding the end of the quarter. The Stock Award shall vest in four
 equal installments, the first installment vesting on the last day of each quarter ending
 and each subsequent installment shall vest every quarter thereafter.

**4.** **Employee Benefits and Perquisites**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Benefits**.
 Executive shall be entitled to participate in such health, group insurance, welfare, pension,
 and other employee benefit plans, programs, and arrangements as are made generally available
 from time to time to senior executives of the Company (which shall include customary health,
 life insurance, and disability plans). Executive shall also have the option to receive a
 medical stipend of up to $3,500 per month. Executive may elect to forego stipend if he/she
 and their family are covered elsewhere.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Fringe Benefits, Perquisites, and Paid Time Off**. During the Term, Executive shall be entitled
 to participate in all fringe benefits and perquisites made available to other senior executives
 of the Company, such participation to be at levels, and on terms and conditions, that are
 commensurate with their position and responsibilities at the Company and that are no less
 favorable than those applicable to other senior executives of the Company. In addition, Executive
 is entitled to unlimited paid time off ()"**PTO**") as needed, subject to prior
 approval by Executive Vice President, so long as doing so is consistent and in balance with
 their job responsibilities and business needs.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Reimbursement of Expenses**. The Company shall reimburse Executive for all reasonable business and travel
 expenses incurred in the performance of their job duties and the promotion of the Company's
 business, promptly upon presentation of appropriate supporting documentation and otherwise
 in accordance with the expense reimbursement policy of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Attorneys' Fees**. The Company shall reimburse Executive, promptly upon presentation of appropriate
 supporting documentation, for all reasonable attorneys' fees incurred by Executive
 in connection with the negotiation and execution of this Agreement, but in no event shall
 such reimbursement exceed $1,000.

**5.** **Termination; Change in Control**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **General**.
 The Company may terminate Executive's employment for Cause. Executive may terminate
 their employment at any time for any reason, but shall be entitled to various compensation
 terms if such employment is not terminated for Good Reason. The Company may terminate Executive's
 employment without Cause, or Executive may terminate Executive's employment with Good
 Reason, in each case, upon providing the other party at least 30 days' written notice
 thereof. Upon termination of Executive's employment, Executive shall be entitled to
 the compensation and benefits described in this Section 5 to the extent applicable and shall
 have no further rights to any compensation or benefits from the Company. For purposes of
 this Agreement, the following terms have the following meanings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) "**Accrued Benefits**" shall mean: (i) accrued but unpaid Base Salary through the Termination
 Date, payable within 30 days following the Termination Date; (ii) any annual cash bonus earned
 but unpaid with respect to the year preceding the year in which the Termination Date occurs,
 payable in accordance with Section 3(a) above; (iii) any long-term incentive award earned
 pursuant to Section 3(c) above but unpaid with respect to performance periods that ended
 in the year preceding the year in which Termination Date occurs; (iv) reimbursement for any
 unreimbursed business expenses incurred through the Termination Date (including any related
 tax gross-up payments), payable within 30 days following the Termination Date; and (v) all
 other payments, benefits, or fringe benefits to which Executive shall be entitled as of the
 Termination Date under the terms of any applicable compensation arrangement or benefit, equity,
 or fringe benefit plan or program or grant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) "**Cause** "
 shall mean: (i) Executive's refusal to perform, or repeated failure to undertake good
 faith efforts to perform, the duties or responsibilities reasonably assigned to Executive
 by the Board, which, if curable, is not cured within 30 days after Executive's written
 receipt of notice thereof from the Company; (ii) Executive's engagement in willful
 gross misconduct or willful gross negligence in and the course of carrying out their duties
 that results in material economic or reputational harm to the Company; (iii) Executive's
 conviction of or plea of guilty or nolo contendere to a felony; or (iv) a material breach
 by Executive of Section 2(b) of this Agreement, which, if curable, is not cured within 30
 days after Executive's receipt of written notice thereof from the Company. Termination
 of Executive's employment shall not be deemed to be for Cause unless Executive has
 had a reasonable opportunity, together with counsel, to respond to all relevant allegations
 upon which a contemplated termination for Cause is based.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) "**Good Reason**" shall mean any of the following that has not been approved in writing and
 shall mean any of the following circumstances that, if curable, has not been cured by the
 Company within 30 days of the Company's receipt of notice thereof from Executive, which
 notice was provided within 90 days of the date on which the circumstance or event constituting
 Good Reason first came into existence: (i) a material reduction in Executive's Base
 Salary; (ii) a material diminution of Executive's titles, duties, responsibilities,
 or authorities as set forth in this Agreement or Executive being required to report to another
 person other than the Board; (iii) a material diminution in the budget over which Executive
 retains authority; (iv) a material change in the location of the Company's offices;
 or (v) a material breach by the Company of this Agreement. Executive's resignation
 will not be treated as being for Good Reason unless Executive's employment terminates
 after the end of the cure period (if curable) and no later than six months after the occurrence
 of the event(s) giving rise to the termination for Good Reason.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) "**Change in Control**" shall mean a liquidation, merger, acquisition, sale of voting control,
 or sale of substantially all of the assets of the Company in which the shareholders of the
 Company immediately prior to the event or transaction do not own a majority of the outstanding
 shares of the surviving corporation after the event or transaction, or series of transactions
 which, in the aggregate would result in the same.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) "**Change-in-Control Severance Payments**" shall mean (i) a pro-rated annual cash bonus for the year in
 which the Termination Date occurs (calculated based on the annual target cash bonus opportunity
 for the year of termination), payable when bonuses are paid to other executives of the Company
 in the year following the year of the Termination Date; (ii) a lump sum cash payment, payable
 on the Termination Date, equal to three times the sum of the following: (x) one year's
 Base Salary at the annualized rate then in effect (or the rate that should be in effect but
 for any Base Salary diminution), (y) the greater of the annual target cash bonus opportunity
 for the year of termination or the highest actual annual cash bonus paid during the three
 preceding completed years, and (z) any target long-term incentive award granted pursuant
 to Section 3(c) above for the year of the Termination Date; (iii) Medical Payment Amounts
 (as defined below) payable each month, commencing on the first day of the month following
 the Termination Date and continuing until the earlier of 12 months following the Termination
 Date or the date on which Executive becomes employed by a third party and becomes eligible
 to participate in such third party's group health plan; and (iv) to the extent permissible
 under applicable law and under any insurance policy insuring the Company's health plan
 (if any), access to continued coverage under the Company's health plan with the full
 cost payable by Executive for a period of up to 12 months commencing on the first day of
 the month following the Termination Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) "**Disability** "
 shall mean that Executive has been unable, with or without reasonable accommodation and due
 to physical or mental incapacity, to substantially perform their duties and responsibilities
 hereunder for at least six months.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) "**Medical Payment Amounts**" shall mean an amount, payable on a monthly basis commencing on
 the first day of the month following the Termination Date, equal to (i) the monthly amount
 of the Consolidated Omnibus Budget Reconciliation Act continuation coverage premium for such
 month under the Company's group medical plans for executives of the Company less the
 monthly amount of Executive's portion of the premium for such month as if Executive
 was still an active employee, plus (ii) a tax gross-up payment so Executive shall have no
 after-tax consequences with respect to the monthly amount described in clause (i) or the
 related tax gross-up.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) "**Severance Payments**" shall mean (i) a lump sum cash payment, payable on the Termination Date,
 equal to three times the sum of the following: (x) one year's Base Salary at the annualized
 rate then in effect (or the rate that should be in effect but for any Base Salary diminution),
 (y) the greater of (I) the annual target cash bonus opportunity for the year of termination
 or (II) the average annual cash bonus for the three preceding completed years (provided,
 however, that if Executive has not been employed for at least three years in which an annual
 cash bonus was paid, such calculation will assume that an annual cash bonus equal to the
 target annual cash bonus opportunity was paid in the missing years), and (z) any target long-term
 incentive award granted pursuant to Section 3(c) above for the year of the Termination Date;
 (ii) Medical Payment Amounts, payable each month, commencing on the first day of the month
 following the Termination Date and continuing until the earlier of 12 months following the
 Termination Date or the date on which Executive becomes employed by a third party and becomes
 eligible to participate in such third party's group health plan; and (iii) to the extent
 permissible under applicable law and under any insurance policy insuring the Company's
 health plan (if any), access to continued coverage under the Company's health plan
 with the full cost payable by Executive for a period of up to 12 months commencing on the
 first day of the month following the Termination Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) "**Termination Date**" shall mean the date on which Executive's employment hereunder terminates
 in accordance with this Agreement (which, in the case of a notice of non-renewal of the Term
 in accordance with Section 1 hereof, shall mean the date on which the Term expires).

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Termination for Cause or Termination by Executive Without Good Reason**. In the event that Executive's
 employment hereunder is terminated by the Company for Cause or by Executive without Good
 Reason, which shall include a non-renewal of the Term by Executive, Executive shall be entitled
 to receive the Accrued Benefits.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Termination Without Cause or Termination by Executive for Good Reason**. In the event that Executive's
 employment hereunder is terminated by the Company without Cause or by Executive for Good
 Reason, Executive shall be entitled to receive the Accrued Benefits and the Severance Payments,
 except as otherwise provided pursuant to Section 5(d).

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Termination Without Cause or Termination by Executive for Good Reason Due to a Change in Control**.
 In the event that Executive's employment hereunder is terminated by the Company without
 Cause or by Executive for Good Reason within two years following or six months prior to a
 Change in Control, Executive shall receive the benefits described in Section 5(c), except
 that Executive shall receive the Change-in-Control Severance Payments in lieu of the Severance
 Payments.

&nbsp;&nbsp;&nbsp;&nbsp;**(e)** **Termination Due to Death or Disability**. In the event that Executive's employment hereunder
 is terminated due to Executive's death or Disability, Executive shall receive the Accrued
 Benefits and one year of the Medical Payment Amounts for Executive in the event of disability
 or Executive's family in the event of Executive's death.

&nbsp;&nbsp;&nbsp;&nbsp;**(f)** **Return of Company Property**. Upon termination of Executive's employment for any reason
 or under any circumstances, Executive shall promptly return any and all of the property of
 the Company and any Affiliates (as defined below) (including, without limitation, all log-in
 and password information for all databases and programs in Executive's possession,
 computers, keys, credit cards, identification tags, documents, data, confidential information,
 work product, and other proprietary materials), and other materials.

&nbsp;&nbsp;&nbsp;&nbsp;**(g)** **Post-Termination Reasonable Cooperation**. Executive agrees and covenants that, following the Term, he/she
 shall, to the extent reasonably requested by the Company, cooperate in good faith with the
 Company to assist the Company in the pursuit or defense of (except if Executive is adverse
 with respect to) any claim, administrative charge, or cause of action by or against the Company
 as to which Executive, by virtue of their employment with the Company or any other position
 that Executive holds that is affiliated with or was held at the request of the Company or
 its Affiliates, has relevant knowledge or information, including by acting as the Company's
 representative in any such proceeding and, without the necessity of a subpoena, providing
 truthful testimony in any jurisdiction or forum. The Company shall reimburse Executive for
 their reasonable out-of-pocket expenses incurred in compliance with this Section 5(g), including
 any reasonable travel expenses and reasonable attorneys' fees incurred by Executive
 and, in the event that Executive is required to spend substantial time on such matters, the
 Company shall compensate Executive at an hourly rate of $250 per hour. The Company shall
 use reasonable business efforts to provide Executive with reasonable advance written notice
 of its need for Executive's reasonable cooperation and shall attempt to coordinate
 with Executive the time and place at which Executive's reasonable cooperation shall
 be provided with the goal of minimizing the impact of such reasonable cooperation on any
 other material pre-scheduled business commitment that Executive may have. Executive's
 cooperation described in this Section 5(g) shall be subject to the indemnification provision
 and obtaining the D&O insurance policy provided under Sections 6(a) and 6(b) hereof,
 respectively.

**6.** **Indemnification; D&O Insurance**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Indemnification**.
 If Executive is made a party, is threatened to be made a party, or reasonably anticipates
 being made a party, to any Proceeding (as hereinafter defined) by reason of the fact that
 Executive is or was a director, officer, shareholder, employee, agent, trustee, consultant,
 or representative of the Company or any of its Affiliates or is or was serving at the request
 of the Company or any of its Affiliates, or in connection with their service hereunder as
 a director, officer, shareholder, employee, agent, trustee, consultant, or representative
 of another Person, or if any Claim (as hereinafter defined) is made, is threatened to be
 made, or is reasonably anticipated to be made, that arises out of or relates to Executive's
 service in any of the foregoing capacities, then Executive shall promptly be indemnified
 and held harmless to the fullest extent permitted or authorized by any Company arrangement,
 or if greater, by applicable law, against any and all costs, expenses, liabilities, and losses
 (including, without limitation, advancement and payment of attorneys' and other professional
 fees and charges, judgments, interest, expenses of investigation, penalties, fines, ERISA
 excise taxes or penalties, and amounts paid or to be paid in settlement, with such legal
 fees advanced to the maximum extent permitted by law) incurred or suffered by Executive in
 connection therewith or in connection with seeking to enforce their rights under this Section
 6(a), and such indemnification shall continue even if Executive has ceased to be a director,
 officer, shareholder, employee, agent, trustee, consultant, or representative of the Company
 or other Person and shall inure to the benefit of their heirs, executors, and administrators.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **D&O Insurance**. At such time as the Company is financially able to do so and at the sole and
 absolute discretion of the Board, the Company shall obtain a directors' and officers'
 liability insurance policy (or policies) providing coverage to Executive that is no less
 favorable in any respect than the coverage then being provided to any other current or former
 director or officer of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Definitions**.
 For purposes of this Agreement, the following terms shall have the following meanings: "**Affiliate** "
 of a Person shall mean any Person that directly or indirectly controls, is controlled by,
 or is under common control with, such Person; "**Claim**" shall mean any claim,
 demand, request, investigation, dispute, controversy, threat, discovery request, or request
 for testimony or information; "**Person**" shall mean any individual, corporation,
 partnership, limited liability company, joint venture, trust, estate, board, committee, agency,
 body, employee benefit plan, or other person or entity; and "**Proceeding** "
 shall mean any threatened or actual action, suit, or proceeding, whether civil, criminal,
 administrative, investigative, appellate, formal, informal, or other.

**7.** **Tax Matters**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Withholding**.
 The Company shall withhold all applicable federal, state, and local taxes, social security,
 and workers' compensation contributions and other amounts as may be required by law
 with respect to compensation payable to Executive pursuant to this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Section 409A**. Notwithstanding anything herein to the contrary, this Agreement is intended to
 be interpreted and applied so that the payment of the benefits set forth herein shall either
 be exempt from, or in the alternative, comply with, the requirements of Section 409A of the
 Internal Revenue Code of 1986, as amended (the "**Code** "), and the published
 guidance thereunder ()"**Section 409A** "). A termination of employment shall
 not be deemed to have occurred for purposes of any provision of this Agreement providing
 for the payment of any amounts or benefits upon or following a termination of employment
 that are considered "nonqualified deferred compensation" under Section 409A unless
 such termination is also a "separation from service" within the meaning of Section
 409A and, for purposes of any such provision of this Agreement, references to a "termination,"
 "Termination Date" or like terms shall mean "separation from service."
 Notwithstanding any provision of this Agreement to the contrary, if Executive is a "specified
 employee" within the meaning of Section 409A on the date of their "separation
 from service," any payments or arrangements due upon a termination of Executive's
 employment under any arrangement that constitutes a "nonqualified deferral of compensation"
 within the meaning of Section 409A and which do not otherwise qualify under the exemptions
 under Treas. Regs. Section 1.409A-1 (including without limitation, the short-term deferral
 exemption or the permitted payments under Treas. Regs. Section 1.409A-1(b)(9)(iii)(A)), shall
 be delayed and paid or provided on the earlier of (a) the date which is six months after
 Executive's "separation from service" for any reason other than death,
 or (b) the date of Executive's death. All tax gross-up payments provided under this
 Agreement or any other agreement with Executive shall be made or provided by the end of Executive's
 taxable year next following Executive's taxable year in which Executive remits the
 related taxes, in accordance with the requirements of Section 409A.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Section 409A Gross-Up**. The Company acknowledges and agrees that if any payment, award, benefit,
 or distribution (or any acceleration of any payment, award, benefit, or distribution) made
 or provided to Executive or for Executive's benefit in connection with this Agreement,
 or Executive's employment with the Company or the termination thereof (the "**Payments** ")
 is determined to be subject to the additional taxes, interest, or penalties imposed by Section
 409A, or any interest or penalties with respect to such additional taxes, interest, or penalties
 (such additional taxes, together with any such interest and penalties, are referred to collectively
 as the "**Section 409A Tax** "), then Executive will be entitled to receive
 an additional payment (a "**409A Gross-Up Payment**") from the Company such
 that the net amount Executive retains after paying any applicable Section 409A Tax and any
 federal, state, or local income or FICA taxes on such 409A Gross-Up Payment, shall be equal
 to the amount Executive would have received if the Section 409A Tax were not applicable to
 the Payments. Unless otherwise agreed in writing by Executive and the Company, all determinations
 of the Section 409A Tax and 409A Gross-Up Payment, if any, will be made by an independent
 accounting firm designated by the Company, and such accounting firm shall be instructed to
 provide the Company and Executive with a written opinion of any determination such accounting
 firm has been requested to provide. The Company shall be responsible for such accounting
 firm's fees. For purposes of determining the amount of the 409A Gross-Up Payment, if
 any, Executive will be deemed to pay federal income tax at the actual marginal rate of federal
 income taxation in the calendar year in which the total Payments are made and state and local
 income taxes at the actual marginal rate of taxation in the state and locality of Executive's
 residence on the date the total Payments are made, net of the maximum reduction in federal
 income taxes that could be obtained from deduction of such state and local taxes. If the
 Section 409A Tax is determined by the Internal Revenue Service, on audit or otherwise, to
 exceed the amount taken into account hereunder in calculating the 409A Gross-Up Payment (including
 by reason of any payment the existence or amount of which cannot be determined at the time
 of the 409A Gross-Up Payment), the Company shall make another 409A Gross-Up Payment in respect
 of such excess (plus any interest, penalties, or additions payable by Executive with respect
 to such excess). The Company and Executive shall each reasonably cooperate with the other
 in connection with any administrative or judicial proceedings concerning the existence or
 amount of liability for Section 409A Tax with respect to the total Payments. The 409A Gross-Up
 Payments provided to Executive shall be made no later than the tenth business day following
 the last date the Payments are made but in all events within the time period specified in
 Section 7(b).

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Separation from Service**. After any Termination Date, Executive shall have no duties or responsibilities
 that are inconsistent with having a "separation from service" within the meaning
 of Section 409A as of the Termination Date and, notwithstanding anything in the Agreement
 to the contrary, distributions upon termination of employment of nonqualified deferred compensation
 may only be made upon a "separation from service" as determined under Section
 409A and such date shall be the Termination Date for purposes of this Agreement. Each payment
 under this Agreement or otherwise shall be treated as a separate payment for purposes of
 Section 409A. In no event may Executive, directly or indirectly, designate the calendar year
 of any payment to be made under this Agreement which constitutes a "nonqualified deferral
 of compensation" within the meaning of Section 409A and to the extent an amount is
 payable within a time period, the time during which such amount is paid shall be in the discretion
 of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;**(e)** **Reimbursements**.
 All reimbursements and in-kind benefits provided under this Agreement shall be made or provided
 in accordance with the requirements of Section 409A. To the extent that any reimbursements
 are taxable to Executive, such reimbursements shall be paid to Executive on or before the
 last day of Executive's taxable year following the taxable year in which the related
 expense was incurred. Reimbursements shall not be subject to liquidation or exchange for
 another benefit and the amount of such reimbursements that Executive receives in one taxable
 year shall not affect the amount of such reimbursements that Executive receives in any other
 taxable year.

&nbsp;&nbsp;&nbsp;&nbsp;**(f)** **Parachute Payments; Gross-Up**. Anything in this Agreement to the contrary notwithstanding, in the
 event that Executive shall become entitled to payments and/or benefits provided by this Agreement
 or any other amounts in the "nature of compensation" (whether pursuant to the
 terms of this Agreement or any other plan, arrangement, or agreement with the Company, or
 any arrangement or agreement with any person whose actions result in a change of ownership
 or effective control or a change in the ownership of a substantial portion of the assets
 of the Company covered by Code Section 280G(b)(2) (a "**280G Change in Control** "),
 or any person affiliated with the Company or such person) as a result of a 280G Change in
 Control (collectively the "**Company Payments** "), and such Company Payments
 will be subject to the tax (the "**Excise Tax**") imposed by Code Section
 4999, the Company shall pay to Executive at the time specified below (i) an additional amount
 (the "**Gross-Up Payment**") such that the net amount retained by Executive,
 after deduction of any Excise Tax on the Company Payments and any U.S. federal, state, and
 for local income or payroll tax upon the Gross-Up Payment provided for by this paragraph,
 but before deduction for any U.S. federal, state, and local income or payroll tax on the
 Company Payments, shall be equal to the Company Payments and (ii) an amount equal to the
 product of any deductions disallowed for federal, state, or local income tax purposes because
 of the inclusion of the Gross-Up Payment in Executive's adjusted gross income multiplied
 by Executive's actual marginal rate of federal, state, or local income taxation, respectively,
 for the calendar year in which the Gross-Up Payment is to be made.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Unless
 otherwise agreed in writing by Executive and the Company, all determinations of the Company
 Payments and the Gross-Up Payments, if any, will be made by an independent accounting firm
 designated by the Company with Executive's approval (the "**Accountant** "),
 and the Accountant shall be instructed to provide the Company and Executive with a written
 opinion of any determination the Accountant has been requested to provide.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) For
 purposes of determining the amount of the Gross-Up Payment, Executive's actual U.S.
 federal income tax rate in the calendar year in which the Gross-Up Payment is to be made
 and state and local income taxes at Executive's actual rate of taxation in the state
 and locality of Executive's residence for the calendar year in which the Company Payment
 is to be made, net of the maximum reduction in U.S. federal income taxes which could be obtained
 from deduction of such state and local taxes if paid in such year, shall be used.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) In
 the event that the Excise Tax is later determined by the Accountant or the Internal Revenue
 Service to exceed the amount taken into account hereunder at the time the Gross-Up Payment
 is made (including by reason of any payment the existence or amount of which cannot be determined
 at the time of the Gross-Up Payment), the Company shall make an additional Gross-Up Payment
 in respect of such excess (plus any interest or penalties payable with respect to such excess)
 at the time that the amount of such excess is finally determined.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) The
 Gross-Up Payment or portion thereof provided for above shall be paid not later than the 60th
 day following a 280G Change in Control which subjects Executive to the Excise Tax; provided,
 however, that if the amount of such Gross-Up Payment or portion thereof cannot be finally
 determined on or before such day, the Company shall pay to Executive on such day an estimate,
 as determined in good faith by the Accountant, of the minimum amount of such payments and
 shall pay the remainder of such payments, as soon as the amount thereof can reasonably be
 determined, but in no event later than the ninetieth day after the occurrence of the event
 subjecting Executive to the Excise Tax. Notwithstanding any other provision of this Agreement,
 all Gross-Up Payments under this Section 7(f)(iv) shall be paid pursuant to Section 7(b)
 of the Agreement. In the event that the amount of the estimated payments exceeds the amount
 subsequently determined to have been due, such excess shall constitute a loan by the Company
 to Executive, payable on the fifth day after demand by the Company (together with interest
 at the rate provided in Code Section 1274(b)(2)(B)).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) The
 Company shall be responsible for all charges of the Accountant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) The
 Company and Executive shall promptly deliver to each other copies of any written communications,
 and summaries of any verbal communications, with any taxing authority regarding the Excise
 Tax covered by this provision.

**8.** **Notices**.
 Any notice, request, instruction, or other document required by the terms of this Agreement,
 or deemed by any of the parties hereto to be desirable, to be given to any other party hereto
 shall be in writing and shall be given by personal delivery, overnight delivery, mailed by
 registered or certified mail, postage prepaid, with return receipt requested, or sent by
 electronic mail (with receipt confirmed) to the addresses of the parties as follows:

---

| | | | |
|:---|:---|:---|:---|
| i. | To: | "Executive" | 5224 Willowhaven Ave |
|  |  |  | Las Vegas NV 89120 |
|  |  |  | Email: steveluna07@gmail.com |
| ii. | To: | "Company" | 5940 South Rainbow Blvd., |
|  |  |  | Las Vegas, NV 89118 |
|  |  |  | Attn: Steven Luna, CEO |
|  |  |  | Email: steve@alternativeballistics.com |

---

The persons and addresses set forth above may be changed from time to time by a notice sent as aforesaid. If notice is given by personal delivery or overnight delivery in accordance with the provisions of this Section, such notice shall be conclusively deemed given at the time of such delivery provided a receipt is obtained from the recipient. If notice is given by mail in accordance with the provisions of this Section, such notice shall be conclusively deemed given upon receipt and delivery or refusal. If notice is given by electronic mail transmission in accordance with the provisions of this Section, such notice shall be conclusively deemed given at the time of delivery if between the hours of 9:00 a.m. and 5:00 p.m. Pacific time on a business day ("business hours") and if not during business hours, at 9:00 a.m. on the next business day following delivery, provided a delivery confirmation is obtained by the sender.

**9.** **Governing Law**. This Agreement shall be governed by and construed and interpreted in accordance
 with the laws of Nevada without giving effect to any choice of law rules or other conflicting
 provision or rule that would cause the laws of any jurisdiction to be applied.

**10.** **Resolution of Disputes through Arbitration; Opt-Out Option**. Executive can opt out of this arbitration
 provision by striking out the provisions below and by placing their initials on this page.
 However, provided Executive does not choose to opt out, the below arbitration provisions
 will apply:

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** Any
 controversy arising out of or relating to Executive's employment (whether or not before
 or after employment), any termination of Executive's employment, this Agreement or
 the enforcement or interpretation of this Agreement, or because of an alleged breach, default,
 or misrepresentation in connection with any of the provisions of this Agreement, including
 (without limitation) any state or federal statutory claims, shall be submitted to arbitration
 in Clark County, Nevada, before a sole arbitrator (the "**Arbitrator**") selected
 from Judicial Arbitration Mediation Services ()"**JAMS** "), or if JAMS is not
 able to supply the arbitrator, such arbitrator shall be selected from the American Arbitration
 Association ()"**AAA** "), and shall be conducted in accordance with the provisions
 of Nevada Code of Civil Procedure as the exclusive remedy of such dispute; provided, however,
 that provisional injunctive relief may, but need not, be sought in a court of law while arbitration
 proceedings are pending, and any provisional injunctive relief granted by such court shall
 remain effective until the matter is finally determined by the Arbitrator.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** Final
 resolution of any dispute through arbitration may include any remedy or relief that would
 be available in a court of law, including any and all remedies provided by applicable state
 or federal statutes. At the conclusion of the arbitration, the Arbitrator shall issue a written
 decision that sets forth the essential findings and conclusions upon which the Arbitrator's
 award or decision is based. Any award or relief granted by the Arbitrator hereunder shall
 be final and binding on the parties hereto and may be enforced by any court of competent
 jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** By
 agreeing to arbitration, the parties agree that there will be no limitations on discovery.
 The parties shall be entitled to conduct discovery as they would be in court, as set forth
 in the Nevada Code of Civil Procedure.

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** The
 parties acknowledge and agree that they are voluntarily waiving any rights to trial by jury
 in any action, proceeding or counterclaim brought by either of the parties against the other
 in connection with any matter whatsoever arising out of or in any way connected with any
 of the matters referenced in the first sentence of Section 10(a).

&nbsp;&nbsp;&nbsp;&nbsp;**(e)** The
 parties agree that the Company shall be responsible for payment of the forum costs of any
 arbitration hereunder, including the Arbitrator's fee. The parties further agree that
 in any proceeding with respect to such matters, the prevailing party will be entitled to
 recover their reasonable attorney's fees and costs from the non-prevailing party (other
 than forum costs associated with the arbitration which in any event shall be paid by the
 Company).

**11.** **Arbitration Opt-Out Forum; Attorneys' Fees and Costs**. In the event Executive elects to opt
 out of the arbitration provision in Section 10 above, the parties each submit to the exclusive
 jurisdiction of the federal courts (or state courts if federal jurisdiction is lacking) located
 within Clark County, Nevada. In the event of a lawsuit or other legal proceeding arising
 out of or related to this Agreement in which Executive prevails (as determined by the deciding
 court), the Company shall reimburse Executive for their reasonable attorneys' fees
 and costs incurred in connection with such lawsuit or legal proceeding, in addition to any
 other relief to which Executive may be entitled.

**12.** **Amendments; Waivers**. This Agreement may not be modified or amended or terminated except by an instrument
 in writing, signed by Executive and a duly authorized officer of the Company (other than
 Executive). By an instrument in writing similarly executed (and not by any other means),
 either party may waive compliance by the other party with any provision of this Agreement
 that such other party was or is obligated to comply with or perform; provided, however, that
 such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent
 failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder
 shall operate as a waiver thereof, nor shall any single or partial exercise of any right,
 remedy, or power hereunder preclude any other or further exercise thereof or the exercise
 of any other right, remedy, or power provided herein or by law or in equity. To be effective,
 any written waiver must specifically refer to the condition(s) or provision(s) of this Agreement
 being waived.

**13.** **Inconsistencies**.
 In the event of any inconsistency between any provision of this Agreement and any provision
 of any Company arrangement, the provisions of this Agreement shall control, unless Executive
 and the Company otherwise agree in a writing that expressly refers to the provision of this
 Agreement that is being waived.

**14.** **Assignment**.
 Except as otherwise specifically provided herein, neither party shall assign or transfer
 this Agreement nor any rights hereunder without the consent of the other party, and any attempted
 or purported assignment without such consent shall be void; provided, however, that any assignment
 or transfer pursuant to a merger or consolidation, or the sale or liquidation of all or substantially
 all of the business and assets of the Company shall be valid, so long as the assignee or
 transferee (a) is the successor to all or substantially all of the business and assets of
 the Company, and (b) assumes the liabilities, obligations and duties of the Company, as contained
 in this Agreement, either contractually or as a matter of law. Executive's consent
 shall be required for any such transaction. This Agreement shall otherwise bind and inure
 to the benefit of the parties hereto and their respective successors, penalties, assigns,
 heirs, legatees, devisees, executors, administrators, and legal representatives.

**15.** **Voluntary Execution; Representations**. Executive acknowledges that (a) he has consulted with or
 has had the opportunity to consult with independent counsel of their own choosing concerning
 this Agreement and has been advised to do so by the Company, and (b) he has read and understands
 this Agreement, is competent and of sound mind to execute this Agreement, is fully aware
 of the legal effect of this Agreement, and has entered into it freely based on their own
 judgment and without duress. The Company represents and warrants that it is fully authorized,
 by any person or body whose authorization is required, to enter into this Agreement and to
 perform its obligations hereunder.

**16.** **Headings**.
 The headings of the Sections and subsections contained in this Agreement are for convenience
 only and shall not be deemed to control or affect the meaning or construction of any provision
 of this Agreement.

**17.** **Construction**.
 The language used in this Agreement shall be deemed to be the language chosen by the parties
 to express their mutual intent, and no rule of strict construction shall be applied against
 any party.

**18.** **Beneficiaries/References**.
 Executive shall be entitled, to the extent permitted under applicable law, to select and
 change a beneficiary or beneficiaries to receive any compensation or benefit hereunder following
 Executive's death by giving written notice thereof. In the event of Executive's
 death or a judicial determination of their incompetence, references in this Agreement to
 Executive shall be deemed, where appropriate, to refer to their beneficiary, estate, or other
 legal representative.

**19.** **Survivorship**.
 Except as otherwise set forth in this Agreement, the respective rights and obligations of
 the parties shall survive any termination of Executive's employment.

**20.** **Severability**.
 It is the desire and intent of the parties hereto that the provisions of this Agreement be
 enforced to the fullest extent permissible under the laws and public policies applied in
 each jurisdiction in which enforcement is sought. Accordingly, if any particular provision
 of this Agreement shall be adjudicated by a court of competent jurisdiction or arbitrator
 to be invalid, prohibited, or unenforceable for any reason, such provision, as to such jurisdiction,
 shall be ineffective, without invalidating the remaining provisions of this Agreement or
 affecting the validity or enforceability of such provision in any other jurisdiction. Notwithstanding
 the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited,
 or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly
 drawn, without invalidating the remaining provisions of this Agreement or affecting the validity
 or enforceability of such provision in any other jurisdiction.

**21.** **No Mitigation/No Offset**. Executive shall be under no obligation to seek other employment
 or to otherwise mitigate the obligations of the Company under this Agreement, and there shall
 be no offset against amounts or benefits due to Executive under this Agreement or otherwise
 on account of any claim (other than any preexisting debts then due in accordance with their
 terms) the Company may have against their or any remuneration or other benefit earned or
 received by Executive after such termination.

**22.** **Counterparts**.
 This Agreement may be executed in any number of counterparts, each of which shall be deemed
 an original, but all such counterparts shall together constitute one and the same instrument.
 Signatures delivered by facsimile or PDF shall be effective for all purposes.

**23.** **Entire Agreement**. This Agreement contains the entire agreement of the parties and supersedes
 all prior or contemporaneous negotiations, correspondence, understandings, and agreements
 between the parties, regarding the subject matter of this Agreement.

**24.** **Definition of "days."** When used herein, the term "days" refers to calendar
 days unless otherwise specified.

**[SIGNATURE PAGE TO FOLLOW]**

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the Effective Date.

**COMPANY**

Alternative Ballistics Corporation,

a Nevada corporation

---

| | |
|:---|:---|
| By: | */s/ Vanessa Luna* |
| Name: | Vanessa Luna |
| Title: | Chairperson of the Board of Directors |

---

**EXECUTIVE**

---

| | |
|:---|:---|
| By: | */s/ Steven Luna* |
| Name: | Steven Luna |

---

Effective Date: Beginning on May 1, 2025

## Add

**Exhibit 6.10**

**2025 Executive Employment Agreement**

This EXECUTIVE EMPLOYMENT AGREEMENT (this "**Agreement**") is made as of signing on May 3, 2025 with an effective date of May 1, 2025 (the "**Effective Date**"), by and between Alternative Ballistics Corporation, a Nevada corporation (together with its successors and assigns, the "**Company**"), and Vanessa Luna ("**Executive**"). This agreement is made new for the calendar year 2025 and supersedes all prior agreements.

**RECITALS**

WHEREAS, the Company and Executive entered into that certain Executive Employment Agreement, dated December 1, 2021 and Company and Executive later amended and restated the Agreement as of August 23, 2024 (the "Prior Agreement"). This new agreement will immediately take effect and supersede the Prior Agreements in its entirety as set forth in this Agreement; and

WHEREAS, the Company desires to employ Executive, and Executive desires to be employed by the Company, as the Company's **Executive Vice President**.

NOW, THEREFORE, in consideration of the foregoing recitals, the mutual covenants, and conditions herein, and other good and valuable considerations, the receipt and adequacy of which are hereby acknowledged, the parties hereby agree as follows:

**AGREEMENT**

**1.** **Employment and Term**. The Company hereby agrees to employ Executive, and Executive hereby accepts
 employment by the Company, on the terms and conditions hereinafter set forth. Executive's
 term of employment by the Company under this Agreement (the "**Term**") shall
 commence on the Effective Date and end on December 31, 2025, subject to automatic renewal
 of the Term for additional one-year periods unless either the Company or Executive gives
 the other party written notice of intent not to renew the Term not less than 60 days before
 the date on which the Term otherwise would automatically renew. Notwithstanding the foregoing,
 the Term may be terminated earlier in accordance with Section 5.

**2.** **Position, Duties, and Responsibilities**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Position and Duties**. During the Term, the Company shall employ Executive as **Executive Vice President**. Executive shall have, subject to the general direction of the Company's
 Board of Directors (the "**Board** "), such duties, powers, and authority as
 are commensurate with their position as **Executive Vice President** and such other duties
 and responsibilities that are commensurate with their positions as reasonably delegated to
 them from time to time by the Board. In this position, Executive shall report directly to
 the Board and Chief Executive Officer.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Exclusive Services and Efforts**. Executive agrees to devote their efforts, energies, and skill to
 the discharge of the duties and responsibilities attributable to their position and, except
 as set forth herein, agrees to devote substantially all of their professional time and attention
 to the business and affairs of the Company. Notwithstanding the foregoing, Executive shall
 be entitled to engage in (a) service on the board of directors of two for-profit companies,
 businesses, or trade organizations at any time during the Term; provided that he shall not
 serve on the board of any entity that materially competes with the Company, (b) service on
 the board of directors of not-for-profit organizations, (c) other charitable activities and
 community affairs, and (d) management of their personal and family investments and affairs,
 in each case to the extent such activities do not, either individually or in the aggregate,
 materially interfere with the performance of their duties and responsibilities to the Company.
 Executive may only engage in other employment or business activities not covered by the aforementioned
 with the prior written consent of the Board. It is understood that Executive runs a consulting
 business named Luna Consultant Group, LLC. and the Board has agreed that Executive may continue
 to run her company in the same capacity as she has previously.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Compliance with Company Policies**. To the extent not inconsistent with the terms and conditions of
 this Agreement and with due regard for their position, Executive shall be subject to the
 Bylaws, policies, practices, procedures, and rules of the Company, including those policies
 and procedures set forth in the Company's Code of Conduct and Ethics, but in no event
 shall anything in such documents be construed to expand the definition of Cause hereunder.

**3.** **Compensation**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Base Salary**. During the first year of the Term, the Company shall pay to the Executive an
 annual salary of $175,000 ()"**Base Salary** "). Thereafter, the Board or Compensation
 Committee of the Board if and when enacted (the "**Committee**") shall consider
 increases in Base Salary for subsequent years in connection with performance and a review
 of compensation provided at peer companies, which companies shall be subject to review on
 a continuing basis (the "**Peer Group** "), taking into account Company and
 individual performance objectives. Executive shall have the option to defer Executive's
 Base Salary, subject to applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Annual Cash Bonus**. The Board or Committee shall award Executive's annual cash bonus based
 on an evaluation of performance and Peer Group compensation practices, taking into account
 Company and individual performance objectives. Notwithstanding the foregoing, the Board or
 Committee may grant a special bonus at any time. Annual cash bonuses shall be deemed "earned"
 if Executive is employed on the last day of the year to which the bonus relates and shall
 be paid no later than March 15 of the year immediately following the year to which the annual
 bonus relates. For each complete fiscal year of the Company (each such fiscal year, a "Bonus
 Year") during the Employment Period, Executive shall be eligible for discretionary
 bonus compensation with a target amount equal to eighty percent (80%) of Executive's
 Base Salary (The **"Annual Bonus")** 

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Incentive Plan Participation**. During the Term, Executive shall be eligible to participate in Company
 equity incentive plans according to the recommendation of the Committee, if any, and approval
 of the Board.

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Stock Award**. The Company shall pay to the Executive a restricted stock award of $600,000 worth
 of shares of common stock pursuant to the Company's then existing equity incentive
 plan (the "Stock Award"). Thereafter, the Board or Committee shall consider stock
 awards for subsequent years. The Stock Award shall begin on May 1, 2025 and be granted on
 the last day of each quarter ending thereafter. The number of shares of the Company's
 common stock awarded will be calculated at the then current "Fair Market Value,"
 which shall be determined by the Board or, if the shares are traded or quoted in an exchange
 or an over the counter marketplace, by the average of the last sale price of the shares for
 the ten trading days preceding the end of the quarter. The Stock Award shall vest in equal
 installments, the first installment vesting on the last day of each quarter ending and each
 subsequent installment shall vest every quarter thereafter.

**4.** **Employee Benefits and Perquisites**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Benefits**.
 Executive shall be entitled to participate in such health, group insurance, welfare, pension,
 and other employee benefit plans, programs, and arrangements as are made generally available
 from time to time to senior executives of the Company (which shall include customary health,
 life insurance, and disability plans). Executive shall also have the option to receive a
 medical stipend of up to $3,000 per month. Executive may elect to forego stipend if he/she
 and their family are covered elsewhere.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Fringe Benefits, Perquisites, and Paid Time Off**. During the Term, Executive shall be entitled
 to participate in all fringe benefits and perquisites made available to other senior executives
 of the Company, such participation to be at levels, and on terms and conditions, that are
 commensurate with their position and responsibilities at the Company and that are no less
 favorable than those applicable to other senior executives of the Company. In addition, Executive
 is entitled to unlimited paid time off ()"**PTO**") as needed, subject to prior
 approval by the Chief Executive Officer or Executive Vice President, so long as doing so
 is consistent and in balance with their job responsibilities and business needs.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Reimbursement of Expenses**. The Company shall reimburse Executive for all reasonable business and travel
 expenses incurred in the performance of their job duties and the promotion of the Company's
 business, promptly upon presentation of appropriate supporting documentation and otherwise
 in accordance with the expense reimbursement policy of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Attorneys' Fees**. The Company shall reimburse Executive, promptly upon presentation of appropriate
 supporting documentation, for all reasonable attorneys' fees incurred by Executive
 in connection with the negotiation and execution of this Agreement, but in no event shall
 such reimbursement exceed $1,000.

**5.** **Termination; Change in Control**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **General**.
 The Company may terminate Executive's employment for Cause. Executive may terminate
 their employment at any time for any reason, but shall be entitled to various compensation
 terms if such employment is not terminated for Good Reason. The Company may terminate Executive's
 employment without Cause, or Executive may terminate Executive's employment with Good
 Reason, in each case, upon providing the other party at least 30 days' written notice
 thereof. Upon termination of Executive's employment, Executive shall be entitled to
 the compensation and benefits described in this Section 5 to the extent applicable and shall
 have no further rights to any compensation or benefits from the Company. For purposes of
 this Agreement, the following terms have the following meanings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) "**Accrued Benefits**" shall mean: (i) accrued but unpaid Base Salary through the Termination
 Date, payable within 30 days following the Termination Date; (ii) any annual cash bonus earned
 but unpaid with respect to the year preceding the year in which the Termination Date occurs,
 payable in accordance with Section 3(a) above; (iii) any long-term incentive award earned
 pursuant to Section 3(c) above but unpaid with respect to performance periods that ended
 in the year preceding the year in which Termination Date occurs; (iv) reimbursement for any
 unreimbursed business expenses incurred through the Termination Date (including any related
 tax gross-up payments), payable within 30 days following the Termination Date; and (v) all
 other payments, benefits, or fringe benefits to which Executive shall be entitled as of the
 Termination Date under the terms of any applicable compensation arrangement or benefit, equity,
 or fringe benefit plan or program or grant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) "**Cause** "
 shall mean: (i) Executive's refusal to perform, or repeated failure to undertake good
 faith efforts to perform, the duties or responsibilities reasonably assigned to Executive
 by the Board, which, if curable, is not cured within 30 days after Executive's written
 receipt of notice thereof from the Company; (ii) Executive's engagement in willful
 gross misconduct or willful gross negligence in and the course of carrying out their duties
 that results in material economic or reputational harm to the Company; (iii) Executive's
 conviction of or plea of guilty or nolo contendere to a felony; or (iv) a material breach
 by Executive of Section 2(b) of this Agreement, which, if curable, is not cured within 30
 days after Executive's receipt of written notice thereof from the Company. Termination
 of Executive's employment shall not be deemed to be for Cause unless Executive has
 had a reasonable opportunity, together with counsel, to respond to all relevant allegations
 upon which a contemplated termination for Cause is based.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) "**Good Reason**" shall mean any of the following that has not been approved in writing and
 shall mean any of the following circumstances that, if curable, has not been cured by the
 Company within 30 days of the Company's receipt of notice thereof from Executive, which
 notice was provided within 90 days of the date on which the circumstance or event constituting
 Good Reason first came into existence: (i) a material reduction in Executive's Base
 Salary; (ii) a material diminution of Executive's titles, duties, responsibilities,
 or authorities as set forth in this Agreement or Executive being required to report to another
 person other than the Board; (iii) a material diminution in the budget over which Executive
 retains authority; (iv) a material change in the location of the Company's offices;
 or (v) a material breach by the Company of this Agreement. Executive's resignation
 will not be treated as being for Good Reason unless Executive's employment terminates
 after the end of the cure period (if curable) and no later than six months after the occurrence
 of the event(s) giving rise to the termination for Good Reason.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) "**Change in Control**" shall mean a liquidation, merger, acquisition, sale of voting control,
 or sale of substantially all of the assets of the Company in which the shareholders of the
 Company immediately prior to the event or transaction do not own a majority of the outstanding
 shares of the surviving corporation after the event or transaction, or series of transactions
 which, in the aggregate would result in the same.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) "**Change-in-Control Severance Payments**" shall mean (i) a pro-rated annual cash bonus for the year in
 which the Termination Date occurs (calculated based on the annual target cash bonus opportunity
 for the year of termination), payable when bonuses are paid to other executives of the Company
 in the year following the year of the Termination Date; (ii) a lump sum cash payment, payable
 on the Termination Date, equal to two times the sum of the following: (x) one year's
 Base Salary at the annualized rate then in effect (or the rate that should be in effect but
 for any Base Salary diminution), (y) the greater of the annual target cash bonus opportunity
 for the year of termination or the highest actual annual cash bonus paid during the three
 preceding completed years, and (z) any target long-term incentive award granted pursuant
 to Section 3(c) above for the year of the Termination Date; (iii) Medical Payment Amounts
 (as defined below) payable each month, commencing on the first day of the month following
 the Termination Date and continuing until the earlier of 12 months following the Termination
 Date or the date on which Executive becomes employed by a third party and becomes eligible
 to participate in such third party's group health plan; and (iv) to the extent permissible
 under applicable law and under any insurance policy insuring the Company's health plan
 (if any), access to continued coverage under the Company's health plan with the full
 cost payable by Executive for a period of up to 12 months commencing on the first day of
 the month following the Termination Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) "**Disability** "
 shall mean that Executive has been unable, with or without reasonable accommodation and due
 to physical or mental incapacity, to substantially perform their duties and responsibilities
 hereunder for at least six months.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) "**Medical Payment Amounts**" shall mean an amount, payable on a monthly basis commencing on
 the first day of the month following the Termination Date, equal to (i) the monthly amount
 of the Consolidated Omnibus Budget Reconciliation Act continuation coverage premium for such
 month under the Company's group medical plans for executives of the Company less the
 monthly amount of Executive's portion of the premium for such month as if Executive
 was still an active employee, plus (ii) a tax gross-up payment so Executive shall have no
 after-tax consequences with respect to the monthly amount described in clause (i) or the
 related tax gross-up.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) "**Severance Payments**" shall mean (i) a lump sum cash payment, payable on the Termination Date,
 equal to two times the sum of the following: (x) one year's Base Salary at the annualized
 rate then in effect (or the rate that should be in effect but for any Base Salary diminution),
 (y) the greater of (I) the annual target cash bonus opportunity for the year of termination
 or (II) the average annual cash bonus for the three preceding completed years (provided,
 however, that if Executive has not been employed for at least three years in which an annual
 cash bonus was paid, such calculation will assume that an annual cash bonus equal to the
 target annual cash bonus opportunity was paid in the missing years), and (z) any target long-term
 incentive award granted pursuant to Section 3(c) above for the year of the Termination Date;
 (ii) Medical Payment Amounts, payable each month, commencing on the first day of the month
 following the Termination Date and continuing until the earlier of 12 months following the
 Termination Date or the date on which Executive becomes employed by a third party and becomes
 eligible to participate in such third party's group health plan; and (iii) to the extent
 permissible under applicable law and under any insurance policy insuring the Company's
 health plan (if any), access to continued coverage under the Company's health plan
 with the full cost payable by Executive for a period of up to 12 months commencing on the
 first day of the month following the Termination Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) "**Termination Date**" shall mean the date on which Executive's employment hereunder terminates
 in accordance with this Agreement (which, in the case of a notice of non-renewal of the Term
 in accordance with Section 1 hereof, shall mean the date on which the Term expires).

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Termination for Cause or Termination by Executive Without Good Reason**. In the event that Executive's
 employment hereunder is terminated by the Company for Cause or by Executive without Good
 Reason, which shall include a non-renewal of the Term by Executive, Executive shall be entitled
 to receive the Accrued Benefits.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Termination Without Cause or Termination by Executive for Good Reason**. In the event that Executive's
 employment hereunder is terminated by the Company without Cause or by Executive for Good
 Reason, Executive shall be entitled to receive the Accrued Benefits and the Severance Payments,
 except as otherwise provided pursuant to Section 5(d).

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Termination Without Cause or Termination by Executive for Good Reason Due to a Change in Control**.
 In the event that Executive's employment hereunder is terminated by the Company without
 Cause or by Executive for Good Reason within two years following or six months prior to a
 Change in Control, Executive shall receive the benefits described in Section 5(c), except
 that Executive shall receive the Change-in-Control Severance Payments in lieu of the Severance
 Payments.

&nbsp;&nbsp;&nbsp;&nbsp;**(e)** **Termination Due to Death or Disability**. In the event that Executive's employment hereunder
 is terminated due to Executive's death or Disability, Executive shall receive the Accrued
 Benefits and one year of the Medical Payment Amounts for Executive in the event of disability
 or Executive's family in the event of Executive's death.

&nbsp;&nbsp;&nbsp;&nbsp;**(f)** **Return of Company Property**. Upon termination of Executive's employment for any reason
 or under any circumstances, Executive shall promptly return any and all of the property of
 the Company and any Affiliates (as defined below) (including, without limitation, all log-in
 and password information for all databases and programs in Executive's possession,
 computers, keys, credit cards, identification tags, documents, data, confidential information,
 work product, and other proprietary materials), and other materials.

&nbsp;&nbsp;&nbsp;&nbsp;**(g)** **Post-Termination Reasonable Cooperation**. Executive agrees and covenants that, following the Term, he/she
 shall, to the extent reasonably requested by the Company, cooperate in good faith with the
 Company to assist the Company in the pursuit or defense of (except if Executive is adverse
 with respect to) any claim, administrative charge, or cause of action by or against the Company
 as to which Executive, by virtue of their employment with the Company or any other position
 that Executive holds that is affiliated with or was held at the request of the Company or
 its Affiliates, has relevant knowledge or information, including by acting as the Company's
 representative in any such proceeding and, without the necessity of a subpoena, providing
 truthful testimony in any jurisdiction or forum. The Company shall reimburse Executive for
 their reasonable out-of-pocket expenses incurred in compliance with this Section 5(g), including
 any reasonable travel expenses and reasonable attorneys' fees incurred by Executive
 and, in the event that Executive is required to spend substantial time on such matters, the
 Company shall compensate Executive at an hourly rate of $250 per hour. The Company shall
 use reasonable business efforts to provide Executive with reasonable advance written notice
 of its need for Executive's reasonable cooperation and shall attempt to coordinate
 with Executive the time and place at which Executive's reasonable cooperation shall
 be provided with the goal of minimizing the impact of such reasonable cooperation on any
 other material pre-scheduled business commitment that Executive may have. Executive's
 cooperation described in this Section 5(g) shall be subject to the indemnification provision
 and obtaining the D&O insurance policy provided under Sections 6(a) and 6(b) hereof,
 respectively.

**6.** **Indemnification; D&O Insurance**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Indemnification**.
 If Executive is made a party, is threatened to be made a party, or reasonably anticipates
 being made a party, to any Proceeding (as hereinafter defined) by reason of the fact that
 Executive is or was a director, officer, shareholder, employee, agent, trustee, consultant,
 or representative of the Company or any of its Affiliates or is or was serving at the request
 of the Company or any of its Affiliates, or in connection with their service hereunder as
 a director, officer, shareholder, employee, agent, trustee, consultant, or representative
 of another Person, or if any Claim (as hereinafter defined) is made, is threatened to be
 made, or is reasonably anticipated to be made, that arises out of or relates to Executive's
 service in any of the foregoing capacities, then Executive shall promptly be indemnified
 and held harmless to the fullest extent permitted or authorized by any Company arrangement,
 or if greater, by applicable law, against any and all costs, expenses, liabilities, and losses
 (including, without limitation, advancement and payment of attorneys' and other professional
 fees and charges, judgments, interest, expenses of investigation, penalties, fines, ERISA
 excise taxes or penalties, and amounts paid or to be paid in settlement, with such legal
 fees advanced to the maximum extent permitted by law) incurred or suffered by Executive in
 connection therewith or in connection with seeking to enforce their rights under this Section
 6(a), and such indemnification shall continue even if Executive has ceased to be a director,
 officer, shareholder, employee, agent, trustee, consultant, or representative of the Company
 or other Person and shall inure to the benefit of their heirs, executors, and administrators.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **D&O Insurance**. At such time as the Company is financially able to do so and at the sole and
 absolute discretion of the Board, the Company shall obtain a directors' and officers'
 liability insurance policy (or policies) providing coverage to Executive that is no less
 favorable in any respect than the coverage then being provided to any other current or former
 director or officer of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Definitions**.
 For purposes of this Agreement, the following terms shall have the following meanings: "**Affiliate** "
 of a Person shall mean any Person that directly or indirectly controls, is controlled by,
 or is under common control with, such Person; "**Claim**" shall mean any claim,
 demand, request, investigation, dispute, controversy, threat, discovery request, or request
 for testimony or information; "**Person**" shall mean any individual, corporation,
 partnership, limited liability company, joint venture, trust, estate, board, committee, agency,
 body, employee benefit plan, or other person or entity; and "**Proceeding** "
 shall mean any threatened or actual action, suit, or proceeding, whether civil, criminal,
 administrative, investigative, appellate, formal, informal, or other.

**7.** **Tax Matters**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Withholding**.
 The Company shall withhold all applicable federal, state, and local taxes, social security,
 and workers' compensation contributions and other amounts as may be required by law
 with respect to compensation payable to Executive pursuant to this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Section 409A**. Notwithstanding anything herein to the contrary, this Agreement is intended to
 be interpreted and applied so that the payment of the benefits set forth herein shall either
 be exempt from, or in the alternative, comply with, the requirements of Section 409A of the
 Internal Revenue Code of 1986, as amended (the "**Code** "), and the published
 guidance thereunder ()"**Section 409A** "). A termination of employment shall
 not be deemed to have occurred for purposes of any provision of this Agreement providing
 for the payment of any amounts or benefits upon or following a termination of employment
 that are considered "nonqualified deferred compensation" under Section 409A unless
 such termination is also a "separation from service" within the meaning of Section
 409A and, for purposes of any such provision of this Agreement, references to a "termination,"
 "Termination Date" or like terms shall mean "separation from service."
 Notwithstanding any provision of this Agreement to the contrary, if Executive is a "specified
 employee" within the meaning of Section 409A on the date of their "separation
 from service," any payments or arrangements due upon a termination of Executive's
 employment under any arrangement that constitutes a "nonqualified deferral of compensation"
 within the meaning of Section 409A and which do not otherwise qualify under the exemptions
 under Treas. Regs. Section 1.409A-1 (including without limitation, the short-term deferral
 exemption or the permitted payments under Treas. Regs. Section 1.409A-1(b)(9)(iii)(A)), shall
 be delayed and paid or provided on the earlier of (a) the date which is six months after
 Executive's "separation from service" for any reason other than death,
 or (b) the date of Executive's death. All tax gross-up payments provided under this
 Agreement or any other agreement with Executive shall be made or provided by the end of Executive's
 taxable year next following Executive's taxable year in which Executive remits the
 related taxes, in accordance with the requirements of Section 409A.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Section 409A Gross-Up**. The Company acknowledges and agrees that if any payment, award, benefit,
 or distribution (or any acceleration of any payment, award, benefit, or distribution) made
 or provided to Executive or for Executive's benefit in connection with this Agreement,
 or Executive's employment with the Company or the termination thereof (the "**Payments** ")
 is determined to be subject to the additional taxes, interest, or penalties imposed by Section
 409A, or any interest or penalties with respect to such additional taxes, interest, or penalties
 (such additional taxes, together with any such interest and penalties, are referred to collectively
 as the "**Section 409A Tax** "), then Executive will be entitled to receive
 an additional payment (a "**409A Gross-Up Payment**") from the Company such
 that the net amount Executive retains after paying any applicable Section 409A Tax and any
 federal, state, or local income or FICA taxes on such 409A Gross-Up Payment, shall be equal
 to the amount Executive would have received if the Section 409A Tax were not applicable to
 the Payments. Unless otherwise agreed in writing by Executive and the Company, all determinations
 of the Section 409A Tax and 409A Gross-Up Payment, if any, will be made by an independent
 accounting firm designated by the Company, and such accounting firm shall be instructed to
 provide the Company and Executive with a written opinion of any determination such accounting
 firm has been requested to provide. The Company shall be responsible for such accounting
 firm's fees. For purposes of determining the amount of the 409A Gross-Up Payment, if
 any, Executive will be deemed to pay federal income tax at the actual marginal rate of federal
 income taxation in the calendar year in which the total Payments are made and state and local
 income taxes at the actual marginal rate of taxation in the state and locality of Executive's
 residence on the date the total Payments are made, net of the maximum reduction in federal
 income taxes that could be obtained from deduction of such state and local taxes. If the
 Section 409A Tax is determined by the Internal Revenue Service, on audit or otherwise, to
 exceed the amount taken into account hereunder in calculating the 409A Gross-Up Payment (including
 by reason of any payment the existence or amount of which cannot be determined at the time
 of the 409A Gross-Up Payment), the Company shall make another 409A Gross-Up Payment in respect
 of such excess (plus any interest, penalties, or additions payable by Executive with respect
 to such excess). The Company and Executive shall each reasonably cooperate with the other
 in connection with any administrative or judicial proceedings concerning the existence or
 amount of liability for Section 409A Tax with respect to the total Payments. The 409A Gross-Up
 Payments provided to Executive shall be made no later than the tenth business day following
 the last date the Payments are made but in all events within the time period specified in
 Section 7(b).

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Separation from Service**. After any Termination Date, Executive shall have no duties or responsibilities
 that are inconsistent with having a "separation from service" within the meaning
 of Section 409A as of the Termination Date and, notwithstanding anything in the Agreement
 to the contrary, distributions upon termination of employment of nonqualified deferred compensation
 may only be made upon a "separation from service" as determined under Section
 409A and such date shall be the Termination Date for purposes of this Agreement. Each payment
 under this Agreement or otherwise shall be treated as a separate payment for purposes of
 Section 409A. In no event may Executive, directly or indirectly, designate the calendar year
 of any payment to be made under this Agreement which constitutes a "nonqualified deferral
 of compensation" within the meaning of Section 409A and to the extent an amount is
 payable within a time period, the time during which such amount is paid shall be in the discretion
 of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;**(e)** **Reimbursements**.
 All reimbursements and in-kind benefits provided under this Agreement shall be made or provided
 in accordance with the requirements of Section 409A. To the extent that any reimbursements
 are taxable to Executive, such reimbursements shall be paid to Executive on or before the
 last day of Executive's taxable year following the taxable year in which the related
 expense was incurred. Reimbursements shall not be subject to liquidation or exchange for
 another benefit and the amount of such reimbursements that Executive receives in one taxable
 year shall not affect the amount of such reimbursements that Executive receives in any other
 taxable year.

&nbsp;&nbsp;&nbsp;&nbsp;**(f)** **Parachute Payments; Gross-Up**. Anything in this Agreement to the contrary notwithstanding, in the
 event that Executive shall become entitled to payments and/or benefits provided by this Agreement
 or any other amounts in the "nature of compensation" (whether pursuant to the
 terms of this Agreement or any other plan, arrangement, or agreement with the Company, or
 any arrangement or agreement with any person whose actions result in a change of ownership
 or effective control or a change in the ownership of a substantial portion of the assets
 of the Company covered by Code Section 280G(b)(2) (a "**280G Change in Control** "),
 or any person affiliated with the Company or such person) as a result of a 280G Change in
 Control (collectively the "**Company Payments** "), and such Company Payments
 will be subject to the tax (the "**Excise Tax**") imposed by Code Section
 4999, the Company shall pay to Executive at the time specified below (i) an additional amount
 (the "**Gross-Up Payment**") such that the net amount retained by Executive,
 after deduction of any Excise Tax on the Company Payments and any U.S. federal, state, and
 for local income or payroll tax upon the Gross-Up Payment provided for by this paragraph,
 but before deduction for any U.S. federal, state, and local income or payroll tax on the
 Company Payments, shall be equal to the Company Payments and (ii) an amount equal to the
 product of any deductions disallowed for federal, state, or local income tax purposes because
 of the inclusion of the Gross-Up Payment in Executive's adjusted gross income multiplied
 by Executive's actual marginal rate of federal, state, or local income taxation, respectively,
 for the calendar year in which the Gross-Up Payment is to be made.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Unless
 otherwise agreed in writing by Executive and the Company, all determinations of the Company
 Payments and the Gross-Up Payments, if any, will be made by an independent accounting firm
 designated by the Company with Executive's approval (the "**Accountant** "),
 and the Accountant shall be instructed to provide the Company and Executive with a written
 opinion of any determination the Accountant has been requested to provide.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) For
 purposes of determining the amount of the Gross-Up Payment, Executive's actual U.S.
 federal income tax rate in the calendar year in which the Gross-Up Payment is to be made
 and state and local income taxes at Executive's actual rate of taxation in the state
 and locality of Executive's residence for the calendar year in which the Company Payment
 is to be made, net of the maximum reduction in U.S. federal income taxes which could be obtained
 from deduction of such state and local taxes if paid in such year, shall be used.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) In
 the event that the Excise Tax is later determined by the Accountant or the Internal Revenue
 Service to exceed the amount taken into account hereunder at the time the Gross-Up Payment
 is made (including by reason of any payment the existence or amount of which cannot be determined
 at the time of the Gross-Up Payment), the Company shall make an additional Gross-Up Payment
 in respect of such excess (plus any interest or penalties payable with respect to such excess)
 at the time that the amount of such excess is finally determined.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) The
 Gross-Up Payment or portion thereof provided for above shall be paid not later than the 60th
 day following a 280G Change in Control which subjects Executive to the Excise Tax; provided,
 however, that if the amount of such Gross-Up Payment or portion thereof cannot be finally
 determined on or before such day, the Company shall pay to Executive on such day an estimate,
 as determined in good faith by the Accountant, of the minimum amount of such payments and
 shall pay the remainder of such payments, as soon as the amount thereof can reasonably be
 determined, but in no event later than the ninetieth day after the occurrence of the event
 subjecting Executive to the Excise Tax. Notwithstanding any other provision of this Agreement,
 all Gross-Up Payments under this Section 7(f)(iv) shall be paid pursuant to Section 7(b)
 of the Agreement. In the event that the amount of the estimated payments exceeds the amount
 subsequently determined to have been due, such excess shall constitute a loan by the Company
 to Executive, payable on the fifth day after demand by the Company (together with interest
 at the rate provided in Code Section 1274(b)(2)(B)).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) The
 Company shall be responsible for all charges of the Accountant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) The
 Company and Executive shall promptly deliver to each other copies of any written communications,
 and summaries of any verbal communications, with any taxing authority regarding the Excise
 Tax covered by this provision.

**8.** **Notices**.
 Any notice, request, instruction, or other document required by the terms of this Agreement,
 or deemed by any of the parties hereto to be desirable, to be given to any other party hereto
 shall be in writing and shall be given by personal delivery, overnight delivery, mailed by
 registered or certified mail, postage prepaid, with return receipt requested, or sent by
 electronic mail (with receipt confirmed) to the addresses of the parties as follows:

---

| | | | |
|:---|:---|:---|:---|
| i. | To: | "Executive" | 84 Alamere Falls Dr |
|  |  |  | Las Vegas NV 89138 |
|  |  |  | Email: vanessa.luna0204@gmail.com |
| ii. | To: | "Company" | 5940 South Rainbow Blvd., |
|  |  |  | Las Vegas, NV 89118 |
|  |  |  | Attn: Steven Luna, CEO |
|  |  |  | Email: steve@alternativeballistics.com |

---

The persons and addresses set forth above may be changed from time to time by a notice sent as aforesaid. If notice is given by personal delivery or overnight delivery in accordance with the provisions of this Section, such notice shall be conclusively deemed given at the time of such delivery provided a receipt is obtained from the recipient. If notice is given by mail in accordance with the provisions of this Section, such notice shall be conclusively deemed given upon receipt and delivery or refusal. If notice is given by electronic mail transmission in accordance with the provisions of this Section, such notice shall be conclusively deemed given at the time of delivery if between the hours of 9:00 a.m. and 5:00 p.m. Pacific time on a business day ("business hours") and if not during business hours, at 9:00 a.m. on the next business day following delivery, provided a delivery confirmation is obtained by the sender.

**9.** **Governing Law**. This Agreement shall be governed by and construed and interpreted in accordance
 with the laws of Nevada without giving effect to any choice of law rules or other conflicting
 provision or rule that would cause the laws of any jurisdiction to be applied.

**10.** **Resolution of Disputes through Arbitration; Opt-Out Option**. Executive can opt out of this arbitration
 provision by striking out the provisions below and by placing their initials on this page.
 However, provided Executive does not choose to opt out, the below arbitration provisions
 will apply:

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** Any
 controversy arising out of or relating to Executive's employment (whether or not before
 or after employment), any termination of Executive's employment, this Agreement or
 the enforcement or interpretation of this Agreement, or because of an alleged breach, default,
 or misrepresentation in connection with any of the provisions of this Agreement, including
 (without limitation) any state or federal statutory claims, shall be submitted to arbitration
 in Clark County, Nevada, before a sole arbitrator (the "**Arbitrator**") selected
 from Judicial Arbitration Mediation Services ()"**JAMS** "), or if JAMS is not
 able to supply the arbitrator, such arbitrator shall be selected from the American Arbitration
 Association ()"**AAA** "), and shall be conducted in accordance with the provisions
 of Nevada Code of Civil Procedure as the exclusive remedy of such dispute; provided, however,
 that provisional injunctive relief may, but need not, be sought in a court of law while arbitration
 proceedings are pending, and any provisional injunctive relief granted by such court shall
 remain effective until the matter is finally determined by the Arbitrator.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** Final
 resolution of any dispute through arbitration may include any remedy or relief that would
 be available in a court of law, including any and all remedies provided by applicable state
 or federal statutes. At the conclusion of the arbitration, the Arbitrator shall issue a written
 decision that sets forth the essential findings and conclusions upon which the Arbitrator's
 award or decision is based. Any award or relief granted by the Arbitrator hereunder shall
 be final and binding on the parties hereto and may be enforced by any court of competent
 jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** By
 agreeing to arbitration, the parties agree that there will be no limitations on discovery.
 The parties shall be entitled to conduct discovery as they would be in court, as set forth
 in the Nevada Code of Civil Procedure.

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** The
 parties acknowledge and agree that they are voluntarily waiving any rights to trial by jury
 in any action, proceeding or counterclaim brought by either of the parties against the other
 in connection with any matter whatsoever arising out of or in any way connected with any
 of the matters referenced in the first sentence of Section 10(a).

&nbsp;&nbsp;&nbsp;&nbsp;**(e)** The
 parties agree that the Company shall be responsible for payment of the forum costs of any
 arbitration hereunder, including the Arbitrator's fee. The parties further agree that
 in any proceeding with respect to such matters, the prevailing party will be entitled to
 recover their reasonable attorney's fees and costs from the non-prevailing party (other
 than forum costs associated with the arbitration which in any event shall be paid by the
 Company).

**11.** **Arbitration Opt-Out Forum; Attorneys' Fees and Costs**. In the event Executive elects to opt
 out of the arbitration provision in Section 10 above, the parties each submit to the exclusive
 jurisdiction of the federal courts (or state courts if federal jurisdiction is lacking) located
 within Clark County, Nevada. In the event of a lawsuit or other legal proceeding arising
 out of or related to this Agreement in which Executive prevails (as determined by the deciding
 court), the Company shall reimburse Executive for their reasonable attorneys' fees
 and costs incurred in connection with such lawsuit or legal proceeding, in addition to any
 other relief to which Executive may be entitled.

**12.** **Amendments; Waivers**. This Agreement may not be modified or amended or terminated except by an instrument
 in writing, signed by Executive and a duly authorized officer of the Company (other than
 Executive). By an instrument in writing similarly executed (and not by any other means),
 either party may waive compliance by the other party with any provision of this Agreement
 that such other party was or is obligated to comply with or perform; provided, however, that
 such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent
 failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder
 shall operate as a waiver thereof, nor shall any single or partial exercise of any right,
 remedy, or power hereunder preclude any other or further exercise thereof or the exercise
 of any other right, remedy, or power provided herein or by law or in equity. To be effective,
 any written waiver must specifically refer to the condition(s) or provision(s) of this Agreement
 being waived.

**13.** **Inconsistencies**.
 In the event of any inconsistency between any provision of this Agreement and any provision
 of any Company arrangement, the provisions of this Agreement shall control, unless Executive
 and the Company otherwise agree in a writing that expressly refers to the provision of this
 Agreement that is being waived.

**14.** **Assignment**.
 Except as otherwise specifically provided herein, neither party shall assign or transfer
 this Agreement nor any rights hereunder without the consent of the other party, and any attempted
 or purported assignment without such consent shall be void; provided, however, that any assignment
 or transfer pursuant to a merger or consolidation, or the sale or liquidation of all or substantially
 all of the business and assets of the Company shall be valid, so long as the assignee or
 transferee (a) is the successor to all or substantially all of the business and assets of
 the Company, and (b) assumes the liabilities, obligations and duties of the Company, as contained
 in this Agreement, either contractually or as a matter of law. Executive's consent
 shall be required for any such transaction. This Agreement shall otherwise bind and inure
 to the benefit of the parties hereto and their respective successors, penalties, assigns,
 heirs, legatees, devisees, executors, administrators, and legal representatives.

**15.** **Voluntary Execution; Representations**. Executive acknowledges that (a) he has consulted with or
 has had the opportunity to consult with independent counsel of their own choosing concerning
 this Agreement and has been advised to do so by the Company, and (b) he has read and understands
 this Agreement, is competent and of sound mind to execute this Agreement, is fully aware
 of the legal effect of this Agreement, and has entered into it freely based on their own
 judgment and without duress. The Company represents and warrants that it is fully authorized,
 by any person or body whose authorization is required, to enter into this Agreement and to
 perform its obligations hereunder.

**16.** **Headings**.
 The headings of the Sections and subsections contained in this Agreement are for convenience
 only and shall not be deemed to control or affect the meaning or construction of any provision
 of this Agreement.

**17.** **Construction**.
 The language used in this Agreement shall be deemed to be the language chosen by the parties
 to express their mutual intent, and no rule of strict construction shall be applied against
 any party.

**18.** **Beneficiaries/References**.
 Executive shall be entitled, to the extent permitted under applicable law, to select and
 change a beneficiary or beneficiaries to receive any compensation or benefit hereunder following
 Executive's death by giving written notice thereof. In the event of Executive's
 death or a judicial determination of their incompetence, references in this Agreement to
 Executive shall be deemed, where appropriate, to refer to their beneficiary, estate, or other
 legal representative.

**19.** **Survivorship**.
 Except as otherwise set forth in this Agreement, the respective rights and obligations of
 the parties shall survive any termination of Executive's employment.

**20.** **Severability**.
 It is the desire and intent of the parties hereto that the provisions of this Agreement be
 enforced to the fullest extent permissible under the laws and public policies applied in
 each jurisdiction in which enforcement is sought. Accordingly, if any particular provision
 of this Agreement shall be adjudicated by a court of competent jurisdiction or arbitrator
 to be invalid, prohibited, or unenforceable for any reason, such provision, as to such jurisdiction,
 shall be ineffective, without invalidating the remaining provisions of this Agreement or
 affecting the validity or enforceability of such provision in any other jurisdiction. Notwithstanding
 the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited,
 or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly
 drawn, without invalidating the remaining provisions of this Agreement or affecting the validity
 or enforceability of such provision in any other jurisdiction.

**21.** **No Mitigation/No Offset**. Executive shall be under no obligation to seek other employment
 or to otherwise mitigate the obligations of the Company under this Agreement, and there shall
 be no offset against amounts or benefits due to Executive under this Agreement or otherwise
 on account of any claim (other than any preexisting debts then due in accordance with their
 terms) the Company may have against their or any remuneration or other benefit earned or
 received by Executive after such termination.

**22.** **Counterparts**.
 This Agreement may be executed in any number of counterparts, each of which shall be deemed
 an original, but all such counterparts shall together constitute one and the same instrument.
 Signatures delivered by facsimile or PDF shall be effective for all purposes.

**23.** **Entire Agreement**. This Agreement contains the entire agreement of the parties and supersedes
 all prior or contemporaneous negotiations, correspondence, understandings, and agreements
 between the parties, regarding the subject matter of this Agreement.

**24.** **Definition of "days."** When used herein, the term "days" refers to calendar
 days unless otherwise specified.

**[SIGNATURE PAGE TO FOLLOW]**

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the Effective Date.

**COMPANY**

Alternative Ballistics Corporation,

a Nevada corporation

---

| | |
|:---|:---|
| By: | */s/ Steven Luna* |
| Name: | Steven Luna |
| Title: | Chief Executive Officer |

---

**EXECUTIVE**

---

| | |
|:---|:---|
| By: | */s/ Vanessa Luna* |
| Name: | Vanessa Luna |

---

Effective Date: Beginning on May 1, 2025

## Add

**Exhibit 6.11**

**2025 Executive Employment Agreement**

This EXECUTIVE EMPLOYMENT AGREEMENT (this "**Agreement**") is made as of signing on May 3, 2025 with an effective date of May 1, 2025 (the "**Effective Date**"), by and between Alternative Ballistics Corporation, a Nevada corporation (together with its successors and assigns, the "**Company**"), and Jason LeBlanc ("**Executive**"). This agreement is made new for the calendar year 2025 and supersedes all prior agreements.

**RECITALS**

WHEREAS, the Company and Executive entered into that certain Executive Employment Agreement, dated December 1, 2021 and Company and Executive later amended and restated the Agreement as of August 23, 2024 (the "Prior Agreement"). This new agreement will immediately take effect and supersede the Prior Agreements in its entirety as set forth in this Agreement; and

WHEREAS, the Company desires to employ Executive, and Executive desires to be employed by the Company, as the Company's **Chief Operating Officer**.

NOW, THEREFORE, in consideration of the foregoing recitals, the mutual covenants, and conditions herein, and other good and valuable considerations, the receipt and adequacy of which are hereby acknowledged, the parties hereby agree as follows:

**AGREEMENT**

**1.** **Employment and Term**. The Company hereby agrees to employ Executive, and Executive hereby accepts
 employment by the Company, on the terms and conditions hereinafter set forth. Executive's
 term of employment by the Company under this Agreement (the "**Term**") shall
 commence on the Effective Date and end on December 31, 2025, subject to automatic renewal
 of the Term for additional one-year periods unless either the Company or Executive gives
 the other party written notice of intent not to renew the Term not less than 60 days before
 the date on which the Term otherwise would automatically renew. Notwithstanding the foregoing,
 the Term may be terminated earlier in accordance with Section 5.

**2.** **Position, Duties, and Responsibilities**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Position and Duties**. During the Term, the Company shall employ Executive as **Chief Operating Officer**. Executive shall have, subject to the general direction of the Company's
 Board of Directors (the "**Board** "), such duties, powers, and authority as
 are commensurate with their position as **Chief Operating Officer** and such other duties
 and responsibilities that are commensurate with their positions as reasonably delegated to
 them from time to time by the Board. In this position, Executive shall report directly to
 the Chief Executive Officer.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Exclusive Services and Efforts**. Executive agrees to devote their efforts, energies, and skill to
 the discharge of the duties and responsibilities attributable to their position and, except
 as set forth herein, agrees to devote substantially all of their professional time and attention
 to the business and affairs of the Company. Notwithstanding the foregoing, Executive shall
 be entitled to engage in (a) service on the board of directors of two for-profit companies,
 businesses, or trade organizations at any time during the Term; provided that he shall not
 serve on the board of any entity that materially competes with the Company, (b) service on
 the board of directors of not-for-profit organizations, (c) other charitable activities and
 community affairs, and (d) management of their personal and family investments and affairs,
 in each case to the extent such activities do not, either individually or in the aggregate,
 materially interfere with the performance of their duties and responsibilities to the Company.
 Executive may only engage in other employment or business activities not covered by the aforementioned
 with the prior written consent of the Board.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Compliance with Company Policies**. To the extent not inconsistent with the terms and conditions of
 this Agreement and with due regard for their position, Executive shall be subject to the
 Bylaws, policies, practices, procedures, and rules of the Company, including those policies
 and procedures set forth in the Company's Code of Conduct and Ethics, but in no event
 shall anything in such documents be construed to expand the definition of Cause hereunder.

**3.** **Compensation**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Base Salary**. During the first year of the Term, the Company shall pay to the Executive an
 annual salary of $150,000 ()"**Base Salary** "). Thereafter, the Board or Compensation
 Committee of the Board if and when enacted (the "**Committee**") shall consider
 increases in Base Salary for subsequent years in connection with performance and a review
 of compensation provided at peer companies, which companies shall be subject to review on
 a continuing basis (the "**Peer Group** "), taking into account Company and
 individual performance objectives. Executive shall have the option to defer Executive's
 Base Salary, subject to applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Annual Cash Bonus**. The Board or Committee shall award Executive's annual cash bonus based
 on an evaluation of performance and Peer Group compensation practices, taking into account
 Company and individual performance objectives. Notwithstanding the foregoing, the Board or
 Committee may grant a special bonus at any time. Annual cash bonuses shall be deemed "earned"
 if Executive is employed on the last day of the year to which the bonus relates and shall
 be paid no later than March 15 of the year immediately following the year to which the annual
 bonus relates. For each complete fiscal year of the Company (each such fiscal year, a "Bonus
 Year") during the Employment Period, Executive shall be eligible for discretionary
 bonus compensation with a target amount equal to eighty percent (80%) of Executive's
 Base Salary (The **"Annual Bonus")** 

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Incentive Plan Participation**. During the Term, Executive shall be eligible to participate in Company
 equity incentive plans according to the recommendation of the Committee, if any, and approval
 of the Board.

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Stock Award**. The Company shall pay to the Executive a restricted stock award of $480,000 worth
 of shares of common stock pursuant to the Company's then existing equity incentive
 plan (the "Stock Award"). Thereafter, the Board or Committee shall consider stock
 awards for subsequent years. The Stock Award shall begin on May 1, 2025 and be granted on
 the last day of each quarter ending for the term of the Agreement. The number of shares of
 the Company's common stock awarded will be calculated at the then current "Fair
 Market Value," which shall be determined by the Board or, if the shares are traded
 or quoted in an exchange or an over the counter marketplace, by the average of the last sale
 price of the shares for the ten trading days preceding the end of the quarter. The Stock
 Award shall vest in equal installments, the first installment vesting on the last day of
 each quarter ending and each subsequent installment shall vest every quarter thereafter.

**4.** **Employee Benefits and Perquisites**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Benefits**.
 Executive shall be entitled to participate in such health, group insurance, welfare, pension,
 and other employee benefit plans, programs, and arrangements as are made generally available
 from time to time to senior executives of the Company (which shall include customary health,
 life insurance, and disability plans). Executive shall also have the option to receive a
 medical stipend of up to $2,000 per month. Executive may elect to forego stipend if he/she
 and their family are covered elsewhere.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Fringe Benefits, Perquisites, and Paid Time Off**. During the Term, Executive shall be entitled
 to participate in all fringe benefits and perquisites made available to other senior executives
 of the Company, such participation to be at levels, and on terms and conditions, that are
 commensurate with their position and responsibilities at the Company and that are no less
 favorable than those applicable to other senior executives of the Company. In addition, Executive
 is entitled to unlimited paid time off ()"**PTO**") as needed, subject to prior
 approval by the Chief Executive Officer or Executive Vice President, so long as doing so
 is consistent and in balance with their job responsibilities and business needs.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Reimbursement of Expenses**. The Company shall reimburse Executive for all reasonable business and travel
 expenses incurred in the performance of their job duties and the promotion of the Company's
 business, promptly upon presentation of appropriate supporting documentation and otherwise
 in accordance with the expense reimbursement policy of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Attorneys' Fees**. The Company shall reimburse Executive, promptly upon presentation of appropriate
 supporting documentation, for all reasonable attorneys' fees incurred by Executive
 in connection with the negotiation and execution of this Agreement, but in no event shall
 such reimbursement exceed $1,000.

**5.** **Termination; Change in Control**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **General**.
 The Company may terminate Executive's employment for Cause. Executive may terminate
 their employment at any time for any reason, but shall be entitled to various compensation
 terms if such employment is not terminated for Good Reason. The Company may terminate Executive's
 employment without Cause, or Executive may terminate Executive's employment with Good
 Reason, in each case, upon providing the other party at least 30 days' written notice
 thereof. Upon termination of Executive's employment, Executive shall be entitled to
 the compensation and benefits described in this Section 5 to the extent applicable and shall
 have no further rights to any compensation or benefits from the Company. For purposes of
 this Agreement, the following terms have the following meanings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) "**Accrued Benefits**" shall mean: (i) accrued but unpaid Base Salary through the Termination
 Date, payable within 30 days following the Termination Date; (ii) any annual cash bonus earned
 but unpaid with respect to the year preceding the year in which the Termination Date occurs,
 payable in accordance with Section 3(a) above; (iii) any long-term incentive award earned
 pursuant to Section 3(c) above but unpaid with respect to performance periods that ended
 in the year preceding the year in which Termination Date occurs; (iv) reimbursement for any
 unreimbursed business expenses incurred through the Termination Date (including any related
 tax gross-up payments), payable within 30 days following the Termination Date; and (v) all
 other payments, benefits, or fringe benefits to which Executive shall be entitled as of the
 Termination Date under the terms of any applicable compensation arrangement or benefit, equity,
 or fringe benefit plan or program or grant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) "**Cause** "
 shall mean: (i) Executive's refusal to perform, or repeated failure to undertake good
 faith efforts to perform, the duties or responsibilities reasonably assigned to Executive
 by the Board, which, if curable, is not cured within 30 days after Executive's written
 receipt of notice thereof from the Company; (ii) Executive's engagement in willful
 gross misconduct or willful gross negligence in and the course of carrying out their duties
 that results in material economic or reputational harm to the Company; (iii) Executive's
 conviction of or plea of guilty or nolo contendere to a felony; or (iv) a material breach
 by Executive of Section 2(b) of this Agreement, which, if curable, is not cured within 30
 days after Executive's receipt of written notice thereof from the Company. Termination
 of Executive's employment shall not be deemed to be for Cause unless Executive has
 had a reasonable opportunity, together with counsel, to respond to all relevant allegations
 upon which a contemplated termination for Cause is based.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) "**Good Reason**" shall mean any of the following that has not been approved in writing and
 shall mean any of the following circumstances that, if curable, has not been cured by the
 Company within 30 days of the Company's receipt of notice thereof from Executive, which
 notice was provided within 90 days of the date on which the circumstance or event constituting
 Good Reason first came into existence: (i) a material reduction in Executive's Base
 Salary; (ii) a material diminution of Executive's titles, duties, responsibilities,
 or authorities as set forth in this Agreement or Executive being required to report to another
 person other than the Board; (iii) a material diminution in the budget over which Executive
 retains authority; (iv) a material change in the location of the Company's offices;
 or (v) a material breach by the Company of this Agreement. Executive's resignation
 will not be treated as being for Good Reason unless Executive's employment terminates
 after the end of the cure period (if curable) and no later than six months after the occurrence
 of the event(s) giving rise to the termination for Good Reason.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) "**Change in Control**" shall mean a liquidation, merger, acquisition, sale of voting control,
 or sale of substantially all of the assets of the Company in which the shareholders of the
 Company immediately prior to the event or transaction do not own a majority of the outstanding
 shares of the surviving corporation after the event or transaction, or series of transactions
 which, in the aggregate would result in the same.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) "**Change-in-Control Severance Payments**" shall mean (i) a pro-rated annual cash bonus for the year in
 which the Termination Date occurs (calculated based on the annual target cash bonus opportunity
 for the year of termination), payable when bonuses are paid to other executives of the Company
 in the year following the year of the Termination Date; (ii) a lump sum cash payment, payable
 on the Termination Date, equal to one times the sum of the following: (x) one year's
 Base Salary at the annualized rate then in effect (or the rate that should be in effect but
 for any Base Salary diminution), (y) the greater of the annual target cash bonus opportunity
 for the year of termination or the highest actual annual cash bonus paid during the three
 preceding completed years, and (z) any target long-term incentive award granted pursuant
 to Section 3(c) above for the year of the Termination Date; (iii) Medical Payment Amounts
 (as defined below) payable each month, commencing on the first day of the month following
 the Termination Date and continuing until the earlier of 12 months following the Termination
 Date or the date on which Executive becomes employed by a third party and becomes eligible
 to participate in such third party's group health plan; and (iv) to the extent permissible
 under applicable law and under any insurance policy insuring the Company's health plan
 (if any), access to continued coverage under the Company's health plan with the full
 cost payable by Executive for a period of up to 12 months commencing on the first day of
 the month following the Termination Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) "**Disability** "
 shall mean that Executive has been unable, with or without reasonable accommodation and due
 to physical or mental incapacity, to substantially perform their duties and responsibilities
 hereunder for at least six months.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) "**Medical Payment Amounts**" shall mean an amount, payable on a monthly basis commencing on
 the first day of the month following the Termination Date, equal to (i) the monthly amount
 of the Consolidated Omnibus Budget Reconciliation Act continuation coverage premium for such
 month under the Company's group medical plans for executives of the Company less the
 monthly amount of Executive's portion of the premium for such month as if Executive
 was still an active employee, plus (ii) a tax gross-up payment so Executive shall have no
 after-tax consequences with respect to the monthly amount described in clause (i) or the
 related tax gross-up.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) "**Severance Payments**" shall mean (i) a lump sum cash payment, payable on the Termination Date,
 equal to one times the sum of the following: (x) one year's Base Salary at the annualized
 rate then in effect (or the rate that should be in effect but for any Base Salary diminution),
 (y) the greater of (I) the annual target cash bonus opportunity for the year of termination
 or (II) the average annual cash bonus for the three preceding completed years (provided,
 however, that if Executive has not been employed for at least three years in which an annual
 cash bonus was paid, such calculation will assume that an annual cash bonus equal to the
 target annual cash bonus opportunity was paid in the missing years), and (z) any target long-term
 incentive award granted pursuant to Section 3(c) above for the year of the Termination Date;
 (ii) Medical Payment Amounts, payable each month, commencing on the first day of the month
 following the Termination Date and continuing until the earlier of 12 months following the
 Termination Date or the date on which Executive becomes employed by a third party and becomes
 eligible to participate in such third party's group health plan; and (iii) to the extent
 permissible under applicable law and under any insurance policy insuring the Company's
 health plan (if any), access to continued coverage under the Company's health plan
 with the full cost payable by Executive for a period of up to 12 months commencing on the
 first day of the month following the Termination Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) "**Termination Date**" shall mean the date on which Executive's employment hereunder terminates
 in accordance with this Agreement (which, in the case of a notice of non-renewal of the Term
 in accordance with Section 1 hereof, shall mean the date on which the Term expires).

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Termination for Cause or Termination by Executive Without Good Reason**. In the event that Executive's
 employment hereunder is terminated by the Company for Cause or by Executive without Good
 Reason, which shall include a non-renewal of the Term by Executive, Executive shall be entitled
 to receive the Accrued Benefits.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Termination Without Cause or Termination by Executive for Good Reason**. In the event that Executive's
 employment hereunder is terminated by the Company without Cause or by Executive for Good
 Reason, Executive shall be entitled to receive the Accrued Benefits and the Severance Payments,
 except as otherwise provided pursuant to Section 5(d).

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Termination Without Cause or Termination by Executive for Good Reason Due to a Change in Control**.
 In the event that Executive's employment hereunder is terminated by the Company without
 Cause or by Executive for Good Reason within two years following or six months prior to a
 Change in Control, Executive shall receive the benefits described in Section 5(c), except
 that Executive shall receive the Change-in-Control Severance Payments in lieu of the Severance
 Payments.

&nbsp;&nbsp;&nbsp;&nbsp;**(e)** **Termination Due to Death or Disability**. In the event that Executive's employment hereunder
 is terminated due to Executive's death or Disability, Executive shall receive the Accrued
 Benefits and one year of the Medical Payment Amounts for Executive in the event of disability
 or Executive's family in the event of Executive's death.

&nbsp;&nbsp;&nbsp;&nbsp;**(f)** **Return of Company Property**. Upon termination of Executive's employment for any reason
 or under any circumstances, Executive shall promptly return any and all of the property of
 the Company and any Affiliates (as defined below) (including, without limitation, all log-in
 and password information for all databases and programs in Executive's possession,
 computers, keys, credit cards, identification tags, documents, data, confidential information,
 work product, and other proprietary materials), and other materials.

&nbsp;&nbsp;&nbsp;&nbsp;**(g)** **Post-Termination Reasonable Cooperation**. Executive agrees and covenants that, following the Term, he/she
 shall, to the extent reasonably requested by the Company, cooperate in good faith with the
 Company to assist the Company in the pursuit or defense of (except if Executive is adverse
 with respect to) any claim, administrative charge, or cause of action by or against the Company
 as to which Executive, by virtue of their employment with the Company or any other position
 that Executive holds that is affiliated with or was held at the request of the Company or
 its Affiliates, has relevant knowledge or information, including by acting as the Company's
 representative in any such proceeding and, without the necessity of a subpoena, providing
 truthful testimony in any jurisdiction or forum. The Company shall reimburse Executive for
 their reasonable out-of-pocket expenses incurred in compliance with this Section 5(g), including
 any reasonable travel expenses and reasonable attorneys' fees incurred by Executive
 and, in the event that Executive is required to spend substantial time on such matters, the
 Company shall compensate Executive at an hourly rate of $250 per hour. The Company shall
 use reasonable business efforts to provide Executive with reasonable advance written notice
 of its need for Executive's reasonable cooperation and shall attempt to coordinate
 with Executive the time and place at which Executive's reasonable cooperation shall
 be provided with the goal of minimizing the impact of such reasonable cooperation on any
 other material pre-scheduled business commitment that Executive may have. Executive's
 cooperation described in this Section 5(g) shall be subject to the indemnification provision
 and obtaining the D&O insurance policy provided under Sections 6(a) and 6(b) hereof,
 respectively.

**6.** **Indemnification; D&O Insurance**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Indemnification**.
 If Executive is made a party, is threatened to be made a party, or reasonably anticipates
 being made a party, to any Proceeding (as hereinafter defined) by reason of the fact that
 Executive is or was a director, officer, shareholder, employee, agent, trustee, consultant,
 or representative of the Company or any of its Affiliates or is or was serving at the request
 of the Company or any of its Affiliates, or in connection with their service hereunder as
 a director, officer, shareholder, employee, agent, trustee, consultant, or representative
 of another Person, or if any Claim (as hereinafter defined) is made, is threatened to be
 made, or is reasonably anticipated to be made, that arises out of or relates to Executive's
 service in any of the foregoing capacities, then Executive shall promptly be indemnified
 and held harmless to the fullest extent permitted or authorized by any Company arrangement,
 or if greater, by applicable law, against any and all costs, expenses, liabilities, and losses
 (including, without limitation, advancement and payment of attorneys' and other professional
 fees and charges, judgments, interest, expenses of investigation, penalties, fines, ERISA
 excise taxes or penalties, and amounts paid or to be paid in settlement, with such legal
 fees advanced to the maximum extent permitted by law) incurred or suffered by Executive in
 connection therewith or in connection with seeking to enforce their rights under this Section
 6(a), and such indemnification shall continue even if Executive has ceased to be a director,
 officer, shareholder, employee, agent, trustee, consultant, or representative of the Company
 or other Person and shall inure to the benefit of their heirs, executors, and administrators.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **D&O Insurance**. At such time as the Company is financially able to do so and at the sole and
 absolute discretion of the Board, the Company shall obtain a directors' and officers'
 liability insurance policy (or policies) providing coverage to Executive that is no less
 favorable in any respect than the coverage then being provided to any other current or former
 director or officer of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Definitions**.
 For purposes of this Agreement, the following terms shall have the following meanings: "**Affiliate** "
 of a Person shall mean any Person that directly or indirectly controls, is controlled by,
 or is under common control with, such Person; "**Claim**" shall mean any claim,
 demand, request, investigation, dispute, controversy, threat, discovery request, or request
 for testimony or information; "**Person**" shall mean any individual, corporation,
 partnership, limited liability company, joint venture, trust, estate, board, committee, agency,
 body, employee benefit plan, or other person or entity; and "**Proceeding** "
 shall mean any threatened or actual action, suit, or proceeding, whether civil, criminal,
 administrative, investigative, appellate, formal, informal, or other.

**7.** **Tax Matters**.

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Withholding**.
 The Company shall withhold all applicable federal, state, and local taxes, social security,
 and workers' compensation contributions and other amounts as may be required by law
 with respect to compensation payable to Executive pursuant to this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Section 409A**. Notwithstanding anything herein to the contrary, this Agreement is intended to
 be interpreted and applied so that the payment of the benefits set forth herein shall either
 be exempt from, or in the alternative, comply with, the requirements of Section 409A of the
 Internal Revenue Code of 1986, as amended (the "**Code** "), and the published
 guidance thereunder ()"**Section 409A** "). A termination of employment shall
 not be deemed to have occurred for purposes of any provision of this Agreement providing
 for the payment of any amounts or benefits upon or following a termination of employment
 that are considered "nonqualified deferred compensation" under Section 409A unless
 such termination is also a "separation from service" within the meaning of Section
 409A and, for purposes of any such provision of this Agreement, references to a "termination,"
 "Termination Date" or like terms shall mean "separation from service."
 Notwithstanding any provision of this Agreement to the contrary, if Executive is a "specified
 employee" within the meaning of Section 409A on the date of their "separation
 from service," any payments or arrangements due upon a termination of Executive's
 employment under any arrangement that constitutes a "nonqualified deferral of compensation"
 within the meaning of Section 409A and which do not otherwise qualify under the exemptions
 under Treas. Regs. Section 1.409A-1 (including without limitation, the short-term deferral
 exemption or the permitted payments under Treas. Regs. Section 1.409A-1(b)(9)(iii)(A)), shall
 be delayed and paid or provided on the earlier of (a) the date which is six months after
 Executive's "separation from service" for any reason other than death,
 or (b) the date of Executive's death. All tax gross-up payments provided under this
 Agreement or any other agreement with Executive shall be made or provided by the end of Executive's
 taxable year next following Executive's taxable year in which Executive remits the
 related taxes, in accordance with the requirements of Section 409A.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Section 409A Gross-Up**. The Company acknowledges and agrees that if any payment, award, benefit,
 or distribution (or any acceleration of any payment, award, benefit, or distribution) made
 or provided to Executive or for Executive's benefit in connection with this Agreement,
 or Executive's employment with the Company or the termination thereof (the "**Payments** ")
 is determined to be subject to the additional taxes, interest, or penalties imposed by Section
 409A, or any interest or penalties with respect to such additional taxes, interest, or penalties
 (such additional taxes, together with any such interest and penalties, are referred to collectively
 as the "**Section 409A Tax** "), then Executive will be entitled to receive
 an additional payment (a "**409A Gross-Up Payment**") from the Company such
 that the net amount Executive retains after paying any applicable Section 409A Tax and any
 federal, state, or local income or FICA taxes on such 409A Gross-Up Payment, shall be equal
 to the amount Executive would have received if the Section 409A Tax were not applicable to
 the Payments. Unless otherwise agreed in writing by Executive and the Company, all determinations
 of the Section 409A Tax and 409A Gross-Up Payment, if any, will be made by an independent
 accounting firm designated by the Company, and such accounting firm shall be instructed to
 provide the Company and Executive with a written opinion of any determination such accounting
 firm has been requested to provide. The Company shall be responsible for such accounting
 firm's fees. For purposes of determining the amount of the 409A Gross-Up Payment, if
 any, Executive will be deemed to pay federal income tax at the actual marginal rate of federal
 income taxation in the calendar year in which the total Payments are made and state and local
 income taxes at the actual marginal rate of taxation in the state and locality of Executive's
 residence on the date the total Payments are made, net of the maximum reduction in federal
 income taxes that could be obtained from deduction of such state and local taxes. If the
 Section 409A Tax is determined by the Internal Revenue Service, on audit or otherwise, to
 exceed the amount taken into account hereunder in calculating the 409A Gross-Up Payment (including
 by reason of any payment the existence or amount of which cannot be determined at the time
 of the 409A Gross-Up Payment), the Company shall make another 409A Gross-Up Payment in respect
 of such excess (plus any interest, penalties, or additions payable by Executive with respect
 to such excess). The Company and Executive shall each reasonably cooperate with the other
 in connection with any administrative or judicial proceedings concerning the existence or
 amount of liability for Section 409A Tax with respect to the total Payments. The 409A Gross-Up
 Payments provided to Executive shall be made no later than the tenth business day following
 the last date the Payments are made but in all events within the time period specified in
 Section 7(b).

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Separation from Service**. After any Termination Date, Executive shall have no duties or responsibilities
 that are inconsistent with having a "separation from service" within the meaning
 of Section 409A as of the Termination Date and, notwithstanding anything in the Agreement
 to the contrary, distributions upon termination of employment of nonqualified deferred compensation
 may only be made upon a "separation from service" as determined under Section
 409A and such date shall be the Termination Date for purposes of this Agreement. Each payment
 under this Agreement or otherwise shall be treated as a separate payment for purposes of
 Section 409A. In no event may Executive, directly or indirectly, designate the calendar year
 of any payment to be made under this Agreement which constitutes a "nonqualified deferral
 of compensation" within the meaning of Section 409A and to the extent an amount is
 payable within a time period, the time during which such amount is paid shall be in the discretion
 of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;**(e)** **Reimbursements**.
 All reimbursements and in-kind benefits provided under this Agreement shall be made or provided
 in accordance with the requirements of Section 409A. To the extent that any reimbursements
 are taxable to Executive, such reimbursements shall be paid to Executive on or before the
 last day of Executive's taxable year following the taxable year in which the related
 expense was incurred. Reimbursements shall not be subject to liquidation or exchange for
 another benefit and the amount of such reimbursements that Executive receives in one taxable
 year shall not affect the amount of such reimbursements that Executive receives in any other
 taxable year.

&nbsp;&nbsp;&nbsp;&nbsp;**(f)** **Parachute Payments; Gross-Up**. Anything in this Agreement to the contrary notwithstanding, in the
 event that Executive shall become entitled to payments and/or benefits provided by this Agreement
 or any other amounts in the "nature of compensation" (whether pursuant to the
 terms of this Agreement or any other plan, arrangement, or agreement with the Company, or
 any arrangement or agreement with any person whose actions result in a change of ownership
 or effective control or a change in the ownership of a substantial portion of the assets
 of the Company covered by Code Section 280G(b)(2) (a "**280G Change in Control** "),
 or any person affiliated with the Company or such person) as a result of a 280G Change in
 Control (collectively the "**Company Payments** "), and such Company Payments
 will be subject to the tax (the "**Excise Tax**") imposed by Code Section
 4999, the Company shall pay to Executive at the time specified below (i) an additional amount
 (the "**Gross-Up Payment**") such that the net amount retained by Executive,
 after deduction of any Excise Tax on the Company Payments and any U.S. federal, state, and
 for local income or payroll tax upon the Gross-Up Payment provided for by this paragraph,
 but before deduction for any U.S. federal, state, and local income or payroll tax on the
 Company Payments, shall be equal to the Company Payments and (ii) an amount equal to the
 product of any deductions disallowed for federal, state, or local income tax purposes because
 of the inclusion of the Gross-Up Payment in Executive's adjusted gross income multiplied
 by Executive's actual marginal rate of federal, state, or local income taxation, respectively,
 for the calendar year in which the Gross-Up Payment is to be made.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Unless
 otherwise agreed in writing by Executive and the Company, all determinations of the Company
 Payments and the Gross-Up Payments, if any, will be made by an independent accounting firm
 designated by the Company with Executive's approval (the "**Accountant** "),
 and the Accountant shall be instructed to provide the Company and Executive with a written
 opinion of any determination the Accountant has been requested to provide.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) For
 purposes of determining the amount of the Gross-Up Payment, Executive's actual U.S.
 federal income tax rate in the calendar year in which the Gross-Up Payment is to be made
 and state and local income taxes at Executive's actual rate of taxation in the state
 and locality of Executive's residence for the calendar year in which the Company Payment
 is to be made, net of the maximum reduction in U.S. federal income taxes which could be obtained
 from deduction of such state and local taxes if paid in such year, shall be used.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) In
 the event that the Excise Tax is later determined by the Accountant or the Internal Revenue
 Service to exceed the amount taken into account hereunder at the time the Gross-Up Payment
 is made (including by reason of any payment the existence or amount of which cannot be determined
 at the time of the Gross-Up Payment), the Company shall make an additional Gross-Up Payment
 in respect of such excess (plus any interest or penalties payable with respect to such excess)
 at the time that the amount of such excess is finally determined.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) The
 Gross-Up Payment or portion thereof provided for above shall be paid not later than the 60th
 day following a 280G Change in Control which subjects Executive to the Excise Tax; provided,
 however, that if the amount of such Gross-Up Payment or portion thereof cannot be finally
 determined on or before such day, the Company shall pay to Executive on such day an estimate,
 as determined in good faith by the Accountant, of the minimum amount of such payments and
 shall pay the remainder of such payments, as soon as the amount thereof can reasonably be
 determined, but in no event later than the ninetieth day after the occurrence of the event
 subjecting Executive to the Excise Tax. Notwithstanding any other provision of this Agreement,
 all Gross-Up Payments under this Section 7(f)(iv) shall be paid pursuant to Section 7(b)
 of the Agreement. In the event that the amount of the estimated payments exceeds the amount
 subsequently determined to have been due, such excess shall constitute a loan by the Company
 to Executive, payable on the fifth day after demand by the Company (together with interest
 at the rate provided in Code Section 1274(b)(2)(B)).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) The
 Company shall be responsible for all charges of the Accountant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) The
 Company and Executive shall promptly deliver to each other copies of any written communications,
 and summaries of any verbal communications, with any taxing authority regarding the Excise
 Tax covered by this provision.

**8.** **Notices**.
 Any notice, request, instruction, or other document required by the terms of this Agreement,
 or deemed by any of the parties hereto to be desirable, to be given to any other party hereto
 shall be in writing and shall be given by personal delivery, overnight delivery, mailed by
 registered or certified mail, postage prepaid, with return receipt requested, or sent by
 electronic mail (with receipt confirmed) to the addresses of the parties as follows:

---

| | | | |
|:---|:---|:---|:---|
| i. | To: | "Executive" | 10722 Esmereldas Drive |
|  |  |  | San Diego, CA 92124 |
|  |  |  | Email: Jason.10.leblanc@gmail.com |
| ii. | To: | "Company" | 5940 South Rainbow Blvd., |
|  |  |  | Las Vegas, NV 89118 |
|  |  |  | Attn: Steven Luna, CEO |
|  |  |  | Email: steve@alternativeballistics.com |

---

The persons and addresses set forth above may be changed from time to time by a notice sent as aforesaid. If notice is given by personal delivery or overnight delivery in accordance with the provisions of this Section, such notice shall be conclusively deemed given at the time of such delivery provided a receipt is obtained from the recipient. If notice is given by mail in accordance with the provisions of this Section, such notice shall be conclusively deemed given upon receipt and delivery or refusal. If notice is given by electronic mail transmission in accordance with the provisions of this Section, such notice shall be conclusively deemed given at the time of delivery if between the hours of 9:00 a.m. and 5:00 p.m. Pacific time on a business day ("business hours") and if not during business hours, at 9:00 a.m. on the next business day following delivery, provided a delivery confirmation is obtained by the sender.

**9.** **Governing Law**. This Agreement shall be governed by and construed and interpreted in accordance
 with the laws of Nevada without giving effect to any choice of law rules or other conflicting
 provision or rule that would cause the laws of any jurisdiction to be applied.

**10.** **Resolution of Disputes through Arbitration; Opt-Out Option**. Executive can opt out of this arbitration
 provision by striking out the provisions below and by placing their initials on this page.
 However, provided Executive does not choose to opt out, the below arbitration provisions
 will apply:

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** Any
 controversy arising out of or relating to Executive's employment (whether or not before
 or after employment), any termination of Executive's employment, this Agreement or
 the enforcement or interpretation of this Agreement, or because of an alleged breach, default,
 or misrepresentation in connection with any of the provisions of this Agreement, including
 (without limitation) any state or federal statutory claims, shall be submitted to arbitration
 in Clark County, Nevada, before a sole arbitrator (the "**Arbitrator**") selected
 from Judicial Arbitration Mediation Services ()"**JAMS** "), or if JAMS is not
 able to supply the arbitrator, such arbitrator shall be selected from the American Arbitration
 Association ()"**AAA** "), and shall be conducted in accordance with the provisions
 of Nevada Code of Civil Procedure as the exclusive remedy of such dispute; provided, however,
 that provisional injunctive relief may, but need not, be sought in a court of law while arbitration
 proceedings are pending, and any provisional injunctive relief granted by such court shall
 remain effective until the matter is finally determined by the Arbitrator.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** Final
 resolution of any dispute through arbitration may include any remedy or relief that would
 be available in a court of law, including any and all remedies provided by applicable state
 or federal statutes. At the conclusion of the arbitration, the Arbitrator shall issue a written
 decision that sets forth the essential findings and conclusions upon which the Arbitrator's
 award or decision is based. Any award or relief granted by the Arbitrator hereunder shall
 be final and binding on the parties hereto and may be enforced by any court of competent
 jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** By
 agreeing to arbitration, the parties agree that there will be no limitations on discovery.
 The parties shall be entitled to conduct discovery as they would be in court, as set forth
 in the Nevada Code of Civil Procedure.

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** The
 parties acknowledge and agree that they are voluntarily waiving any rights to trial by jury
 in any action, proceeding or counterclaim brought by either of the parties against the other
 in connection with any matter whatsoever arising out of or in any way connected with any
 of the matters referenced in the first sentence of Section 10(a).

&nbsp;&nbsp;&nbsp;&nbsp;**(e)** The
 parties agree that the Company shall be responsible for payment of the forum costs of any
 arbitration hereunder, including the Arbitrator's fee. The parties further agree that
 in any proceeding with respect to such matters, the prevailing party will be entitled to
 recover their reasonable attorney's fees and costs from the non-prevailing party (other
 than forum costs associated with the arbitration which in any event shall be paid by the
 Company).

**11.** **Arbitration Opt-Out Forum; Attorneys' Fees and Costs**. In the event Executive elects to opt
 out of the arbitration provision in Section 10 above, the parties each submit to the exclusive
 jurisdiction of the federal courts (or state courts if federal jurisdiction is lacking) located
 within Clark County, Nevada. In the event of a lawsuit or other legal proceeding arising
 out of or related to this Agreement in which Executive prevails (as determined by the deciding
 court), the Company shall reimburse Executive for their reasonable attorneys' fees
 and costs incurred in connection with such lawsuit or legal proceeding, in addition to any
 other relief to which Executive may be entitled.

**12.** **Amendments; Waivers**. This Agreement may not be modified or amended or terminated except by an instrument
 in writing, signed by Executive and a duly authorized officer of the Company (other than
 Executive). By an instrument in writing similarly executed (and not by any other means),
 either party may waive compliance by the other party with any provision of this Agreement
 that such other party was or is obligated to comply with or perform; provided, however, that
 such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent
 failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder
 shall operate as a waiver thereof, nor shall any single or partial exercise of any right,
 remedy, or power hereunder preclude any other or further exercise thereof or the exercise
 of any other right, remedy, or power provided herein or by law or in equity. To be effective,
 any written waiver must specifically refer to the condition(s) or provision(s) of this Agreement
 being waived.

**13.** **Inconsistencies**.
 In the event of any inconsistency between any provision of this Agreement and any provision
 of any Company arrangement, the provisions of this Agreement shall control, unless Executive
 and the Company otherwise agree in a writing that expressly refers to the provision of this
 Agreement that is being waived.

**14.** **Assignment**.
 Except as otherwise specifically provided herein, neither party shall assign or transfer
 this Agreement nor any rights hereunder without the consent of the other party, and any attempted
 or purported assignment without such consent shall be void; provided, however, that any assignment
 or transfer pursuant to a merger or consolidation, or the sale or liquidation of all or substantially
 all of the business and assets of the Company shall be valid, so long as the assignee or
 transferee (a) is the successor to all or substantially all of the business and assets of
 the Company, and (b) assumes the liabilities, obligations and duties of the Company, as contained
 in this Agreement, either contractually or as a matter of law. Executive's consent
 shall be required for any such transaction. This Agreement shall otherwise bind and inure
 to the benefit of the parties hereto and their respective successors, penalties, assigns,
 heirs, legatees, devisees, executors, administrators, and legal representatives.

**15.** **Voluntary Execution; Representations**. Executive acknowledges that (a) he has consulted with or
 has had the opportunity to consult with independent counsel of their own choosing concerning
 this Agreement and has been advised to do so by the Company, and (b) he has read and understands
 this Agreement, is competent and of sound mind to execute this Agreement, is fully aware
 of the legal effect of this Agreement, and has entered into it freely based on their own
 judgment and without duress. The Company represents and warrants that it is fully authorized,
 by any person or body whose authorization is required, to enter into this Agreement and to
 perform its obligations hereunder.

**16.** **Headings**.
 The headings of the Sections and subsections contained in this Agreement are for convenience
 only and shall not be deemed to control or affect the meaning or construction of any provision
 of this Agreement.

**17.** **Construction**.
 The language used in this Agreement shall be deemed to be the language chosen by the parties
 to express their mutual intent, and no rule of strict construction shall be applied against
 any party.

**18.** **Beneficiaries/References**.
 Executive shall be entitled, to the extent permitted under applicable law, to select and
 change a beneficiary or beneficiaries to receive any compensation or benefit hereunder following
 Executive's death by giving written notice thereof. In the event of Executive's
 death or a judicial determination of their incompetence, references in this Agreement to
 Executive shall be deemed, where appropriate, to refer to their beneficiary, estate, or other
 legal representative.

**19.** **Survivorship**.
 Except as otherwise set forth in this Agreement, the respective rights and obligations of
 the parties shall survive any termination of Executive's employment.

**20.** **Severability**.
 It is the desire and intent of the parties hereto that the provisions of this Agreement be
 enforced to the fullest extent permissible under the laws and public policies applied in
 each jurisdiction in which enforcement is sought. Accordingly, if any particular provision
 of this Agreement shall be adjudicated by a court of competent jurisdiction or arbitrator
 to be invalid, prohibited, or unenforceable for any reason, such provision, as to such jurisdiction,
 shall be ineffective, without invalidating the remaining provisions of this Agreement or
 affecting the validity or enforceability of such provision in any other jurisdiction. Notwithstanding
 the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited,
 or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly
 drawn, without invalidating the remaining provisions of this Agreement or affecting the validity
 or enforceability of such provision in any other jurisdiction.

**21.** **No Mitigation/No Offset**. Executive shall be under no obligation to seek other employment
 or to otherwise mitigate the obligations of the Company under this Agreement, and there shall
 be no offset against amounts or benefits due to Executive under this Agreement or otherwise
 on account of any claim (other than any preexisting debts then due in accordance with their
 terms) the Company may have against their or any remuneration or other benefit earned or
 received by Executive after such termination.

**22.** **Counterparts**.
 This Agreement may be executed in any number of counterparts, each of which shall be deemed
 an original, but all such counterparts shall together constitute one and the same instrument.
 Signatures delivered by facsimile or PDF shall be effective for all purposes.

**23.** **Entire Agreement**. This Agreement contains the entire agreement of the parties and supersedes
 all prior or contemporaneous negotiations, correspondence, understandings, and agreements
 between the parties, regarding the subject matter of this Agreement.

**24.** **Definition of "days."** When used herein, the term "days" refers to calendar
 days unless otherwise specified.

**[SIGNATURE PAGE TO FOLLOW]**

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the Effective Date.

**COMPANY**

Alternative Ballistics Corporation,

a Nevada corporation

---

| | |
|:---|:---|
| By: | */s/ Steven Luna* |
| Name: | Steven Luna |
| Title: | Chief Executive Officer |

---

**EXECUTIVE**

---

| | |
|:---|:---|
| By: | */s/ Jason LeBlanc* |
| Name: | Jason LeBlanc |

---

Effective Date: Beginning on May 1, 2025

## Add

**Exhibit 6.12**

![](ex6-12_001.jpg)

**ADDENDUM TO DIRECTOR AGREEMENT**<br>

This Addendum (the "Addendum") to the Director Agreement dated effective as of September 20, 2024 (the "Agreement") by and between Alternative Ballistics Corporation, a Nevada corporation (the "Company"), and Bruce Culver (the "Director") is entered into and made effective as of June 25, 2025.

**RECITALS**

**WHEREAS,** Section 2.(a) of the Agreement provides that the Director shall receive cash compensation of $5,000 per quarter for services rendered;

**WHEREAS,** the Company and the Director desire to amend the Agreement to provide for the payment of such quarterly compensation in the form of shares of the Company's common stock in lieu of cash until further notice;

**NOW, THEREFORE**, in consideration of the mutual covenants contained herein and in the Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;1. Equity
in Lieu of Cash Compensation Notwithstanding anything to the contrary in Section 2.(a) of the Agreement, the Director agrees to
accept the quarterly cash compensation of $5,000 in the form of shares of the Company's common stock in lieu of cash.

2. Valuation and Issuance The number of shares to be issued each quarter shall be calculated based on the fair market value of the Company's common stock on the last business day of the applicable quarter, as determined in good faith by the Company's Board of Directors.

3. Securities Law Compliance The shares issued pursuant to this Addendum shall be considered "restricted securities" as defined in Rule 144 under the Securities Act of 1933, as amended, and shall bear the applicable restrictive legends. The Director acknowledges and agrees that such shares may not be sold, transferred, or otherwise disposed of without compliance with applicable federal and state securities laws.

4. No Other Amendments Except as expressly modified herein, all terms and conditions of the Agreement shall remain in full force and effect.

**IN WITNESS WHEREOF**, the parties have executed this Addendum as of the date first written above.

**ALTERNATIVE BALLISTICS CORPORATION**

---

| | |
|:---|:---|
| By: | */s/ Steven Luna* |
| Name: | Steven Luna |
| Title: | Chief Executive Officer |

---

**DIRECTOR**

---

| | |
|:---|:---|
| By: | */s/ Bruce Culver* |
| Name: | Bruce Culver |

---

## Add

**Exhibit 6.13**

![](ex6-13_001.jpg)

**ADDENDUM TO DIRECTOR AGREEMENT**<br>

This Addendum (the "Addendum") to the Director Agreement dated effective as of September 20, 2024 (the "Agreement") by and between Alternative Ballistics Corporation, a Nevada corporation (the "Company"), and Bruce Amaro (the "Director") is entered into and made effective as of June 25, 2025.

**RECITALS**

**WHEREAS,** Section 2.(a) of the Agreement provides that the Director shall receive cash compensation of $5,000 per quarter for services rendered;

**WHEREAS,** the Company and the Director desire to amend the Agreement to provide for the payment of such quarterly compensation in the form of shares of the Company's common stock in lieu of cash until further notice;

**NOW, THEREFORE**, in consideration of the mutual covenants contained herein and in the Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;1. Equity in Lieu of Cash Compensation Notwithstanding anything to the contrary in Section 2.(a) of the Agreement, the Director agrees to accept the quarterly cash compensation of $5,000 in the form of shares of the Company's common stock in lieu of cash.

2. Valuation and Issuance The number of shares to be issued each quarter shall be calculated based on the fair market value of the Company's common stock on the last business day of the applicable quarter, as determined in good faith by the Company's Board of Directors.

3. Securities Law Compliance The shares issued pursuant to this Addendum shall be considered "restricted securities" as defined in Rule 144 under the Securities Act of 1933, as amended, and shall bear the applicable restrictive legends. The Director acknowledges and agrees that such shares may not be sold, transferred, or otherwise disposed of without compliance with applicable federal and state securities laws.

4. No Other Amendments Except as expressly modified herein, all terms and conditions of the Agreement shall remain in full force and effect.

![](ex6-13_001.jpg)

**IN WITNESS WHEREOF**, the parties have executed this Addendum as of the date first written above.

**ALTERNATIVE BALLISTICS CORPORATION**

---

| | |
|:---|:---|
| By: | */s/ Steven Luna* |
| Name: | Steven Luna |
| Title: | Chief Executive Officer |

---

**DIRECTOR**

---

| | |
|:---|:---|
| By: | */s/ Bruce Amaro* |
| Name: | Bruce Amaro |

---

## Add

**Exhibit 6.14**

![](ex6-14_001.jpg)

**Restricted Common Stock Award Agreement**

This Restricted Stock Award Agreement (this "**Agreement**") is made and entered into as of January 1, 2025 (the "**Grant Date**") by and between Alternative Ballistics Corporation, a Nevada corporation (the "Company") and Cuento LLC, a California limited liability company (the "**Cuento**").

**WHEREAS**, the Board of Directors has approved the issuance of stock awards from time to time for the purpose of retaining the services of selected employees, consultants, and other independent advisors in the service of the Company.

**WHEREAS**, the Board of Directors of the Company has determined that it is in the best interests of the Company and its shareholders to grant the award of Restricted Stock provided for herein in exchange for services to be provided by Cuento.

**NOW, THEREFORE**, the parties hereto, intending to be legally bound, agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. <u>Grant of Restricted Stock</u>. The Company hereby issues to Cuento on the Grant Date a Restricted Stock Award consisting of, in the aggregate, $30,000 worth of shares of Common Stock of the Company (the "**Restricted Stock**"), per quarter, on the terms and conditions and subject to the restrictions set forth in this Agreement. The number of shares of the Company's common stock awarded will be calculated at the then current "Fair Market Value," which shall be determined by the Board or, if the shares are traded or quoted in an exchange or an over the counter marketplace, by the average of the last sale price of the shares for the ten trading days preceding the end of the quarter. The shares will be issued on the last day of each quarter during the term of the Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. <u>Consideration</u>. The grant of the Restricted Stock is made in consideration of the services to be rendered by Cuento to the Company pursuant to the terms of the Marketing & Promotional Services Agreement entered into on January 1, 2025 (the "**MPSA**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. <u>Restricted Period; Vesting</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1. Except as otherwise provided herein, provided that Cuento remains in Continuous Service through the applicable vesting date, and further provided that any additional conditions and performance goals set forth in the MPSA have been met, the Restricted Stock will vest in accordance with the following schedule:

---

| | |
|:---|:---|
| **Vesting Date** | **Shares of Common Stock** |
| March 31, 2025 | $30000 |
| June 30, 2025 | $30000 |

---

The period over which the Restricted Stock vests is referred to as the "**Restricted Period.**"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2. Upon termination of the MPSA at any time before all of Cuento's Restricted Stock has vested, Cuento's unvested Restricted Stock shall be immediately and automatically forfeited upon such termination and neither the Company nor any Affiliate shall have any further obligations to Cuento under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3. The foregoing vesting schedule notwithstanding, upon the occurrence of a Change in Control, 100% of the unvested Restricted Stock shall vest as of the date of the Change in Control.

![](ex6-14_001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. <u>Restrictions</u>. Subject to any exceptions set forth in this Agreement, during the Restricted Period, the Restricted Stock or the rights relating thereto may not be assigned, alienated, pledged, attached, sold, or otherwise transferred or encumbered by Cuento. Any attempt to assign, alienate, pledge, attach, sell, or otherwise transfer or encumber the Restricted Stock or the rights relating thereto during the Restricted Period shall be wholly ineffective. Subsequent to the Restricted Period, the Restricted Stock may only be assigned, alienated, pledged, attached, sold, or otherwise transferred or encumbered as allowed by law in the particular circumstance. The Company has the right to prohibit any such aforementioned action or to require a legitimate legal opinion from a licensed attorney at Cuento's expense prior to recognizing such action. The Company also has the right to require a permitted transferee to execute such legal documents and agreements as the Company, in its sole discretion, deems necessary, prior to permitting such transfer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. <u>Rights as Shareholder; Dividends</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1. Cuento shall be the record owner of the Restricted Stock, as, when, and if vested, until the shares of Common Stock are sold or otherwise disposed of, and shall be entitled to all of the rights of a shareholder of the Company including, without limitation, the right to vote such shares and receive all dividends or other distributions paid with respect to such shares. Notwithstanding the foregoing, any dividends or other distributions shall be subject to the same restrictions on transferability as the shares of Restricted Stock with respect to which they were paid.

The Company may issue stock certificates or evidence Cuento's interest by using a restricted book entry account with the Company's transfer agent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2. If Cuento forfeits any rights Cuento has under this Agreement in accordance with Section 3 of this Agreement, Cuento shall, on the date of such forfeiture, no longer have any rights as a shareholder with respect to the Restricted Stock and shall no longer be entitled to vote or receive dividends on such shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. <u>No Right to Continued Service</u>. This Agreement shall not confer upon Cuento any right to be retained as a Service Provider of the Company or in any other capacity. Further, nothing in this Agreement shall be construed to limit the discretion of the Company to terminate the MPSA at any time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. <u>Company Representations.</u> The Company represents and warrants to Cuento as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.1. <u>Power and Authority</u>. The Company has the power and authority to execute and deliver this Agreement and consummate the transactions contemplated hereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.2. <u>Organization and Qualification</u>. The Company is incorporated, duly organized, validly existing and in good standing under the laws of the State of Nevada.

![](ex6-14_001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.3. <u>Validity and Enforceability</u>. This Agreement and all other instruments or documents executed by the Company in connection herewith have been duly executed by the Company, and constitute legal, valid and binding obligations of the Company, enforceable in accordance with their respective terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors' rights generally and general principles of equity (whether considered in an action at law or in equity). The terms of this Agreement and the underlying transaction comply with all applicable laws of the United States of America and of any applicable state thereof and no consent, approval, order or authorization of, or registration, qualifications, designation, declaration or filing with, any federal, state or local governmental authority on the part of the Company is required in connection with the consummation of the repurchase of shares contemplated by this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.4. <u>Authorized Capital Stock of Company</u>. The authorized capital stock of the Company consists of 250,000,000 shares of Common Stock and 10,000,000 shares of Preferred Stock, each having a par value of $0.001, of which 139,713,996 shares of Common Stock are issued and outstanding as of December 31, 2024. All the Company's shares are validly issued, fully paid, and nonassessable and have been issued in full compliance with all federal and state securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. <u>Section 83(b) Election</u>. In its sole discretion and upon the advice of its own legal and financial advisors and not on any advice of the Company, Cuento may make an election under Code Section 83(b) (a "**Section 83(b) Election**") with respect to the Restricted Stock. Any such election must be made within 30 days after the Grant Date. If Cuento elects to make a Section 83(b) Election, Cuento shall provide the Company with a copy of an executed version and satisfactory evidence of the filing of the executed Section 83(b) Election with the US Internal Revenue Service. Cuento agrees to assume full responsibility for ensuring that the Section 83(b) Election is actually and timely filed with the US Internal Revenue Service and for all tax consequences resulting from the Section 83(b) Election.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. <u>Compliance with Law</u>. The issuance and transfer of shares of Common Stock shall be subject to compliance by the Company and Cuento with all applicable requirements of federal and state securities laws and with all applicable requirements of any stock exchange on which the Company's shares of Common Stock may be listed. No shares of Common Stock shall be issued or transferred unless and until any then applicable requirements of state and federal laws and regulatory agencies have been fully complied with to the satisfaction of the Company and its counsel. Cuento understands that the Company is under no obligation to register the shares of Common Stock with the Securities and Exchange Commission, any state securities commission or any stock exchange to effect such compliance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. <u>Legends</u>. A legend may be placed on any certificate(s) or other document(s) delivered to the Director indicating restrictions on transferability of the shares of Restricted Stock pursuant to this Agreement or any other restrictions that the Committee may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any applicable federal or state securities laws or any stock exchange on which the shares of Common Stock are then listed or quoted.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. <u>Notices</u>. Any notice required to be delivered to the Company under this Agreement shall be in writing and addressed to the President of the Company at the Company's principal corporate offices. Any notice required to be delivered to Cuento under this Agreement shall be in writing and addressed to the Cuento at the address as shown in the records of the Company. Either party may designate another address in writing (or by such other method approved by the Company) from time to time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. <u>Governing Law</u>. This Agreement will be construed and interpreted in accordance with the laws of the State of California without regard to conflict of law principles.

![](ex6-14_001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. <u>Arbitration</u>. Any controversy arising out of or relating to this Agreement or the enforcement or interpretation of this Agreement, or because of an alleged breach, default, or misrepresentation in connection with any of the provisions of this Agreement, including (without limitation) any state or federal statutory claims, shall be submitted to arbitration in San Diego County, California, before a sole arbitrator (the "Arbitrator") selected from Judicial Arbitration Mediation Services ("JAMS"), or if JAMS is not able to supply the arbitrator, such arbitrator shall be selected from the American Arbitration Association ("AAA"), and shall be conducted in accordance with the provisions of California Code of Civil Procedure §§ 1280 et. seq. as the exclusive remedy of such dispute; provided, however, that provisional injunctive relief may, but need not, be sought in a court of law while arbitration proceedings are pending, and any provisional injunctive relief granted by such court shall remain effective until the matter is finally determined by the Arbitrator. Final resolution of any dispute through arbitration may include any remedy or relief that would be available in a court of law, including any and all remedies provided by applicable state or federal statutes. At the conclusion of the arbitration, the Arbitrator shall issue a written decision that sets forth the essential findings and conclusions upon which the Arbitrator's award or decision is based. Any award or relief granted by the Arbitrator hereunder shall be final and binding on the parties hereto and may be enforced by any court of competent jurisdiction. By agreeing to arbitration, the parties agree that there will be no limitations on discovery. The parties shall be entitled to conduct discovery as they would be in court, as set forth in the California Code of Civil Procedure. The parties acknowledge and agree that they are voluntarily waiving any rights to trial by jury in any action, proceeding or counterclaim brought by either of the parties against the other in connection with any matter whatsoever arising out of or in any way connected with any of the matters referenced in the first sentence of this section. The parties agree that the payment of the forum costs of any arbitration hereunder, including the Arbitrator's fee, shall be shared equally by the parties. The parties further agree that in any proceeding with respect to such matters, the prevailing party will be entitled to recover its reasonable attorney's fees and costs from the non-prevailing party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. <u>Successors and Assigns</u>. The Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon Cuento and its successors and assigns.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. <u>Severability</u>. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each provision of this Agreement shall be severable and enforceable to the extent permitted by law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. <u>Discretionary Nature of Agreement</u>. The grant of the Restricted Stock in this Agreement does not create any contractual right or other right to receive any Restricted Stock or other Awards in the future. Future Awards, if any, will be at the sole discretion of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. <u>Counterparts</u>. This Agreement may be executed in counterparts, each of which shall be deemed an original but all of which together will constitute one and the same instrument. Counterpart signature pages to this Agreement transmitted by facsimile, by electronic mail in portable document format (.pdf), or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document, will have the same effect as physical delivery of the paper document bearing an original signature.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18. <u>Acceptance</u>. Cuento hereby acknowledges receipt of this Agreement. Cuento has read and understands the terms and provisions thereof, and accepts the Restricted Stock subject to all of the terms and conditions of this Agreement. Cuento acknowledges that there may be adverse tax consequences upon the grant or vesting of the Restricted Stock or disposition of the shares and Cuento has been advised to consult a tax advisor prior to such grant, vesting or disposition.

![](ex6-14_001.jpg)

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

ALTERNATIVE BALLISTICS CORPORATION

---

| | |
|:---|:---|
| By: | */s/ Steven Luna* |
| Name: | Steven Luna |
| Title: | Chief Executive Officer |

---

CUENTO, LLC

---

| | |
|:---|:---|
| By: | */s/ Wayne Partello* |
| Name: | Wayne Partello |
| Title: | Chief Executive Officer |

---

## Add

**Exhibit 6.15**

**THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW IS AVAILABLE.**

This Amended and Restated Warrant Agreement (this "Warrant") has been issued pursuant to an Amended and Restated Subscription Agreement dated January 21, 2025 (the "Subscription Agreement") between the Company and the holder of this Warrant (the "Holder"). Capitalized terms not otherwise defined herein shall have the meaning set forth in the Subscription Agreement, the provisions of which are incorporated herein by reference. This Warrant amends and restates the Warrant Agreement dated August 2, 2024.

**ALTERNATIVE BALLISTICS CORPORATION**

**a Nevada Corporation**

**AMENDED AND RESTATED WARRANT AGREEMENT**

**To Purchase up to One Million Shares of Common Stock**

Issue Date: January 21, 2025

THIS CERTIFIES that, for value received, SOLYCO CAC LLC, a Michigan limited liability company, or its assigns (the "Holder"), is entitled, upon the terms and subject to the conditions hereinafter set forth, at any time on or after the date hereof, to subscribe for and purchase from, ALTERNATIVE BALLISTICS CORPORATION, a Nevada corporation (the "Company"), certain fully paid, non-assessable shares of the Company's common stock, par value $0.001 ("Common Stock") set forth in Section 1 below at the Exercise Price (defined below), provided that such right will terminate, if not terminated earlier in accordance with the provisions hereof, at 5:00 p.m. (Pacific time) on the five year anniversary of the Issue Date (the "Expiration Date"). The purchase price and the number of shares for which this warrant (each a "Warrant," and collectively, the "Warrants") is exercisable are subject to adjustment, as provided herein.

As used herein the following terms, unless the context otherwise requires, have the following respective meanings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The term "Company" shall include Alternative Ballistics Corporation and any entity which shall succeed or assume the obligations of Alternative Ballistics Corporation hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The term "Warrant Shares" includes (i) the Company's common stock and (ii) any other securities into which or for which any of the Common Stock may be converted or exchanged pursuant to a plan of recapitalization, reorganization, merger, sale of assets or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The term "Other Securities" refers to any stock (other than Common Stock) and other securities of the Company or any other person (corporate or otherwise) which the holder of the Warrant at any time shall be entitled to receive, or shall have received, on the exercise of the Warrant, in lieu of or in addition to Common Stock, or which at any time shall be issuable or shall have been issued in exchange for or in replacement of Common Stock or Other Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) A "Qualified Offering" shall mean a public offering in the United States pursuant to a registration statement declared effective by the Securities and Exchange Commission pursuant to the Securities Act of 1933, with minimum gross proceeds of $5,000,000, pursuant to which the common stock is listed for trading on Nasdaq or a similar U.S. nationally-recognized stock exchange.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) "Qualified Offering Price" shall be defined as the price at which the Qualified Offering is consummated.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The term "Conversion Price" shall be such price equal to the lesser of (i) a 30% discount to the Qualified Offering Price and (ii) any conversion price offered to other noteholders on notes issued subsequent to the issue date of the Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The term "Exercise Price" shall be equal to the lower of (i) $2.00 or (ii) a 50% discount to the Qualified Offering Price.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The "Note" refers to that certain Promissory Note dated on even date herewith issued to the Holder pursuant to the above-referenced Subscription Agreement.

1. <u>Number of Shares Issuable upon Exercise</u>.

Unless sooner terminated in accordance herewith, from and after the date hereof through and including the Expiration Date, the Holder shall be entitled to receive up to one million (1,000,000) Warrant Shares, upon exercise of this Warrant in whole or in part, by delivery of an original or fax copy of the exercise notice attached hereto as <u>Annex A</u> (the "Notice of Exercise") along with payment to the Company of the Exercise Price.

2. <u>Exercise of Warrant</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The purchase rights represented by this Warrant are exercisable by the registered Holder hereof, in whole at any time or in part from time to time by delivery of the Notice of Exercise duly completed and delivered to the office of the Company, and upon payment of the Exercise Price of the shares thereby purchased (in the manner provided in Section 2(d) hereof); whereupon the Holder of this Warrant shall be entitled to receive a certificate for the number of Warrant Shares so purchased; provided that the Company will place on each certificate a legend substantially the same as that appearing on this Warrant, in addition to any legend required by any applicable state or federal law. If this Warrant is exercised in part, the Company will issue to the Holder hereof a new Warrant upon the same terms as this Warrant but for the balance of Warrant Shares for which this Warrant remains exercisable. The Company agrees that upon exercise of this Warrant the Holder shall be deemed to be the record owner of the Warrant Shares issued upon exercise as of the close of business on the date on which this Warrant shall have been exercised as aforesaid. This Warrant will be surrendered at the time of exercise or if lost, stolen, misplaced, or destroyed, the Holder will comply with Section 11 below.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Certificates for Warrant Shares purchased hereunder shall be delivered to the Holder hereof within a reasonable time after the date on which this Warrant shall have been exercised as aforesaid.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The Company covenants that all Warrant Shares which may be issued upon the exercise of rights represented by this Warrant will, upon exercise of the rights represented by this Warrant, be fully paid and nonassessable and free from all preemptive rights, taxes, liens, and charges in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue which shall be paid by the Company in accordance with Section 6 below).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) In order to exercise this Warrant with respect to all or any part of the Warrant Shares for which this Warrant is at the time exercisable, Holder (or any other person or persons exercising the Warrant) must take the following actions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Execute and deliver to the Company a written notice of exercise stating the number of Warrant Shares being purchased (in whole shares only) and such other information set forth on the form of Notice of Exercise attached hereto as Annex A; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Pay the aggregate Exercise Price for the Warrant Shares by cash, wire transfer, or check made payable to the order of the Company.

3. <u>Leak Out</u>.

During the Leak Out Period (defined below), the Holder's sale of common stock upon exercise of the Warrants shall be limited to 5% of the daily trading volume of the common stock on the immediately prior Trading Day. "Trading Day" shall mean a day on which Nasdaq or a similar U.S. nationally-recognized stock exchange is open for trading. "Leak Out Period" shall mean 12 months following the closing of the Qualified Offering.

4. <u>Mandatory Exercise of Warrants</u>.

At such time, if ever, that the Common Stock is listed on a national securities exchange or quoted in an over-the-counter market, the closing price of the Common Stock equals or exceeds $5.00 per share (which amount may be adjusted for certain capital events, such as stock splits) for ten consecutive trading days (the "Closing Price Measuring Period"), then the Company shall have the right to require the Holder to exercise all or any portion of this Warrant still unexercised, into fully paid, validly issued, and nonassessable shares of Common Stock at the Exercise Price. The Company may exercise its right to require exercise under this Section 4 by delivering within not more than five trading days following the end of such Closing Price Measuring Period a written notice thereof by electronic mail to the Holder (the "Mandatory Exercise Notice"). The Mandatory Exercise Notice shall be irrevocable. Following receipt of the Mandatory Exercise Notice, the Holder will be required to exercise all or any portion of this Warrant still unexercised within 30 calendar days from the date of the Mandatory Exercise Notice (the "Mandatory Exercise Period"). Any unexercised portion of this Warrant on the day immediately following the last day of the Mandatory Exercise Period shall be immediately forfeited.

5. <u>No Fractional Shares</u>.

The Company shall not be required to issue fractional Warrant Shares upon the exercise of this Warrant or to deliver Warrant Certificates which evidence fractional Warrant Shares. In the event that a fraction of a Warrant Share would, except for the provisions of this Section 5, be issuable upon the exercise of this Warrant, the Company shall round the fraction down to the next whole number of the Warrant Share.

6. <u>Charges, Taxes, and Expenses</u>.

Issuance of certificates for Warrant Shares upon the exercise of this Warrant shall be made without charge to the Holder hereof for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Company, and such certificates shall be issued in the name of the Holder of this Warrant, or in such name or names as may be directed by the Holder of this Warrant; provided, however, that in the event certificates for Warrant Shares are to be issued in a name other than the name of the Holder of this Warrant, the Company may require, as a condition thereto, that the transferee execute an appropriate investment representation as may be reasonably required by the Company.

7. <u>No Rights as Shareholders</u>.

This Warrant does not entitle the Holder hereof to any voting rights or other rights as a Shareholder of the Company prior to the exercise hereof.

8. <u>Securities Law Representations</u>.

Holder represents and warrants to Company as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Holder acknowledges that the Warrant Shares will initially be "restricted securities" (as such term is defined in Rule 144 promulgated under the Act) ("Rule 144") and that the certificates evidencing the Warrant Shares will include this legend:

"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW IS AVAILABLE."

Holder further acknowledges that the Warrant Shares cannot be sold unless registered with the United States Securities and Exchange Commission and qualified by appropriate state securities regulators, or unless Holder obtains written consent from Company and otherwise complies with an exemption from such registration and qualification (including, without limitation, compliance with Rule 144).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Holder has adequate means of providing for current needs and contingencies, has no need for liquidity in the investment, and is able to bear the economic risk of an investment in the Warrant and Warrant Shares offered by Company of the size contemplated. Holder represents that Holder is able to bear the economic risk of the investment and at the present time can afford a complete loss of such investment. Holder has had a full opportunity to inspect the books and records of the Company and to make any and all inquiries of Company officers and directors regarding the Company and its business as Holder has deemed appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Holder is an "Accredited Investor" as defined in Regulation D of the Securities Act or Holder, either alone or with Holder's professional advisers who are unaffiliated with, have no equity interest in and are not compensated by Company or any affiliate or selling agent of Company, directly or indirectly, has sufficient knowledge and experience in financial and business matters that Holder is capable of evaluating the merits and risks of an investment in the Warrant and Warrant Shares offered by Company and of making an informed investment decision with respect thereto and has the capacity to protect Holder's own interests in connection with Holder's proposed investment in the Warrant and Warrant Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Holder is acquiring the Warrant and Warrant Shares solely for Holder's own account as principal, for investment purposes only and not with a view to the resale or distribution thereof, in whole or in part, and no other person or entity has a direct or indirect beneficial interest in such Warrant or Warrant Shares.

9. <u>Rule 144 Opinions</u>.

The Company will, at its own expense, provide any and all legal opinions required for the removal of any restrictive legend from any stock certificates representing Warrant Shares under Rule 144. The Company will not unreasonably withhold any legal opinion required for the removal of the restrictive legend from any certificates representing the Warrant Shares pursuant to Rule 144 and will process such request within five business days of receipt of such request.

10. <u>Exchange and Registry of Warrant</u>.

This Warrant is exchangeable, upon the surrender hereof by the registered Holder at the office of the Company, for a new Warrant or Warrants aggregating the total Warrant Shares of the surrendered Warrant of like tenor and dated as of such exchange. The Company shall maintain at its office a registry showing the name and address of the registered Holder of this Warrant. This Warrant may be surrendered for exchange, transfer, or exercise, in accordance with its terms, at such office of the Company, and the Company shall be entitled to rely in all respects, prior to written notice to the contrary, upon such registry.

11. <u>Loss, Theft, Destruction, or Mutilation of Warrant</u>.

Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction, or mutilation of this Warrant, and in case of loss, theft, or destruction, of indemnity reasonably satisfactory to it, and upon reimbursement to the Company of all reasonable expenses incidental thereto, and upon surrender and cancellation of this Warrant, if mutilated, the Company will make and deliver a new Warrant of like tenor (but with no additional rights or obligations) and dated as of such cancellation, in lieu of this Warrant.

12. <u>Saturdays, Sundays, Holidays, etc.</u>

If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall be a Saturday or a Sunday or shall be a legal holiday, then such action may be taken or such right may be exercised on the next succeeding day not a Saturday, Sunday, or legal holiday.

13. <u>Cash Distributions</u>.

If the Company issues cash dividends or interest on the Company's Common Stock or Other Securities that may become purchasable hereunder, the Exercise Price under this Warrant will be adjusted to reflect the diluted value of the Warrant.

14. <u>Consolidation, Merger, or Sale of the Company</u>.

If the Company is a party to a consolidation, merger, or transfer of assets which reclassifies or changes its outstanding Common Stock, the successor corporation (or corporation controlling the successor corporation or the Company, as the case may be) shall by operation of law assume the Company's obligations under this Warrant. Upon consummation of such transaction, the Warrants shall automatically become exercisable for the kind and amount of securities, cash, or other assets which the holder of a Warrant would have owned immediately after the consolidation, merger, or transfer if the holder had exercised the Warrant immediately before the effective date of such transaction. As a condition to the consummation of such transaction, the Company shall arrange for the person or entity obligated to issue securities or deliver cash or other assets upon exercise of the Warrant to, concurrently with the consummation of such transaction, assume the Company's obligations hereunder by executing an instrument so providing and further providing for adjustments which shall be as nearly equivalent as may be practical to the adjustments provided for in this Section 14.

15. <u>Adjustments for Stock Splits, Combinations, etc.</u>

The number of shares and class of capital stock purchasable under this Warrant are subject to adjustment from time to time as set forth in this Section 15.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Adjustment for change in capital stock. If the Company:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) pays a dividend or makes a distribution on its Common Stock, in each case, in shares of its Common Stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) subdivides its outstanding shares of Common Stock into a greater number of shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) combines its outstanding shares of Common Stock into a smaller number of shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) makes a distribution on its Common Stock in shares of its capital stock other than Common Stock; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) issues by reclassification of its shares of Common Stock any shares of its capital stock;

then the number and classes of shares purchasable upon exercise of each Warrant in effect immediately prior to such action shall be adjusted so that the holder of any Warrant thereafter exercised may receive the number and classes of shares of capital stock of the Company which such holder would have owned immediately following such action if such holder had exercised the Warrant immediately prior to such action.

For a dividend or distribution, the adjustment shall become effective immediately after the record date for the dividend or distribution. For a subdivision, combination, or reclassification, the adjustment shall become effective immediately after the effective date of the subdivision, combination, or reclassification.

If after an adjustment the Holder, upon exercise of a Warrant, may receive shares of two or more classes of capital stock of the Company, the Board of Directors of the Company shall in good faith determine the allocation of the adjusted Exercise Price between or among the classes of capital stock. After such allocation, that portion of the Exercise Price applicable to each share of each such class of capital stock shall thereafter be subject to adjustment on terms comparable to those applicable to Common Stock in this Warrant. Notwithstanding the allocation of the Exercise Price between or among shares of capital stock as provided by this Section 15(a), a Warrant may only be exercised in full by payment of the entire Exercise Price currently in effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Company will not, by amendment of its Articles of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue, or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company. The Company shall at all times in good faith assist in the carrying out of all the provisions of this Section 15 and take all necessary or appropriate actions to protect the exercise rights of the Holders of this Warrant against impairment, including but not limited to obtaining a written agreement from any successor or acquiring entity to honor this Warrant in full and recognizing the Holder's right to the same terms and conditions in any new entity.

16. <u>Certificate as to Adjustments</u>.

In each case of any adjustment or readjustment in the shares of Common Stock (or Other Securities) issuable on the exercise of the Warrant, the Company at its expense will promptly cause its Chief Financial Officer or other appropriate designee to compute such adjustment or readjustment in accordance with the terms of the Warrant and prepare a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based, including a statement of (a) the consideration received or receivable by the Company for any additional shares of Common Stock (or Other Securities) issued or sold or deemed to have been issued or sold, (b) the number of shares of Common Stock (or Other Securities) outstanding or deemed to be outstanding, and (c) the Exercise Price and the number of shares of Common Stock to be received upon exercise of this Warrant, in effect immediately prior to such adjustment or readjustment and as adjusted or readjusted as provided in this Warrant. The Company will forthwith mail a copy of each such certificate to the Holder of the Warrant and any Warrant agent of the Company.

17. <u>Reservation of Stock Issuable on Exercise of Warrant</u>.

The Company will at all times reserve and keep available, solely for issuance and delivery on the exercise of the Warrant, shares of Common Stock (or Other Securities) from time to time issuable on the exercise of the Warrant.

18. <u>Assignment; Exchange of Warrant</u>.

This Warrant, and the rights evidenced hereby, may not be transferred to any third party other than an affiliate of the Holder without the prior written consent of the Company which may be withheld in the sole and absolute discretion of the Company and compliance with applicable securities laws. As a condition precedent to the Company considering whether to consent to a transfer, the Holder shall deliver to the Company a legal opinion from the Holder's counsel that such transfer is exempt from the registration requirements of applicable securities laws at the Holder's expense. If the Company consents to the proposed transfer (if applicable), upon surrender for exchange of this Warrant, together with evidence reasonably satisfactory to the Company demonstrating compliance with applicable securities laws and payment by the Holder of any applicable transfer taxes, the Company will issue and deliver to or on the order of the Holder a new Warrant of like tenor, in the name of the Holder and/or the transferee(s) specified (each a "Transferee"), calling in the aggregate on the face or faces thereof for the number of Warrant Shares called for on the face or faces of the Warrant so surrendered by the Holder; and provided further, that upon any such transfer, the Company may require, as a condition thereto, that the Transferee execute an appropriate investment representation as may be reasonably required by the Company.

19. <u>Notices</u>.

Any notice, request, instruction, or other document required by the terms of this Note, or deemed by any of the Parties hereto to be desirable, to be given to any other Party hereto shall be in writing and shall be given by personal delivery, overnight delivery, mailed by registered or certified mail, postage prepaid, with return receipt requested, or sent by electronic transmission to the addresses of the Parties set forth in the Subscription Agreement. The persons and addresses set forth in the Notice provision of the Subscription Agreement may be changed from time to time by a notice sent as aforesaid. If notice is given by mail in accordance with the provisions of this Section, such notice shall be conclusively deemed given upon receipt and delivery or refusal. If notice is given by electronic mail transmission in accordance with the provisions of this Section, such notice shall be conclusively deemed given at the time of delivery if between the hours of 9:00 a.m. and 5:00 p.m. Pacific time on a business day ("business hours") and if not during business hours, at 9:00 a.m. on the next business day following delivery, provided a delivery confirmation is obtained by the sender.

20. <u>Notices of Record Date</u>.

In case,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company takes a record of the holders of its Common Stock for the purpose of entitling them to subscribe for or purchase any shares of stock of any class or to receive a dividend, distribution, or any other rights;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) There is any capital reorganization of the Company, reclassification of the capital stock of the Company (other than a subdivision or combination of its outstanding shares of Common Stock), or consolidation or merger of the Company with or into another corporation which does not constitute a sale of the Company; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) There is a voluntary or involuntary dissolution, liquidation, or winding up of the Company;

then, and in any such case, the Company shall cause to be mailed to the Holder, at least 20 business days prior to the date hereinafter specified, a notice stating the date on which (i) a record is to be taken for the purpose of such dividend, distribution or rights, or (ii) such reclassification, reorganization, consolidation, merger, dissolution, liquidation, or winding up is to take place and the date, if any is to be fixed, as of which holders of Common Stock of record shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such reclassification, reorganization, consolidation, merger, dissolution, liquidation, or winding up.

21. <u>Amendments and Supplements</u>.

The Company may from time to time supplement or amend this Warrant without the approval of any Holders in order to cure any ambiguity or to correct or supplement any provision contained herein which may be defective or inconsistent with any other provision, or to make any other provisions in regard to matters or questions herein arising hereunder which the Company may deem necessary or desirable and which shall not materially adversely affect the interest of the Holder. All other supplements or amendments to this Warrant must be signed by the party against whom such supplement or amendment is to be enforced.

22. <u>Investment Intent</u>.

Holder represents and warrants to the Company that Holder is acquiring the Warrants for investment and with no present intention of distributing or reselling any of the Warrants.

23. <u>Miscellaneous</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) This Warrant shall be governed by and construed in accordance with the laws of the State of California without regard to principles of conflicts of laws. The Company and the Holder hereby submit to the exclusive jurisdiction of the Courts of Orange County, State of California for the resolution of all legal disputes arising under the terms of this Warrant. The Company and the Holder agree to waive trial by jury.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) If any action or proceeding is brought by the Company on the one hand or by the Holder on the other hand to enforce or continue any provision of this Warrant, the prevailing party's costs and expenses, including its reasonable attorneys' fees, in connection with such action or proceeding shall be paid by the other party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) In the event that any provision of this Warrant is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of this Warrant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The headings in this Warrant are for purposes of reference only and shall not limit or otherwise affect any of the terms hereof.

**[SIGNATURE PAGE FOLLOWS]**

**IN WITNESS WHEREOF**, the Company has caused this Warrant to be executed by its officers thereunto duly authorized as of the date first written above.

---

| | |
|:---|:---|
| **COMPANY:** | **COMPANY:** |
| **ALTERNATIVE BALLISTICS CORPORATION**, | **ALTERNATIVE BALLISTICS CORPORATION**, |
| a Nevada corporation | a Nevada corporation |
|  | */s/ Steven Luna* |
| By: | Steven Luna |
| Its: | Chief Executive Officer |

---

---

| | |
|:---|:---|
| **HOLDER:** | **HOLDER:** |
| **SOLYCO CAC LLC,** | **SOLYCO CAC LLC,** |
| a Michigan limited liability company | a Michigan limited liability company |
|  | */s/ John Garcia* |
| By: | John Garcia |
| Its: | Managing Director |

---

**ANNEX A**

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF CERTAIN STATES, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW IS AVAILABLE.

NOTICE OF EXERCISE

The undersigned hereby elects irrevocably to exercise the within Warrant and to purchase _______ shares of Common Stock of Alternative Ballistics Corporation and hereby makes payment of $___________ (at the rate of $________________ per share) in payment of the Exercise Price pursuant hereto. Please issue the shares as to which this Warrant is exercised in accordance with the instructions given below.

INSTRUCTIONS FOR REGISTRATION OF SHARES

Name (print) _______________________________________________

Address (print) _______________________________________________

Address (print) _______________________________________________

ASSIGNMENT

FOR VALUE RECEIVED, _________ does hereby sell, assign, and transfer unto __________, the right to purchase _______________shares of Common Stock of Alternative Ballistics Corporation, evidenced by the within Warrant, and does hereby irrevocably constitute and appoint ___________ attorney to transfer such right on the books of Alternative Ballistics Corporation, with full power of substitution on the premises.

Dated: __________, 20___

Signature: ________________________________

Notice: The signature of Notice of Exercise or Assignment must correspond with the name as written upon the face of the within Warrant in every particular without alteration or enlargement or any change whatsoever.

## Add

**Exhibit 6.16**

![](ex6-16_001.jpg)

**<u>THIRD AMENDMENT TO CONVERTIBLE PROMISSORY NOTE</u>**

This THIRD AMENDMENT TO CONVERTIBLE PROMISSORY NOTE (this "**<u>Third Amendment</u>**") is dated effective as of May 21, 2025 (the **"<u>Amendment Effective Date</u>**"), by and between **Alternative Ballistics Corporation**, a Nevada Corporation (the "**<u>Company</u>**") and Sky Financial & Intelligence LLC ("**<u>Sky</u>**"), and Kenneth Haller ("**<u>Haller</u>**"), or their respective assignees (Sky and Haller, collectively referred to as "<u>**Holder**</u>" and together with the Company, the "**<u>Parties</u>**").

**WHEREAS**, the Company and the Holder entered into that certain Convertible Promissory Note, dated as of March 29, 2022, pursuant to which the Company issued to the Holder a convertible promissory note in the original principal amount of $1,000,000 (together with all accrued interest thereon, the "**<u>Original Note</u>**");

**WHEREAS**, the Company and the Holder entered into that certain First Amendment to Original Note, dated as of August 23, 2023 (the "**<u>First Amendment</u>**"), pursuant to which the parties amended certain terms of the Original Note, including, among other things, the maturity date, and in consideration of the Holder's agreement to enter into the First Amendment, the Company issued to the Holder a warrant to purchase securities of the Company, dated as of August 23, 2023 (the "**<u>Warrant</u>**");

**WHEREAS**, the Company and the Holder entered into that certain Second Amendment to Convertible Promissory Note, dated as of August 15, 2024 (the "**<u>Second Amendment</u>**"), pursuant to which the parties further amended certain terms of the Original Note, as previously amended by the First Amendment;

**WHEREAS**, the Company and the Holder now desire to further amend the Original Note, as amended by the First Amendment and Second Amendment, pursuant to the terms and conditions set forth in this Third Amendment; and

**WHEREAS**, as an inducement for the Holder to enter into this Third Amendment, the Company shall issue 12,000,000 shares of common stock in the capital of the Company to the Holder.

**NOW, THEREFORE,** in consideration of the premises and the mutual covenants of the parties hereinafter expressed and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto, each intending to be legally bound, agree as follows:

1. <u>Recitals</u>. The recitations set forth in the preamble
of this Third Amendment are true and correct and incorporated herein by this reference.

2. <u>Capitalized Terms</u>. All capitalized terms used in this
Third Amendment shall have the same meaning ascribed to them in the Original Note, except as otherwise specifically set forth herein.

3. <u>Conflicts</u>. In the event of any conflict or ambiguity
by and between the terms and provisions of this Third Amendment and the terms and provisions of the Original Note, the terms and provisions
of this Third Amendment shall control, but only to the extent of any such conflict or ambiguity.

![](ex6-16_001.jpg)

4. <u>Amendment to Original Note</u> 

&nbsp;&nbsp;&nbsp;&nbsp;A. The
 Original Note shall be amended to reflect the extension hereunder, so that the Maturity Date
 shall be March 29, 2027.

&nbsp;&nbsp;&nbsp;&nbsp;B. Any
 reference to "two years" in the recitals of the Original Note, including under
 the subheading "Repayment," is hereby deleted in its entirety and replaced with
 "five years."

5. <u>Share Issuance</u>. Concurrent with the execution and delivery of this Third Amendment, the Company
 shall issue to the Holder 12,000,000 duly authorized, validly issued, fully paid and non-assessable
 shares of common stock of the Company (the " <u>Inducement Shares</u> "), free
 and clear of all liens, claims, and encumbrances. The issuance of the Inducement Shares has
 been made in compliance with all applicable securities laws and does not violate the organizational
 documents of the Company or any agreement binding on the Company.

6. <u>No Interest.</u> The Parties acknowledge and agree that no interest shall accrue on the Original
 Note, as amended by the First Amendment, the Second Amendment, or this Third Amendment, until
 March 29, 2027. The Holder's agreement to defer the accrual of interest as set forth
 herein is a material inducement to the Company's issuance of the Inducement Shares
 to the Holder in connection with this Third Amendment.

7. <u>Not a Novation</u>. This Third Amendment is a modification of the Original Note only and not
 a novation.

8. <u>Effect on Original Note and Transaction Document</u> s. Except as expressly amended by this Amendment,
 all of the terms and provisions of the Original Note shall remain and continue in full force
 and effect after the execution of this Third Amendment, are hereby ratified and confirmed,
 and incorporated herein by this reference.

9. <u>Execution</u>.
 This Third Amendment may be executed in one or more counterparts, all of which taken together
 shall be deemed and considered one and the same amendment. In the event that any signature
 is delivered by facsimile transmission or by e-mail delivery of a ".pdf' format
 file or other similar format file, such signature shall be deemed an original for all purposes
 and shall create a valid and binding obligation of the party executing same with the same
 force and effect as if such facsimile or ".pdf' signature page was an original
 thereof.

![](ex6-16_001.jpg)

IN WITNESS WHEREOF, the parties hereto have duly executed this Third Amendment as of the day and year first above written.

---

| | |
|:---|:---|
| **ALTERNATIVE BALLISTICS CORPORATION** | **ALTERNATIVE BALLISTICS CORPORATION** |
| By: | */s/ Steven Luna* |
| Name: | Steven Luna |
| Title: | Chief Executive Officer |

---

**KENNETH HALLER, on behalf of himself and SKY FINANCIAL & INTELLIGENCE, LLC, a Wyoming limited liability company**

---

| | |
|:---|:---|
| By: | */s/ Kenneth Haller* |
| Name: | Kenneth Haller |
| Its: | Sole Member of Sky Financial & Intelligence, LLC |

---

## Add

**Exhibit 6.17**

**ALTERNATIVE BALLISTICS CORPORATION, A NEVADA CORPORATION**

**BRIDGE LOAN OFFERING DOCUMENTS**

***July 2, 2025***

**Documents included in this package:**

&nbsp;&nbsp;&nbsp;&nbsp;**1.** **Instructions for Payment** 

&nbsp;&nbsp;&nbsp;&nbsp;**2.** **Subscription Agreement** 

&nbsp;&nbsp;&nbsp;&nbsp;**3.** **Investor Representations and Warranties Agreement** 

&nbsp;&nbsp;&nbsp;&nbsp;**4.** **Convertible Note** 

&nbsp;&nbsp;&nbsp;&nbsp;**5.** **Disclosure Document** 

**INSTRUCTIONS FOR PAYMENT**

Review and complete the Bridge Loan Offering Documents and mail or deliver them, along with a check made payable to "Alternative Ballistics Corporation" in the amount of your investment to:

**Alternative Ballistics Corporation**

Attn: Steve Luna, Chief Executive Officer

5940 S. Rainbow Blvd.

Las Vegas, NV 89118

For any inquiries, please contact:

Steve Luna, Chief Executive Officer

Email: steve@alternativeballistics.com

Phone: 619-326-4411

We prefer you to send a wire transfer instead of a check. Please scan and email the signed Bridge Loan Offering Documents to the email address above and send the wire transfer using these instructions:

**Wiring Instructions:**

US Bank

Wire Transfer Department

P.O. Box 64830

St. Paul, MN 55164-0830

Phone: 800-872-2657

Routing Number: 122235821

For Further Credit to: Alternative Ballistics Corporation

Account Number: 157523676557

**<u>SUBSCRIPTION AGREEMENT</u>**

This SUBSCRIPTION AGREEMENT is made on July 2, 2025 by and between Alternative Ballistics Corporation, a Nevada corporation (the "Company") and Vanessa Luna, an individual (the "Investor") (the Company and the Investor may be referred to individually as a "Party" or collectively as the "Parties") as of the date set forth on the signature page of this Agreement.

**RECITALS:**

WHEREAS, the Company is offering to Purchaser a $25,000 Convertible Note, convertible into shares of common stock at a 50% discount to the Qualified Offering Price (defined below) (the "Note");

WHEREAS, the Investor desires to subscribe for the Notes (and together with the shares of common stock into which the Note is convertible, referred to herein as the "Securities") for the purchase price of $25,000 (the "Purchase Price"); and

WHEREAS, this Subscription Agreement is part of a package of documents, including Instructions for Payment, Investor Representations, the Note, and Disclosure Document (hereinafter defined), all of which are incorporated herein by reference (the "Transaction Documents").

NOW THEREFORE, in consideration of the promises and respective mutual agreements herein contained, it is agreed by and between the Parties hereto as follows:

**ARTICLE I.**

**THE SECURITIES**

<u>Section 1.01. THE PURCHASE OF THE SECURITIES</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Subscription*. The Investor is purchasing the Securities, on the terms set forth in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Convertible Note*. The Note shall be in the form attached hereto, the terms of which are hereby incorporated herein as if such Note was fully set forth herein; provided, however, that in the event of any conflict between the express provisions of the Note and this Subscription Agreement, the provisions of the Note shall control.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Loan
 Amount. The Note shall be in the amount of $25,000. Investor shall pay for the Securities
 in three installments, as follows:

---

| | |
|:---|:---|
| Amount | Payment Date |
| $25000 | July 2, 2025 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. Maturity
 Date. The principal balance and all accrued and unpaid interest thereon shall be due and
 payable six (6) months from the date of the Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii. Interest
 Rate. The Note shall bear an interest rate of 15% per annum.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iv. Prepayment.
 In the event of a prepayment of the Loan prior to the Maturity Date, the Company shall pay
 120% of the Principal Balance plus any accrued and unpaid interest on the original Principal
 Balance of the Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;v. Repayment
 Upon a Qualified Offering. In the event a Qualified Offering (defined below) closes prior
 to the Maturity Date, the Investor has the option (a) to be repaid from the proceeds of the
 Qualified Offering within five days from the closing of the Qualified Offering; or (b) in
 the event that the Investor does not exercise such option for repayment, then the Note shall
 automatically convert into shares of common stock 30 days following the closing of the Qualified
 Offering pursuant to the conversion terms set forth below. A "Qualified Offering"
 shall mean a public offering in the United States pursuant to a registration statement declared
 effective by the Securities and Exchange Commission (the "Commission") pursuant
 to the Securities Act of 1933 (the "Act"), with minimum gross proceeds of $5,000,000,
 pursuant to which the common stock is listed for trading on Nasdaq or a similar U.S. nationally-recognized
 stock exchange.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;vi. Conversion.
 The Principal Balance and all accrued and unpaid interest may be converted at any time prior
 to the Maturity Date at the option of the Company into shares of common stock at the Conversion
 Price. The "Conversion Price" shall be such price equal to the lower of (i) a
 50% discount to the "Qualified Offering Price," which shall be defined as the
 price at which the Qualified Offering is consummated and (ii) any conversion price offered
 to other noteholders on notes issued subsequent to the issue date of the Note.

<u>Section 1.02. CLOSING</u>.

The purchase and sale of the Securities will take place at one closing (the "Closing") at a time and date as soon as practicable after all the conditions set forth in Articles III and IV hereof have been satisfied ("Closing Date"), and at such time and location as the Investor and the Company shall agree.

<u>Section 1.03. DELIVERY</u>.

At or prior to the Closing, the Investor shall deliver to the Company the Purchase Price for the Securities and all Transaction Documents signed by the Investor. At the Closing, the Company shall deliver to the Investor all Transaction Documents counter-signed by the Company.

<u>Section 1.04. LEGENDS; SECURITIES NOT REGISTERED UNDER THE SECURITIES ACT OF 1933</u>.

The Securities have not been registered under the Securities Act of 1933, as amended (the "Act"). Each of the certificates for the Securities shall bear substantially the following legend:

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW IS AVAILABLE.

The Offering is not a public offering and is intended to be made pursuant to exemptions from registration as set forth in Section 4(2) of the Act and Regulation D as promulgated by the Securities and Exchange Commission ("SEC") under the Act. This Offering is also intended to be exempt from the registration requirements of various state securities laws as may be applicable.

**ARTICLE II.**

**REPRESENTATIONS AND WARRANTIES**

<u>Section 2.01. INVESTOR REPRESENTATIONS AND WARRANTIES</u>.

The Investor makes each and every one of the representations and warranties set forth in the document entitled Investor Representations and Warranties Agreement attached hereto and incorporated herein by this reference as if such document were set forth herein in its entirety.

<u>Section 2.02. COMPANY REPRESENTATIONS AND WARRANTIES</u>.

The Company hereby represents, warrants, and covenants to the Investor as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company has been duly organized and validly existing as a corporation in good standing under the laws of the state of its incorporation. The Company is duly qualified or licensed and in good standing as a foreign corporation in each jurisdiction in which its ownership or leasing of any properties or the character of its operations requires such qualification or licensing and where failure to so qualify would have a material effect on the Company. The Company has all requisite corporate power and authority, and all material and necessary authorizations, approvals, orders, licenses, certificates, and permits of and from all governmental regulatory officials and bodies to own or lease its properties and conduct its businesses as described in the Company's Offering Circular on Form 1-A dated June 10, 2024 (hereinafter, the "Disclosure Document") and the Company is doing business in compliance with all such authorizations, approvals, orders, licenses, certificates, and permits and all federal, state, and local laws, rules, and regulations concerning the business in which it is engaged except where the failure so to do business in compliance would not have a material adverse effect on the business of the Company. The disclosures herein and in the Disclosure Document concerning the effects of federal, state, and local regulation on the Company's business as currently conducted and as contemplated are correct in all material respects and do not omit to state a material fact. The Company has all corporate power and authority to enter into the Transaction Documents and to carry out the provisions and conditions hereof and thereof, and all consents, authorizations, approvals, and orders required in connection herewith and therewith have been obtained or will have been obtained prior to the Closing Date. No consent, authorization, or order of, and no filing with any court, government agency, or other body is required for the issuance of the Securities pursuant to this Agreement except with respect to applicable federal and state securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) This Agreement and the Transaction Documents have been duly and validly authorized, executed, and delivered by the Company and are valid and binding agreements of the Company, enforceable in accordance with their respective terms, except to the extent that the enforceability hereof or thereof may be limited by (A) bankruptcy, insolvency, reorganization, moratorium, or similar laws from time to time in effect and affecting the rights of creditors generally; (B) limitations upon the power of a court to grant specific performance or any other equitable remedy; or (C) a finding by a court of competent jurisdiction that the indemnification provisions herein are in violation of public policy. The Securities have been duly authorized and are validly issued, fully paid, and non-assessable; all corporate action required to be taken for the authorization, issue, and sale of such securities has been duly and validly taken; and to the best knowledge of the Company, the Securities are not and will not be subject to the preemptive rights of any stockholder of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The Company has good and marketable title to, or valid and enforceable leasehold estates in, all items of real and personal property owned or leased by it, free and clear of all liens, claims, encumbrances, security interests, and defects of any material nature whatsoever, except for Permitted Liens. "Permitted Liens" means liens, claims, encumbrances, security interests, and defects of any material nature whatsoever that are described in the Disclosure Document or otherwise disclosed to the Investor.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) There is no litigation or governmental proceeding pending or threatened against or involving the properties or business of the Company which the Company believes would materially adversely affect the value or the operation of the properties or the business of the Company, except as set forth in the Disclosure Document.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) There has been no material adverse change in the condition or prospects for commercialization of the Company, financial or otherwise, as of the latest dates as of which such condition or prospects, respectively, are set forth in this Agreement and the Disclosure Document; and the outstanding debt, property, and the business of the Company conform in all material respects to the descriptions thereof contained herein and therein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) The Securities shall conform in all respects to all statements in relation thereto contained herein or in the Disclosure Document.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) The Company is not in material violation of its Articles of Incorporation, or its Bylaws. Neither the execution and delivery of the Transaction Documents, nor the issuance of the Securities, nor the consummation of any of the transactions contemplated herein or in the Note, nor the compliance by the Company with the terms and provisions contained herein, or in the Note, has conflicted with or will conflict with, or has resulted in or will result in a breach of, any of the terms and provisions of, or has constituted or will constitute a default under, or has resulted in or will result in the creation or imposition of any lien, charge, or encumbrance upon any property or assets of the Company pursuant to the terms of any indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement or instrument evidencing an obligation for borrowed money, or any other agreement or instrument to which the Company is subject; nor will such action result in any violation of the provisions of the Articles of Incorporation or the Bylaws of the Company, or any statute or any order, rule, or regulation applicable to the Company of any court or of any federal, state, or other regulatory authority or other government body having jurisdiction over the Company; except for any conflict, breach, default, lien, charge, or encumbrance which does not have a material and adverse effect on the Company, any of its business, property, or assets or any transactions contemplated hereby or by the Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) Subsequent to the dates as of which information is given in this Agreement or the Disclosure Document, and except as may otherwise be indicated or contemplated herein or therein, the Company has not entered into any transaction other than in the ordinary course of business or declared or paid any dividend or made any other distribution on or in respect of its capital stock. The Investor acknowledges that the Company may conduct financing activities in the future which would result in the issuance of securities of the Company to third parties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The Company owns or possesses, free and clear of all liens or encumbrances and rights thereto or therein by third parties, other than Permitted Liens, the requisite licenses or other rights to use all trademarks, service marks, copyrights, service names, trade names, patents, patents applications, and licenses necessary to conduct and material to their businesses (including, without limitation any such licenses or rights described herein as being owned or possessed by the Company), and there is no material claim or action by any person pertaining to, or proceeding, pending or threatened, which challenges the exclusive rights of the Company with respect to any trademarks, service marks, copyrights, service names, trade names, patents, patent applications, and licenses used in the conduct of the Company's business (including, without limitation, any such licenses or rights described herein or in the Disclosure Document as being owned or possessed by the Company); the Company's current products, services, and processes do not and will not infringe on any patents currently held by third parties, to the best knowledge of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) Neither the Disclosure Document nor any of the documents contained in the Transaction Documents contain any untrue statement of a material fact or omits to state any material fact required to be stated herein or therein or necessary to make the statements herein or therein, considering the circumstances under which they were made, not misleading. All statements of material facts herein or therein (including, without limitation, any attachment, exhibit, or schedule hereto or thereto) are true and correct as of the date hereof and will be true and correct on the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) The Company shall use the proceeds from this Offering for costs and expenses of related to its initial public offering as well as for general working capital purposes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) Neither the Company, nor any of its respective officers, directors, employees, or agents, nor any other person acting on behalf of the Company has, directly or indirectly, given or agreed to give any money, gift, or similar benefit (other than legal price concessions to customers in the ordinary course of business) to any customer, supplier, employee, or agent of a customer or supplier, or official or employee of a customer or supplier, or official or employee of any governmental agency or instrumentality of any government (domestic or foreign) or any political party or candidate for office (domestic or foreign), or other person who is or may be in a position to help or hinder the business of the Company (or assist it in connection with any actual or proposed transaction) which (A) might subject the Company to any damage or penalty in any civil, criminal, or governmental litigation or proceeding; (B) if not given in the past, might have had a materially adverse effect on the assets, business, or operations of the Company as reflected in the financial statements delivered to the Investor, if any; or (C) if not continued in the future, might adversely affect the assets, business, operations, or prospects of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) The Company has not paid or promised to pay any form of compensation to any unlicensed finders, whether in the form of finder's fees, origination fees, referral fees, or otherwise, in connection with this Offering.

**ARTICLE III.**

**CONDITIONS TO THE INVESTOR'S OBLIGATIONS**

The obligation of the Investor to purchase the Securities at Closing is subject to the following conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The representations and warranties of the Company contained herein shall be true and correct in all material respects on and as of the Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) There shall be no preliminary or permanent injunction or other order, decree, or ruling issued by a court of competent jurisdiction or by a governmental, regulatory, or administrative agency or commission, nor any statute, rule, regulation, or order promulgated or enacted by any governmental authority, prohibiting, or otherwise restraining the sale or purchase of the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) On or prior to the Closing Date, the Investor shall have been furnished such documents, certificates, and opinions as they may reasonably require for the purpose of enabling them to review or pass upon the matters set forth herein, or in order to evidence the accuracy, completeness, or satisfaction of any of the representations, warranties, or conditions herein contained.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Prior to the Closing, (i) there shall have been no material adverse change nor development involving a prospective change in the condition, prospects, or the business activities, financial or otherwise, of the Company as a whole, from the latest dates as of which such condition is set forth in this Subscription Agreement and the Disclosure Document; (ii) there shall have been no transaction, not in the ordinary course of business, entered into by the Company from the latest date as of which the financial condition of the Company is set forth in this Subscription Agreement which is material to the Company and which has not been disclosed to the Investor in writing; (iii) the Company shall not be in default in any material respect under any provision of any instrument relating to any outstanding indebtedness; (iv) no material amount of the assets of the Company shall have been pledged or mortgaged; and (v) no action, suit, or proceeding, at law or in equity, shall have been pending or threatened against the Company or affecting any of its respective properties or businesses before or by any court of federal or state commission, board, or other administrative agency wherein an unfavorable decision, ruling, or finding could materially adversely affect the business, operations, prospects, or financial condition or income of the Company.

**ARTICLE IV.**

**CONDITIONS TO THE COMPANY'S OBLIGATIONS**

The obligation of the Company to sell the Securities under this Agreement at the Closing is subject to the following conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The representations and warranties of the Investor contained in the document entitled Investor Representations and Warranties Agreement attached hereto shall be true and correct in material respects on and as of the Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) There shall be no preliminary or permanent injunction or other order, decree, or ruling issued by a court of competent jurisdiction or by a governmental, regulatory, or administrative agency or commission, nor any statute, rule, regulation, or order promulgated or enacted by any governmental authority, prohibiting, or otherwise restraining the sale or purchase of the Securities.

**ARTICLE V.**

**INDEMNIFICATION**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company hereby agrees to defend, indemnify, and hold harmless the Investor, their stockholders, directors, partners, employees, agents, attorneys, and each person, if any, who controls such Investor within the meaning of the Act against any and all losses, claims, damages, or liabilities to which such Investor or any such stockholder, director, partner, employee, agent, attorney, or controlling person may become subject under the Act or otherwise, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained herein, in the Disclosure Document, or in any statement made to or in any filing with the Commission or to or with any state securities commission, bureau, or office (including any amendments thereto), or arise out of or based upon the omission or alleged omission to state herein or therein a material fact required to be stated herein or therein or necessary to make the statements herein or therein not misleading (unless such statements are made or omitted in reliance upon and in conformity with written information furnished to the Company with respect to such Investor by such Investor expressly for use herein or therein or any amendment hereof or supplement hereto), or any violation by the Company of the Act or state "blue sky" laws, or any breach by the Company of their obligations, representations, or warranties hereunder or with respect to the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Investor hereby agrees to defend, indemnify, and hold harmless the Company and its respective stockholders, directors, employees, agents, and each person, if any, who controls any of the foregoing within the meaning of the Act against any and all losses, claims, damages, or liabilities to which the Company or any of the Company's stockholders, directors, employees, agents, or controlling persons may become subject under the Act or otherwise, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any written statement as it relates to the Offering, as made by the Investor, its stockholders, directors, partners, agents, or employees or any breach by such Investor of its obligations, representations, or warranties hereunder, provided that such statement or breach was made knowingly and intentionally.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Promptly after receipt by an indemnified party under either subparagraph (a) or (b), as the case may be, of the notice of commencement of any action covered by subparagraph (a) or (b), such indemnified party shall within five business days notify the indemnifying party of the commencement thereof; the omission by one indemnified party to so notify such indemnifying party shall not relieve the indemnifying party of its obligations hereunder except to the extent such indemnifying party has been materially prejudiced by such omission, shall not relieve the indemnifying party of its obligation to indemnify any other indemnified party that has given such notice and shall not relieve the indemnifying party of any liability outside of this indemnification. If any action is brought against the indemnified party, it shall notify the indemnifying party in a timely manner, the indemnifying party will be entitled to participate in such action and, to the extent it may desire, to assume and control the defense thereof with counsel chosen by it. After notice from the indemnifying party to such indemnified party of its election to so assume the defense thereof, the indemnifying party will not be liable to such indemnified party under such subparagraph for any legal or other expense subsequently incurred by such indemnified party in connection with the defense thereof, but the indemnified party may, at its own expenses, participate in such defense by counsel chosen by it without, however, impairing the indemnifying party's control of the defense. Notwithstanding anything to the contrary contained herein, the indemnified party shall have the right to choose its own counsel and control the defense of any action, all at the reasonable expense of the indemnifying party, if (i) the employment of such counsel shall have been authorized in writing by the indemnifying party in connection with the defense of such action at the expense of the indemnifying party; (ii) the indemnifying party shall not have employed counsel reasonably satisfactory to such indemnified party to have charge of the defense of such action within a reasonable time after notice of commencement of the action; or (iii) such indemnified party shall have reasonably concluded that there may be defenses available to such indemnified party that differ from the defenses available to the indemnifying party (in which case the indemnifying party shall not have the right to direct the defense of such action on behalf of such indemnified party), in any of which events such reasonable fees and expenses of one additional counsel (for all indemnified parties) shall be borne by the indemnifying party (in the case of the Investor, one additional counsel for Investor). No settlement of any action or proceeding against an indemnified party shall be made without the consent of the indemnified party, which consent shall not be unreasonably withheld.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) In order to provide for just and equitable contribution under the Act in any case in which (i) any indemnified party makes a claim for indemnification pursuant to this paragraph but it is judicially determined (by entry of a final judgment or decree by a court of competent jurisdiction and the expiration of the time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case, notwithstanding the fact the this paragraph provides for indemnification in such case, or (ii) contribution under the Act is required on the part of any such person in circumstances for which indemnification is provided under this paragraph, then, in each such case, the Company shall be solely responsible for all aggregate losses, claims, damages, or liabilities, and the Investor shall not be required to contribute to these losses beyond the amount of the Securities purchased by such Investor pursuant to the Subscription Agreement; provided, that in any such case, no person guilty of a fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.

**ARTICLE VI.**

**NOTICES**

Any notice, request, instruction, or other document required by the terms of this Agreement, or deemed by any of the Parties hereto to be desirable, to be given to any other Party hereto shall be in writing and shall be given by personal delivery, overnight delivery, mailed by registered or certified mail, postage prepaid, with return receipt requested, or sent by electronic mail (with receipt confirmed) to the addresses of the Parties as follows:

---

| | |
|:---|:---|
| Company: | Alternative Ballistics Corporation |
|  | 5940 S. Rainbow Blvd. |
|  | Las Vegas, NV 89118 |
|  | Email: steve@alternativeballistics.com |
|  | Attn: Steven Luna, CEO |
| Investor: | At the address below Investor's signature on this Agreement |

---

The persons and addresses set forth above may be changed from time to time by a notice sent as aforesaid. If notice is given by personal delivery or overnight delivery in accordance with the provisions of this Section, such notice shall be conclusively deemed given at the time of such delivery provided a receipt is obtained from the recipient. If notice is given by mail in accordance with the provisions of this Article, such notice shall be conclusively deemed given upon receipt and delivery or refusal. If notice is given by electronic mail transmission in accordance with the provisions of this Article, such notice shall be conclusively deemed given at the time of delivery if during business hours and if not during business hours, at the next business day after delivery, provided a confirmation is obtained by the sender.

**ARTICLE VII.**

**MISCELLANEOUS**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) This Agreement shall be governed by and construed and interpreted in accordance with the laws of the State of California applicable to contracts made and to be performed entirely therein, without giving effect to the rules of conflicts of law. The Parties agree that the courts of the County of Orange, State of California shall have sole and exclusive jurisdiction and venue for the resolution of all disputes arising under the terms of this Agreement and the transactions contemplated herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) This Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective successors and assigns.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) This Agreement represents the entire agreement between the Parties relating to the subject matter hereof, superseding any and all prior to contemporaneous oral and prior written agreements and understandings. This Agreement may not be modified or amended, nor may any right be waived except by a writing signed by the party against whom the modification or waiver is sought to be enforced.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The warranties, representations, and covenants of the Company and the Investor contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The captions and headings contained herein are solely for convenience of reference and do not constitute a part of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Each of the Transaction Documents is hereby incorporated herein as if each of such attachments were fully set forth herein in its entirety. Each of such attachments is hereby expressly made a part of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. The Parties agree that this Agreement may be executed by facsimile signatures and such signatures shall be deemed originals.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) All Parties to this Agreement have been given the opportunity to consult with counsel of their choice regarding their rights under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The term "days," as used in this Agreement and in all documents contained in the Transaction Documents, refers to calendar days unless otherwise clearly indicated.

**[SIGNATURE PAGE FOLLOWS]**

**IN WITNESS WHEREOF**, intending to be legally bound, the Parties hereto have executed this Agreement as of the July 2, 2025.

---

| | |
|:---|:---|
| **COMPANY:** | **COMPANY:** |
| **Alternative Ballistics Corporation,** | **Alternative Ballistics Corporation,** |
| a Nevada corporation | a Nevada corporation |
| */s/ Steven Luna* | */s/ Steven Luna* |
| By: | Steven Luna |
| Its: | Chief Executive Officer |

---

**PURCHASER:**

---

| | |
|:---|:---|
| */s/ Vanessa Luna* | |
| Vanessa Luna, an individual |  |

---

**PLEASE CHECK ONE:**

I. **If PURCHASER is an individual**:

I certify that I am an "accredited investor" because:

---

| | |
|:---|:---|
| **1. ☐** | I had an individual income of more than $200,000 in each of the two most recent calendar years, and I reasonably expect to have an individual income in excess of $200,000 in the current calendar year; or my spouse and I had joint income in excess of $300,000 in each of the two most recent calendar years, and we reasonably expect to have a joint income in excess of $300,000 in the current calendar year; **or** |

---

---

| | |
|:---|:---|
| **2. ☐** | I have an individual net worth, or my spouse and I have a joint net worth, in excess of $1,000,000 (excluding my (our) primary residence); **or** |

---

---

| | |
|:---|:---|
| **3. ☐** | I hold, in good standing, a Series 7, Series 65, or Series 82 license. |

---

II. **If PURCHASER is a corporation, partnership, employee benefit plan or IRA**, it certifies as
 follows:

&nbsp;&nbsp;&nbsp;&nbsp;A. Has
 the subscribing entity been formed for the specific purpose of investing in the Securities?

☐ YES ☐ NO

If your answer to question A is "No" CHECK whichever of the following statements (1-5) is applicable to you. If your answer to question A is "Yes" the subscribing entity must be able to certify to statement **(B)** below in order to qualify as an "accredited investor."

The undersigned entity certifies that it is an "accredited investor" because it is:

&nbsp;&nbsp;&nbsp;&nbsp;**1.** ☐ an employee benefit plan within the meaning of Title I of the
 Employee Retirement Income Security Act of 1974, provided that the investment decision is
 made by a plan fiduciary, as defined in section 3(21) of such Act, and the plan fiduciary
 is a bank, savings and loan association, insurance company or registered investment adviser; **or** 

&nbsp;&nbsp;&nbsp;&nbsp;**2.** ☐ an employee benefit plan within the meaning of Title I of the
 Employee Retirement Income Security Act of 1974 that has total assets in excess of $5,000,000; **or** 

&nbsp;&nbsp;&nbsp;&nbsp;**3.** ☐ each of its shareholders, partners, or beneficiaries meets
 at least one of the following conditions described above under INDIVIDUAL ACCREDITED INVESTOR
 STATUS. Please also CHECK the appropriate space in that section; **or** 

&nbsp;&nbsp;&nbsp;&nbsp;**4.** ☐ the plan is a self directed employee benefit plan and the investment
 decision is made solely by a person that meets at least one of the conditions described above
 under INDIVIDUAL ACCREDITED INVESTOR STATUS; **or** 

&nbsp;&nbsp;&nbsp;&nbsp;**5.** ☐ a corporation, a partnership or a Massachusetts or similar
 business trust with total assets in excess of $5,000,000; **or** 

&nbsp;&nbsp;&nbsp;&nbsp;**6.** ☐
 all equity owners are Accredited Investors.

&nbsp;&nbsp;&nbsp;&nbsp;B. If
 the answer to Question A above is "Yes," please certify the statement below is
 true and correct:

☐ The undersigned entity certifies that it is an accredited investor because each of its shareholder or beneficiaries meets at least one of the following conditions described above under INDIVIDUAL ACCREDITED INVESTOR STATUS. Please also CHECK the appropriate space in that section.

III. **If PURCHASER is a Trust**, it certifies as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A. Has the subscribing entity been formed for the specific purpose of investing in the Securities?

☐ YES ☐ NO

If your answer to question A is "No" CHECK whichever of the following statements (1-3) is applicable to the subscribing entity. If your answer to question A is "Yes" the subscribing entity must be able to certify to the statement **(3)** below in order to qualify as an "accredited investor."

The undersigned trustee certifies that the trust is an "accredited investor" because:

&nbsp;&nbsp;&nbsp;&nbsp;**1.** ☐ the trust has total assets in excess of $5,000,000 and the
 investment decision has been made by a "sophisticated person"; **or** 

&nbsp;&nbsp;&nbsp;&nbsp;**2.** ☐ the trustee making the investment decision on its behalf is
 a bank (as defined in Section 3(a)(2) of acc), a saving and loan association or other institution
 as defined in Section 3(a)(5)(A) of the Securities Act, acting in its fiduciary capacity; **or** 

&nbsp;&nbsp;&nbsp;&nbsp;**3.** ☐ the undersigned trustee certifies that the trust is an accredited
 investor because the grantor(s) of the trust may revoke the trust at any time and regain
 title to the trust assets and has (have) retained sole investment control over the assets
 of the trust and the (each) grantor(s) meets at least one of the following conditions described
 above under INDIVIDUAL ACCREDITED INVESTOR STATUS. Please also CHECK the appropriate space
 in that section.

**Print Name: Vanessa Luna**

---

| |
|:---|
| */s/ Vanessa Luna* |
| [Signature] |
| 315 Calgrove Street |
| Address |
| Las Vegas, NV 89138 |
| Address |
| Email Address |
| Social Security/Tax I.D. Number |

---

**INVESTOR REPRESENTATIONS AND WARRANTIES AGREEMENT**

This INVESTOR REPRESENTATIONS AND WARRANTIES AGREEMENT ("Agreement"), dated as of the date set forth on the signature page of this Agreement, is by and between Alternative Ballistics Corporation, a Nevada corporation (the "Company") and the purchaser set forth on the signature page of this Agreement, or assigns (the "Investor") (the Company and the Investor may be referred to individually as a "Party" and, collectively, as the "Parties").

**RECITALS:**

This Agreement is being made pursuant to an Offering by the Company of the purchase of a Convertible Note (the "Note") to purchase shares of common stock (collectively with the Note, the shares of common stock into which the Note is convertible, the "Securities"). The Securities are being issued on the Closing (as defined in the Subscription Agreement) pursuant to a Subscription Agreement of even date herewith between the Company and the Investor which contains representations and warranties and additional covenants of the Company with respect to the sale of the Securities. Capitalized terms not otherwise defined herein shall have the meaning set forth in the Subscription Agreement. THE PROVISIONS OF THE SUBSCRIPTION AGREEMENT ARE INCORPORATED HEREIN BY REFERENCE.

**ARTICLE 1.**

**REPRESENTATIONS AND WARRANTIES OF THE INVESTOR**

The Investor hereby represents and warrants that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Investor acknowledges that the Securities are "restricted securities" (as such term is defined in Rule 144 promulgated under the Securities Act of 1933, as amended ("Rule 144"), that the Securities will include the restrictive legend set forth in Section 1.04 of the Subscription Agreement, and, except as otherwise set forth in the Subscription Agreement, that the Securities cannot be sold unless registered with the United States Securities and Exchange Commission ("SEC") and qualified by appropriate state securities regulators, or unless Investor otherwise complies with an exemption from such registration and qualification (including, without limitation, compliance with Rule 144).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Investor has adequate means of providing for current needs and contingencies, has no need for liquidity in the investment, and is able to bear the economic risk of an investment in the Securities. Investor represents that Investor is able to bear the economic risk of the investment and at the present time could afford a complete loss of such investment. Investor has reviewed the Transaction Documents with care. Additionally, Investor has had a full opportunity to inspect the Disclosure Document and to make any and all inquiries of Company officers and directors regarding the Company and its business as Investor has deemed appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Investor is an "Accredited Investor" as defined in Regulation D of the Act. Investor, either alone or with Investor's professional advisers who are unaffiliated with, have no equity interest in, and are not compensated by the Company or any affiliate or selling agent of the Company, directly or indirectly, has sufficient knowledge and experience in financial and business matters that Investor is capable of evaluating the merits and risks of an investment in the Securities offered by the Company and of making an informed investment decision with respect thereto and has the capacity to protect Investor's own interests in connection with Investor's proposed investment in the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Investor is acquiring the Securities solely for Investor's own account as principal, for investment purposes only and not with a view to the resale or distribution thereof, in whole or in part, and no other person or entity has a direct or indirect beneficial interest in such Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Investor will not sell or otherwise transfer the Securities without registration under the Act or an exemption therefrom and fully understands and agrees that Investor must bear the economic risk of Investor's purchase for an indefinite period of time because, among other reasons, the Securities have not been registered under the Act or under the securities laws of any state and, therefore, cannot be resold, pledged, assigned, or otherwise disposed of unless they are subsequently registered under the Act and under the applicable securities laws of such states or unless an exemption from such registration is available.

**ARTICLE 2.**

**MISCELLANEOUS**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) This Agreement shall be governed by and construed and interpreted in accordance with the laws of the State of California applicable to contracts made and to be performed entirely therein, without giving effect to the rules of conflicts of law. The Parties agree that the courts of the County of Orange, State of California shall have sole and exclusive jurisdiction and venue for the resolution of all disputes arising under the terms of this Agreement and the transactions contemplated herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) This Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective successors and assigns.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The warranties and representations of the Investor contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. The Parties agree that this Agreement may be executed by facsimile signatures and such signatures shall be deemed originals.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) All Parties to this Agreement have been given the opportunity to consult with counsel of their choice regarding their rights under this Agreement.

**IN WITNESS WHEREOF**, intending to be legally bound, the Parties hereto have executed this Agreement as of July 2, 2025.

**COMPANY:**

---

| | | |
|:---|:---|:---|
|  | **Alternative Ballistics Corporation,** | **Alternative Ballistics Corporation,** |
|  | a Nevada corporation | a Nevada corporation |
| | */s/ Steven Luna* | */s/ Steven Luna* |
|  | By: | Steven Luna |
|  | Its: | Chief Executive Officer |

---

---

| | |
|:---|:---|
| **INVESTOR:** | **INVESTOR:** |
| **Vanessa Luna, an individual** | **Vanessa Luna, an individual** |
| */s/ Vanessa Luna* | */s/ Vanessa Luna* |
| By: | Vanessa Luna |

---

**THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW IS AVAILABLE.**

**ALTERNATIVE BALLISTICS CORPORATION, A NEVADA CORPORATION**

**CONVERTIBLE NOTE**

This Convertible Note (this "Note") has been issued pursuant to a Subscription Agreement dated July 2, 2025 (the "Subscription Agreement") between the Company and the holder of this Note (the "Noteholder"). Capitalized terms not otherwise defined herein shall have the meaning set forth in the Subscription Agreement, the provisions of which are incorporated herein by reference.

---

| | |
|:---|:---|
| **$25000** | **Date: July 2, 2025** |

---

1. <u>The Obligation</u>. FOR VALUE RECEIVED, the undersigned, Alternative Ballistics Corporation, a Nevada corporation (the "Company"), hereby promises to pay to the order of Vanessa Luna, an individual, or its assigns (collectively, the "Noteholder"), in lawful money of the United States of America, and in immediately payable funds, the principal sum of $25,000 (the "Obligation"). The principal amount loaned by Noteholder to the Company shall accrue interest thereon from the date of this Note. Interest shall be paid according to Section 2 below and all amounts due under this Note shall be paid upon the Maturity Date set forth in Section 3 below. The Company has the right to assign this Note upon written notice to the Noteholder. (The Noteholder and the Company may be referred to individually as a "Party" and collectively as the "Parties" in this Note.)

2. <u>Interest</u>. The principal amount of this Note that may be outstanding from time to time shall bear interest at a rate equal to 15% per annum. Interest, if any, shall be computed hereunder based on a 365-day year and paid for the actual number of days elapsed for any whole or partial month in which principal is outstanding, which interest shall then be due and payable on the Maturity Date.

3. <u>Payment Terms</u>. The principal and interest of this Note shall be due and payable to the Noteholder six (6) months from the date of this Note (the "Maturity Date") unless all principal and interest due under this Note have been prepaid pursuant to Section 4 herein or converted pursuant to Section 5 herein. Payments are to be made to the Noteholder at its address stated in the Subscription Agreement (or such other address as is designated by the Noteholder) in lawful money of the United States of America. Unless otherwise specified, payments received by the Noteholder pursuant to the terms hereof shall be applied, first, to the payment of all expenses, charges, late payment fees, costs, and fees incurred by or payable to the Noteholder and for which the Company is obligated pursuant to the terms of this Note; second, to the payment of interest; and third, to the payment of principal.

4. <u>Prepayment</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1. <u>Prepayment</u>. The Company shall have the right to prepay all or any portion of the Loan outstanding at any time; provided, however, in the event of a prepayment, the Company shall pay 120% of the Principal Balance plus accrued and unpaid interest on the original Principal Balance of the Note. The Company shall deliver a notice of prepayment to Noteholder, which notice shall specify a prepayment date not less than 15 nor more than 30 days from the date of such notice (the "Prepayment Date"); provided, however, that the Investor will continue to have the right to convert the Note until the close of business of the fifth business day prior to the Prepayment Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 <u>Repayment Upon a Qualified Offering</u>. The Company shall immediately notify the Noteholder in the event a Qualified Offering (defined below) closes prior to the Maturity Date. Following such notice, the Noteholder has the option to (a) be repaid from the proceeds of the Qualified Offering within five days from the closing of the Qualified Offering by providing to the Company written notice of its intent to exercise such option for repayment within five days of the notice; or (b) in the event that the Noteholder does not exercise such option for repayment, then the Note shall automatically convert into shares of common stock 30 days following the closing of the Qualified Offering pursuant to the conversion terms set forth in Section 5. A "Qualified Offering" shall mean a public offering in the United States pursuant to a registration statement declared effective by the Securities and Exchange Commission pursuant to the Securities Act of 1933, with minimum gross proceeds of $5,000,000, pursuant to which the common stock is listed for trading on Nasdaq or a similar U.S. nationally-recognized stock exchange

5. <u>Conversion</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1 <u>Conversion Price</u>. The Principal Balance may be converted at any time prior to the Maturity Date at the option of the Company into shares of the Company's common stock at the Conversion Price. The "Conversion Price" shall be such price equal to the lower of (i) a 50% discount to the "Qualified Offering Price," which shall be defined as the price at which the Qualified Offering is consummated and (ii) any conversion price offered to other noteholders on notes issued subsequent to the date of this Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2 <u>Voluntary Conversion</u>. This Note is convertible at the option of the Noteholder, in Noteholder's sole discretion, in whole or in part, at any time prior to the Maturity Date or payment in full of the Note, whichever occurs first, for all or any portion of principal or interest, into shares of Common Stock of the Company at the Conversion Price.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.3 <u>Mechanics of Conversion</u>. To effectuate a Voluntary Conversion, the Noteholder shall deliver to the Company a written Election to Convert, a form of which is attached hereto. Immediately upon receipt of the written Election to Convert, the Company shall issue and cause to be delivered with all reasonable dispatch to or upon the written order of the Noteholder, and in such name or names as the Noteholder may designate, a certificate or other documentary evidence for the full number of shares of common stock ("Common Shares") so purchased upon conversion of the Note. Such certificate or documentary evidence shall be deemed to have been issued and any person so designated to be named therein shall be deemed to have become a holder of record of such securities as of the date of delivery of the Election to Convert, notwithstanding that the certificate or documentary evidence representing such securities shall not actually have been delivered or that the stock transfer books of the Company shall then be closed. The Note shall be convertible, at the election of the Noteholder, either in full or from time to time in part and, in the event that the Note is converted in respect of less than all of the Common Shares specified therein at any time prior to the Maturity Date, a new Note evidencing the remaining portion of the indebtedness shall be issued by the Company to the Noteholder.

6. <u>Representations, Warranties, and Covenants of the Company</u>. In connection with the transactions provided for herein, the Company hereby represents, warrants, and covenants to Noteholder that, as of the date hereof:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1 <u>Organization, Good Standing, and Qualification</u>. The Company is a corporation duly organized and validly existing under the laws of the State of Nevada and has all requisite corporate power and authority to carry on its business as now conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a material adverse effect on its business or properties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2 <u>Authorization</u>. All corporate action has been taken on the part of the Company, its officers, and directors necessary for the authorization, execution, and delivery of this Note. Except as may be limited by applicable bankruptcy, insolvency, reorganization, or similar laws relating to or affecting the enforcement of creditors' rights, the Company has taken all corporate action required to make all of the obligations of the Company reflected in the provisions of this Note the valid and enforceable obligations they purport to be.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3 <u>Compliance with Other Instruments</u>. The Company is not in violation of or in default under its Articles of Incorporation, as amended to date, or in any material respect of any term or provision of any loan, promissory note, mortgage, indebtedness, indenture, contract, agreement, instrument, judgment, order, or decree to which it is party or by which it is bound. The Company is not in violation of any federal or state statute, rule, or regulation applicable to the Company. The execution and delivery of this Note by the Company, the performance by the Company of its obligations pursuant to this Notes, and the issuance of the Common Shares, will not result in any violation of, or conflict with, or constitute a default under, the Company's Articles of Incorporation, as amended to date, or of any of its agreements material to the Company or its business, nor result in the creation of any mortgage, pledge, lien, encumbrance or charge upon any of the properties or assets of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4 <u>Valid Issuance of Common Shares</u>. The Common Shares to be issued, sold, and delivered upon conversion of the Notes will be duly and validly issued, fully paid, and non-assessable and, based in part upon the representations and warranties of the Company in this Note, will be issued in compliance with all applicable federal and state securities laws.

7. <u>Representations and Warranties of Noteholder</u>. In connection with the transactions provided for herein, Noteholder hereby represents and warrants to the Company that, as of the date a Note is issued to such Noteholder:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.1 <u>Authorization</u>. This Note constitutes such Noteholder's valid and legally binding obligation, enforceable in accordance with its terms, except as may be limited by (a) applicable bankruptcy, insolvency, reorganization, or similar laws relating to or affecting the enforcement of creditors' rights and (b) laws relating to the availability of specific performance, injunctive relief, or other equitable remedies. Such Noteholder represents that it has full power and authority to enter into this Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.2 <u>Purchase Entirely for Own Account</u>. Such Noteholder acknowledges that this Note is made with such Noteholder in reliance upon such Noteholder's representation to the Company that this Note and the Common Shares (collectively, the "Securities") will be acquired for investment for such Noteholder's own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that such Noteholder has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Note, such Noteholder further represents that such Noteholder does not have any contract, undertaking, agreement, or arrangement with any person to sell, transfer, or grant participations to such person or to any third person with respect to the Securities. Notwithstanding the foregoing, such Noteholder shall have the right to transfer the Securities, all or in part, to any affiliate of Noteholder. Any such transferees shall execute and deliver appropriate documentation providing that the transferee agrees to be bound by the applicable provisions hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.3 <u>Disclosure of Information</u>. Such Noteholder acknowledges that they have received all the information they consider necessary or appropriate for deciding whether to acquire the Securities. Such Noteholder further represents that they have had an opportunity to ask questions and receive answers from the Company regarding the Company and this Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.4 <u>Investment Experience</u>. Such Noteholder is an investor in securities of companies in the development stage and acknowledges that they able to fend for themselves; can bear the economic risk of this investment; and has such knowledge and experience in financial or business matters that he, she, or it is capable of evaluating the merits and risks of an investment in the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.5 <u>Restricted Securities</u>. Noteholder understands that the Securities are characterized as "restricted securities" under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without registration under the Securities Act, only in certain limited circumstances. Such Noteholder represents that it is familiar with SEC Rule 144, as presently in effect, and understands the resale limitations imposed thereby and by the Securities Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.6 <u>Legends</u>. It is understood that the Securities may bear the following legend:

"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW IS AVAILABLE."

8. <u>Default</u>. The occurrence of any one of the following events shall constitute an Event of Default:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The non-payment, when due, of any principal or interest pursuant to this Note, regardless of whether the Company has received notice of such non-payment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The material breach of any representation or warranty in this Note. In the event the Noteholder becomes aware of a breach of this Section, the Noteholder shall notify the Company in writing of such breach and the Company shall have ten days' notice to effect a cure of such breach;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The material breach of any covenant or undertaking in this Note, not otherwise provided for in this Section. In the event the Noteholder becomes aware of a breach of this Section, the Noteholder shall notify the Company in writing of such breach and the Company shall have ten days' notice to effect a cure of such breach;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) A default shall occur in the payment when due (subject to any applicable grace period), whether by acceleration or otherwise, of any indebtedness of the Company or an event of default or similar event shall occur with respect to such indebtedness, if the effect of such default or event (subject to any required notice and any applicable grace period) would be to accelerate the maturity of any such indebtedness or to permit the holder or holders of such indebtedness to cause such indebtedness to become due and payable prior to its express maturity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The commencement by the Company of any voluntary proceeding under any bankruptcy, reorganization, arrangement, insolvency, readjustment or debt, receivership, dissolution, or liquidation law or statute or any jurisdiction, whether now or hereafter in effect; or the adjudication of the Company as insolvent or bankrupt by a decree of a court of competent jurisdiction; or the petition or application by the Company for, acquiescence in, or consent by the Company to, the appointment of any receiver or trustee for the Company or for all or a substantial part of the property of the Company; or the assignment by the Company for the benefit of creditors; or the written admission of the Company of its inability to pay its debts as they mature; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) The commencement against the Company of any proceeding relating to the Company under any bankruptcy, reorganization, arrangement, insolvency, adjustment of debt, receivership, dissolution or liquidation law or statute or any jurisdiction, whether now or hereafter in effect, provided, however, that the commencement of such a proceeding shall not constitute an Event of Default unless the Company consents to the same or admits in writing the material allegations of same, or said proceeding shall remain undismissed for 30 days; or the issuance of any order, judgment, or decree for the appointment of a receiver or trustee for the Company or for all or a substantial part of the property of the Company, which order, judgment, or decree remains undismissed for 30 days; or a warrant of attachment, execution, or similar process shall be issued against any substantial part of the property of the Company.

Upon the occurrence of any Event of Default, the Noteholder may, by written notice to the Company, declare all or any portion of the unpaid principal amount due to Noteholder, together with all accrued interest thereon, immediately due and payable. The Noteholder may also proceed against any guarantor of this obligation without waiving any rights under the terms of this Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. <u>Notice</u>. Any notice, request, instruction, or other document required by the terms of this Note, or deemed by any of the Parties hereto to be desirable, to be given to any other Party hereto shall be in writing and shall be given by personal delivery, overnight delivery, mailed by registered or certified mail, postage prepaid, with return receipt requested, or sent by electronic transmission to the addresses of the Parties set forth in the Subscription Agreement. The persons and addresses set forth in the Notice provision of the Subscription Agreement may be changed from time to time by a notice sent as aforesaid. If notice is given by mail in accordance with the provisions of this Section, such notice shall be conclusively deemed given upon receipt and delivery or refusal. If notice is given by electronic mail transmission in accordance with the provisions of this Section, such notice shall be conclusively deemed given at the time of delivery if between the hours of 9:00 a.m. and 5:00 p.m. Pacific time on a business day ("business hours") and if not during business hours, at 9:00 a.m. on the next business day following delivery, provided a delivery confirmation is obtained by the sender.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. <u>Choice of Law</u>. This Note and the rights of the Parties hereunder shall be governed by and construed in accordance with the laws of the State of California including all matters of construction, validity, performance, and enforcement and without giving effect to the principles of conflict of laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. <u>Exclusive Jurisdiction and Venue</u>. The Parties agree that the state and federal courts in the County of Orange, State of California shall have sole and exclusive jurisdiction and venue for the resolution of all disputes arising under the terms of this Note and the transactions contemplated herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. <u>Attorneys' Fees</u>. In the event the Noteholder or any assignee thereof shall refer this Note to an attorney for collection, the Company agrees to pay all the costs and expenses incurred in attempting or effecting collection hereunder, including reasonable attorney's fees, whether or not suit is instituted.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. <u>Conformity with Law</u>. It is the intention of the Company and of the Noteholder to conform strictly to applicable usury and similar laws. Accordingly, notwithstanding anything to the contrary in this Note, it is agreed that the aggregate of all charges which constitute interest under applicable usury and similar laws that are contract for, chargeable or receivable under or in respect of this Note, shall under no circumstances exceed the maximum amount of interest permitted by such laws, and any excess, whether occasioned by acceleration or maturity of this Note or otherwise, shall be canceled automatically, and if theretofore paid, shall be either refunded to the Company or credited on the principal amount of this Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. <u>Severability</u>. Every provision of this Note is intended to be severable. In the event any term or provision hereof is declared by a court of competent jurisdiction, to be illegal or invalid for any reason whatsoever, such illegality or invalidity shall not affect the balance of the terms and provisions hereof, which terms and provisions shall remain binding and enforceable.

**[SIGNATURE PAGE FOLLOWS]**

**IN WITNESS WHEREOF**, the Company has signed and sealed this Note and delivered it as of the date first set forth above.

---

| | |
|:---|:---|
| **COMPANY:** | **COMPANY:** |
| **ALTERNATIVE BALLISTICS CORPORATION** | **ALTERNATIVE BALLISTICS CORPORATION** |
| a Nevada corporation | a Nevada corporation |
| */s/ Steven Luna* | */s/ Steven Luna* |
| By: | Steven Luna |
| Its: | Chief Executive Officer |

---

---

| | |
|:---|:---|
| **ACKNOWLEDGED AND AGREED:** | **ACKNOWLEDGED AND AGREED:** |
| **VANESSA LUNA, an individual** | **VANESSA LUNA, an individual** |
| */s/ Vanessa Luna* | */s/ Vanessa Luna* |
| By: | Vanessa Luna |

---

**FORM OF ELECTION TO CONVERT**

The undersigned, the holder(s) of the attached Note, hereby irrevocably elects to exercise the right to convert $_____________ of the Note into shares of Common Stock of Alternative Ballistics Corporation and request that the certificates for such securities be issued in the name of, and delivered to,______________________________________.

---

| | |
|:---|:---|
| Dated: ___________________________________ | SIGNATURE: |
|  | (Signature must conform in all respects to name of Noteholder as specified in the Note) |
|  | (Insert Social Security or Federal Tax I.D. |
|  | Number of Noteholder) |
|  | IF NOTE IS HELD JOINTLY, BOTH PARTIES MUST SIGN: |
|  | (Signature must conform in all respects to name of Noteholder as specified in the Note) |
|  | (Insert Social Security or Federal Tax I.D. |
|  | Number of Joint Noteholder) |

---

**DISCLOSURE DOCUMENT**

Offering Circular on Form 1-A

of

Alternative Ballistics Corporation

dated June 10, 2024

https://www.sec.gov/Archives/edgar/data/1834868/000149315224023306/partiiandiii.htm

## Add

**Exhibit 6.18**

**ALTERNATIVE BALLISTICS CORPORATION,** 

**A NEVADA CORPORATION**

**BRIDGE LOAN OFFERING DOCUMENTS**

***July 22, 2025***

**Documents included in this package:**

&nbsp;&nbsp;&nbsp;&nbsp;**1.** **Instructions for Payment** 

&nbsp;&nbsp;&nbsp;&nbsp;**2.** **Subscription Agreement** 

&nbsp;&nbsp;&nbsp;&nbsp;**3.** **Investor Representations and Warranties Agreement** 

&nbsp;&nbsp;&nbsp;&nbsp;**4.** **Convertible Note** 

&nbsp;&nbsp;&nbsp;&nbsp;**5.** **Warrant Agreement** 

&nbsp;&nbsp;&nbsp;&nbsp;**6.** **Disclosure Document** 

**INSTRUCTIONS FOR PAYMENT**

Review and complete the Bridge Loan Offering Documents and mail or deliver them, along with a check made payable to "Alternative Ballistics Corporation" in the amount of your investment to:

**Alternative Ballistics Corporation**

Attn: Steve Luna, Chief Executive Officer

5940 S. Rainbow Blvd.

Las Vegas, NV 89118

For any inquiries, please contact:

Steve Luna, Chief Executive Officer

Email: steve@alternativeballistics.com

Phone: 619-326-4411

We prefer you to send a wire transfer instead of a check. Please scan and email the signed Bridge Loan Offering Documents to the email address above and send the wire transfer using these instructions:

**Wiring Instructions:**

US Bank

Wire Transfer Department

P.O. Box 64830

St. Paul, MN 55164-0830

Phone: 800-872-2657

Routing Number: 122235821

For Further Credit to: Alternative Ballistics Corporation

Account Number: 157523676557

**<u>SUBSCRIPTION AGREEMENT</u>**

This SUBSCRIPTION AGREEMENT is made on July 22, 2025 by and between Alternative Ballistics Corporation, a Nevada corporation (the "Company") and Solyco CAC LLC, a Michigan limited liability company (the "Investor") (the Company and the Investor may be referred to individually as a "Party" or collectively as the "Parties") as of the date set forth on the signature page of this Agreement.

**RECITALS:**

WHEREAS, the Company is offering to Purchaser a $300,000 Convertible Note, convertible into shares of common stock at a 50% discount to the Qualified Offering Price (defined below) (the "Note") with 100% warrant coverage (the "Warrant");

WHEREAS, the Investor desires to subscribe for the Note and Warrant (and together with the shares of common stock into which the Note is convertible, and the shares of common stock underlying the Warrant, referred to herein as the "Securities") for the purchase price of $300,000 (the "Purchase Price"); and

WHEREAS, this Subscription Agreement is part of a package of documents, including Instructions for Payment, Investor Representations and Warranties Agreement, the Note, Warrant, and Disclosure Document (hereinafter defined), all of which are incorporated herein by reference (the "Transaction Documents").

NOW THEREFORE, in consideration of the promises and respective mutual agreements herein contained, it is agreed by and between the Parties hereto as follows:

**ARTICLE I.**

**THE SECURITIES**

<u>Section 1.01. THE PURCHASE OF THE SECURITIES</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Subscription*. The Investor is purchasing the Securities, on the terms set forth in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Convertible Note*. The Note shall be in the form attached hereto, the terms of which are hereby incorporated herein as if such Note was fully set forth herein; provided, however, that in the event of any conflict between the express provisions of the Note and this Subscription Agreement, the provisions of the Note shall control.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Loan
 Amount. The Note shall be in the amount of $300,000. Investor shall pay for the Securities
 in three installments, as follows:

---

| | |
|:---|:---|
| Amount | Payment Date |
| $100000 | July 25, 2025 |
| $100000 | August 25, 2025 |
| $100000 | September 25, 2025 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. Maturity
 Date. The principal balance and all accrued and unpaid interest thereon shall be due and
 payable nine months from the date of the Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii. Interest
 Rate. The Note shall bear an interest rate of 18% per annum.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iv. Prepayment.
 In the event of a prepayment of the Loan prior to the Maturity Date, the Company shall pay
 120% of the Principal Balance plus any accrued and unpaid interest on the original Principal
 Balance of the Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;v. Repayment
 Upon a Qualified Offering. In the event a Qualified Offering (defined below) closes prior
 to the Maturity Date, the Investor has the option (a) to be repaid from the proceeds of the
 Qualified Offering within five days from the closing of the Qualified Offering; or (b) in
 the event that the Investor does not exercise such option for repayment, then the Note shall
 automatically convert into shares of common stock 30 days following the closing of the Qualified
 Offering pursuant to the conversion terms set forth below. A "Qualified Offering"
 shall mean a public offering in the United States pursuant to a registration statement declared
 effective by the Securities and Exchange Commission (the "Commission") pursuant
 to the Securities Act of 1933 (the "Act"), with minimum gross proceeds of $5,000,000,
 pursuant to which the common stock is listed for trading on Nasdaq or a similar U.S. nationally-recognized
 stock exchange.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;vi. Conversion.
 The Principal Balance and all accrued and unpaid interest may be converted at any time prior
 to the Maturity Date at the option of the Company into shares of common stock at the Conversion
 Price. The "Conversion Price" shall be such price equal to the lower of (i) a
 50% discount to the "Qualified Offering Price," which shall be defined as the
 price at which the Qualified Offering is consummated and (ii) any conversion price offered
 to other noteholders on notes issued subsequent to the issue date of the Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Warrant*. The Warrant shall be in the form attached hereto, the terms of which are hereby incorporated herein as if such Warrant were fully set forth herein; provided, however, that in the event of any conflict between the express provisions of the Warrant and this Subscription Agreement, the provisions of the Warrant shall control.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Exercise
 Price. The Warrant shall have an exercise price equal to the lower of (i) $1.00 or (ii) a
 50% discount to the Qualified Offering Price.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. Term.
 The Warrant shall be exercisable for five years from the date of issuance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii. Leak
 Out. During the Leak Out Period (defined below), the Investor's sale of common stock
 upon exercise of the Warrants shall be limited to 5% of the daily trading volume of the common
 stock on the immediately prior Trading Day. "Trading Day" shall mean a day on
 which Nasdaq or a similar U.S. nationally-recognized stock exchange is open for trading.
 "Leak Out Period" shall mean 12 months following the closing of the Qualified
 Offering.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iv. Mandatory
 Exercise of Warrants. The Company shall have the right to require the Investor to exercise
 all or any portion of the Warrant that is still unexercised for a cash exercise when the
 closing price of the Company's common stock on Nasdaq or a similar U.S. nationally-recognized
 stock exchange equals or exceeds $5.00 for ten consecutive Trading Days. The Company shall
 deliver to the Investor a notice to exercise and any amount not exercised following such
 notice shall be immediately forfeited.

<u>Section 1.02. CLOSING</u>.

The purchase and sale of the Securities will take place at one closing (the "Closing") at a time and date as soon as practicable after all the conditions set forth in Articles III and IV hereof have been satisfied ("Closing Date"), and at such time and location as the Investor and the Company shall agree.

<u>Section 1.03. DELIVERY</u>.

At or prior to the Closing, the Investor shall deliver to the Company the Purchase Price for the Securities and all Transaction Documents signed by the Investor. At the Closing, the Company shall deliver to the Investor all Transaction Documents counter-signed by the Company.

<u>Section 1.04. LEGENDS; SECURITIES NOT REGISTERED UNDER THE SECURITIES ACT OF 1933</u>.

The Securities have not been registered under the Securities Act of 1933, as amended (the "Act"). Each of the certificates for the Securities shall bear substantially the following legend:

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW IS AVAILABLE.

The Offering is not a public offering and is intended to be made pursuant to exemptions from registration as set forth in Section 4(2) of the Act and Regulation D as promulgated by the Securities and Exchange Commission ("SEC") under the Act. This Offering is also intended to be exempt from the registration requirements of various state securities laws as may be applicable.

**ARTICLE II.**

**REPRESENTATIONS AND WARRANTIES**

<u>Section 2.01. INVESTOR REPRESENTATIONS AND WARRANTIES</u>.

The Investor makes each and every one of the representations and warranties set forth in the document entitled Investor Representations and Warranties Agreement attached hereto and incorporated herein by this reference as if such document were set forth herein in its entirety.

<u>Section 2.02. COMPANY REPRESENTATIONS AND WARRANTIES</u>.

The Company hereby represents, warrants, and covenants to the Investor as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company has been duly organized and validly existing as a corporation in good standing under the laws of the state of its incorporation. The Company is duly qualified or licensed and in good standing as a foreign corporation in each jurisdiction in which its ownership or leasing of any properties or the character of its operations requires such qualification or licensing and where failure to so qualify would have a material effect on the Company. The Company has all requisite corporate power and authority, and all material and necessary authorizations, approvals, orders, licenses, certificates, and permits of and from all governmental regulatory officials and bodies to own or lease its properties and conduct its businesses as described in the Company's Offering Circular on Form 1-A dated June 10, 2024 (hereinafter, the "Disclosure Document") and the Company is doing business in compliance with all such authorizations, approvals, orders, licenses, certificates, and permits and all federal, state, and local laws, rules, and regulations concerning the business in which it is engaged except where the failure so to do business in compliance would not have a material adverse effect on the business of the Company. The disclosures herein and in the Disclosure Document concerning the effects of federal, state, and local regulation on the Company's business as currently conducted and as contemplated are correct in all material respects and do not omit to state a material fact. The Company has all corporate power and authority to enter into the Transaction Documents and to carry out the provisions and conditions hereof and thereof, and all consents, authorizations, approvals, and orders required in connection herewith and therewith have been obtained or will have been obtained prior to the Closing Date. No consent, authorization, or order of, and no filing with any court, government agency, or other body is required for the issuance of the Securities pursuant to this Agreement except with respect to applicable federal and state securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) This Agreement and the Transaction Documents have been duly and validly authorized, executed, and delivered by the Company and are valid and binding agreements of the Company, enforceable in accordance with their respective terms, except to the extent that the enforceability hereof or thereof may be limited by (A) bankruptcy, insolvency, reorganization, moratorium, or similar laws from time to time in effect and affecting the rights of creditors generally; (B) limitations upon the power of a court to grant specific performance or any other equitable remedy; or (C) a finding by a court of competent jurisdiction that the indemnification provisions herein are in violation of public policy. The Securities have been duly authorized and are validly issued, fully paid, and non-assessable; all corporate action required to be taken for the authorization, issue, and sale of such securities has been duly and validly taken; and to the best knowledge of the Company, the Securities are not and will not be subject to the preemptive rights of any stockholder of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The Company has good and marketable title to, or valid and enforceable leasehold estates in, all items of real and personal property owned or leased by it, free and clear of all liens, claims, encumbrances, security interests, and defects of any material nature whatsoever, except for Permitted Liens. "Permitted Liens" means liens, claims, encumbrances, security interests, and defects of any material nature whatsoever that are described in the Disclosure Document or otherwise disclosed to the Investor.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) There is no litigation or governmental proceeding pending or threatened against or involving the properties or business of the Company which the Company believes would materially adversely affect the value or the operation of the properties or the business of the Company, except as set forth in the Disclosure Document.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) There has been no material adverse change in the condition or prospects for commercialization of the Company, financial or otherwise, as of the latest dates as of which such condition or prospects, respectively, are set forth in this Agreement and the Disclosure Document; and the outstanding debt, property, and the business of the Company conform in all material respects to the descriptions thereof contained herein and therein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) The Securities shall conform in all respects to all statements in relation thereto contained herein or in the Disclosure Document.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) The Company is not in material violation of its Articles of Incorporation, or its Bylaws. Neither the execution and delivery of the Transaction Documents, nor the issuance of the Securities, nor the consummation of any of the transactions contemplated herein or in the Note or Warrant, nor the compliance by the Company with the terms and provisions contained herein, or in the Note or Warrant, has conflicted with or will conflict with, or has resulted in or will result in a breach of, any of the terms and provisions of, or has constituted or will constitute a default under, or has resulted in or will result in the creation or imposition of any lien, charge, or encumbrance upon any property or assets of the Company pursuant to the terms of any indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement or instrument evidencing an obligation for borrowed money, or any other agreement or instrument to which the Company is subject; nor will such action result in any violation of the provisions of the Articles of Incorporation or the Bylaws of the Company, or any statute or any order, rule, or regulation applicable to the Company of any court or of any federal, state, or other regulatory authority or other government body having jurisdiction over the Company; except for any conflict, breach, default, lien, charge, or encumbrance which does not have a material and adverse effect on the Company, any of its business, property, or assets or any transactions contemplated hereby or by the Note or Warrant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) Subsequent to the dates as of which information is given in this Agreement or the Disclosure Document, and except as may otherwise be indicated or contemplated herein or therein, the Company has not entered into any transaction other than in the ordinary course of business or declared or paid any dividend or made any other distribution on or in respect of its capital stock. The Investor acknowledges that the Company may conduct financing activities in the future which would result in the issuance of securities of the Company to third parties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The Company owns or possesses, free and clear of all liens or encumbrances and rights thereto or therein by third parties, other than Permitted Liens, the requisite licenses or other rights to use all trademarks, service marks, copyrights, service names, trade names, patents, patents applications, and licenses necessary to conduct and material to their businesses (including, without limitation any such licenses or rights described herein as being owned or possessed by the Company), and there is no material claim or action by any person pertaining to, or proceeding, pending or threatened, which challenges the exclusive rights of the Company with respect to any trademarks, service marks, copyrights, service names, trade names, patents, patent applications, and licenses used in the conduct of the Company's business (including, without limitation, any such licenses or rights described herein or in the Disclosure Document as being owned or possessed by the Company); the Company's current products, services, and processes do not and will not infringe on any patents currently held by third parties, to the best knowledge of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) Neither the Disclosure Document nor any of the documents contained in the Transaction Documents contain any untrue statement of a material fact or omits to state any material fact required to be stated herein or therein or necessary to make the statements herein or therein, considering the circumstances under which they were made, not misleading. All statements of material facts herein or therein (including, without limitation, any attachment, exhibit, or schedule hereto or thereto) are true and correct as of the date hereof and will be true and correct on the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) The Company shall use the proceeds from this Offering for costs and expenses of related to its initial public offering as well as for general working capital purposes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) Neither the Company, nor any of its respective officers, directors, employees, or agents, nor any other person acting on behalf of the Company has, directly or indirectly, given or agreed to give any money, gift, or similar benefit (other than legal price concessions to customers in the ordinary course of business) to any customer, supplier, employee, or agent of a customer or supplier, or official or employee of a customer or supplier, or official or employee of any governmental agency or instrumentality of any government (domestic or foreign) or any political party or candidate for office (domestic or foreign), or other person who is or may be in a position to help or hinder the business of the Company (or assist it in connection with any actual or proposed transaction) which (A) might subject the Company to any damage or penalty in any civil, criminal, or governmental litigation or proceeding; (B) if not given in the past, might have had a materially adverse effect on the assets, business, or operations of the Company as reflected in the financial statements delivered to the Investor, if any; or (C) if not continued in the future, might adversely affect the assets, business, operations, or prospects of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) The Company has not paid or promised to pay any form of compensation to any unlicensed finders, whether in the form of finder's fees, origination fees, referral fees, or otherwise, in connection with this Offering.

**ARTICLE III.**

**CONDITIONS TO THE INVESTOR'S OBLIGATIONS**

The obligation of the Investor to purchase the Securities at Closing is subject to the following conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The representations and warranties of the Company contained herein shall be true and correct in all material respects on and as of the Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) There shall be no preliminary or permanent injunction or other order, decree, or ruling issued by a court of competent jurisdiction or by a governmental, regulatory, or administrative agency or commission, nor any statute, rule, regulation, or order promulgated or enacted by any governmental authority, prohibiting, or otherwise restraining the sale or purchase of the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) On or prior to the Closing Date, the Investor shall have been furnished such documents, certificates, and opinions as they may reasonably require for the purpose of enabling them to review or pass upon the matters set forth herein, or in order to evidence the accuracy, completeness, or satisfaction of any of the representations, warranties, or conditions herein contained.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Prior to the Closing, (i) there shall have been no material adverse change nor development involving a prospective change in the condition, prospects, or the business activities, financial or otherwise, of the Company as a whole, from the latest dates as of which such condition is set forth in this Subscription Agreement and the Disclosure Document; (ii) there shall have been no transaction, not in the ordinary course of business, entered into by the Company from the latest date as of which the financial condition of the Company is set forth in this Subscription Agreement which is material to the Company and which has not been disclosed to the Investor in writing; (iii) the Company shall not be in default in any material respect under any provision of any instrument relating to any outstanding indebtedness; (iv) no material amount of the assets of the Company shall have been pledged or mortgaged; and (v) no action, suit, or proceeding, at law or in equity, shall have been pending or threatened against the Company or affecting any of its respective properties or businesses before or by any court of federal or state commission, board, or other administrative agency wherein an unfavorable decision, ruling, or finding could materially adversely affect the business, operations, prospects, or financial condition or income of the Company.

**ARTICLE IV.**

**CONDITIONS TO THE COMPANY'S OBLIGATIONS**

The obligation of the Company to sell the Securities under this Agreement at the Closing is subject to the following conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The representations and warranties of the Investor contained in the document entitled Investor Representations and Warranties Agreement attached hereto shall be true and correct in material respects on and as of the Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) There shall be no preliminary or permanent injunction or other order, decree, or ruling issued by a court of competent jurisdiction or by a governmental, regulatory, or administrative agency or commission, nor any statute, rule, regulation, or order promulgated or enacted by any governmental authority, prohibiting, or otherwise restraining the sale or purchase of the Securities.

**ARTICLE V.**

**INDEMNIFICATION**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company hereby agrees to defend, indemnify, and hold harmless the Investor, their stockholders, directors, partners, employees, agents, attorneys, and each person, if any, who controls such Investor within the meaning of the Act against any and all losses, claims, damages, or liabilities to which such Investor or any such stockholder, director, partner, employee, agent, attorney, or controlling person may become subject under the Act or otherwise, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained herein, in the Disclosure Document, or in any statement made to or in any filing with the Commission or to or with any state securities commission, bureau, or office (including any amendments thereto), or arise out of or based upon the omission or alleged omission to state herein or therein a material fact required to be stated herein or therein or necessary to make the statements herein or therein not misleading (unless such statements are made or omitted in reliance upon and in conformity with written information furnished to the Company with respect to such Investor by such Investor expressly for use herein or therein or any amendment hereof or supplement hereto), or any violation by the Company of the Act or state "blue sky" laws, or any breach by the Company of their obligations, representations, or warranties hereunder or with respect to the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Investor hereby agrees to defend, indemnify, and hold harmless the Company and its respective stockholders, directors, employees, agents, and each person, if any, who controls any of the foregoing within the meaning of the Act against any and all losses, claims, damages, or liabilities to which the Company or any of the Company's stockholders, directors, employees, agents, or controlling persons may become subject under the Act or otherwise, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any written statement as it relates to the Offering, as made by the Investor, its stockholders, directors, partners, agents, or employees or any breach by such Investor of its obligations, representations, or warranties hereunder, provided that such statement or breach was made knowingly and intentionally.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Promptly after receipt by an indemnified party under either subparagraph (a) or (b), as the case may be, of the notice of commencement of any action covered by subparagraph (a) or (b), such indemnified party shall within five business days notify the indemnifying party of the commencement thereof; the omission by one indemnified party to so notify such indemnifying party shall not relieve the indemnifying party of its obligations hereunder except to the extent such indemnifying party has been materially prejudiced by such omission, shall not relieve the indemnifying party of its obligation to indemnify any other indemnified party that has given such notice and shall not relieve the indemnifying party of any liability outside of this indemnification. If any action is brought against the indemnified party, it shall notify the indemnifying party in a timely manner, the indemnifying party will be entitled to participate in such action and, to the extent it may desire, to assume and control the defense thereof with counsel chosen by it. After notice from the indemnifying party to such indemnified party of its election to so assume the defense thereof, the indemnifying party will not be liable to such indemnified party under such subparagraph for any legal or other expense subsequently incurred by such indemnified party in connection with the defense thereof, but the indemnified party may, at its own expenses, participate in such defense by counsel chosen by it without, however, impairing the indemnifying party's control of the defense. Notwithstanding anything to the contrary contained herein, the indemnified party shall have the right to choose its own counsel and control the defense of any action, all at the reasonable expense of the indemnifying party, if (i) the employment of such counsel shall have been authorized in writing by the indemnifying party in connection with the defense of such action at the expense of the indemnifying party; (ii) the indemnifying party shall not have employed counsel reasonably satisfactory to such indemnified party to have charge of the defense of such action within a reasonable time after notice of commencement of the action; or (iii) such indemnified party shall have reasonably concluded that there may be defenses available to such indemnified party that differ from the defenses available to the indemnifying party (in which case the indemnifying party shall not have the right to direct the defense of such action on behalf of such indemnified party), in any of which events such reasonable fees and expenses of one additional counsel (for all indemnified parties) shall be borne by the indemnifying party (in the case of the Investor, one additional counsel for Investor). No settlement of any action or proceeding against an indemnified party shall be made without the consent of the indemnified party, which consent shall not be unreasonably withheld.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) In order to provide for just and equitable contribution under the Act in any case in which (i) any indemnified party makes a claim for indemnification pursuant to this paragraph but it is judicially determined (by entry of a final judgment or decree by a court of competent jurisdiction and the expiration of the time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case, notwithstanding the fact the this paragraph provides for indemnification in such case, or (ii) contribution under the Act is required on the part of any such person in circumstances for which indemnification is provided under this paragraph, then, in each such case, the Company shall be solely responsible for all aggregate losses, claims, damages, or liabilities, and the Investor shall not be required to contribute to these losses beyond the amount of the Securities purchased by such Investor pursuant to the Subscription Agreement; provided, that in any such case, no person guilty of a fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.

**ARTICLE VI.**

**NOTICES**

Any notice, request, instruction, or other document required by the terms of this Agreement, or deemed by any of the Parties hereto to be desirable, to be given to any other Party hereto shall be in writing and shall be given by personal delivery, overnight delivery, mailed by registered or certified mail, postage prepaid, with return receipt requested, or sent by electronic mail (with receipt confirmed) to the addresses of the Parties as follows:

---

| | |
|:---|:---|
| Company: | Alternative Ballistics Corporation |
|  | 5940 S. Rainbow Blvd. |
|  | Las Vegas, NV 89118 |
|  | Email: steve@alternativeballistics.com |
|  | Attn: Steven Luna, CEO |
| Investor: | At the address below Investor's signature on this Agreement |

---

The persons and addresses set forth above may be changed from time to time by a notice sent as aforesaid. If notice is given by personal delivery or overnight delivery in accordance with the provisions of this Section, such notice shall be conclusively deemed given at the time of such delivery provided a receipt is obtained from the recipient. If notice is given by mail in accordance with the provisions of this Article, such notice shall be conclusively deemed given upon receipt and delivery or refusal. If notice is given by electronic mail transmission in accordance with the provisions of this Article, such notice shall be conclusively deemed given at the time of delivery if during business hours and if not during business hours, at the next business day after delivery, provided a confirmation is obtained by the sender.

**ARTICLE VII.**

**MISCELLANEOUS**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) This Agreement shall be governed by and construed and interpreted in accordance with the laws of the State of California applicable to contracts made and to be performed entirely therein, without giving effect to the rules of conflicts of law. The Parties agree that the courts of the County of Orange, State of California shall have sole and exclusive jurisdiction and venue for the resolution of all disputes arising under the terms of this Agreement and the transactions contemplated herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) This Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective successors and assigns.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) This Agreement represents the entire agreement between the Parties relating to the subject matter hereof, superseding any and all prior to contemporaneous oral and prior written agreements and understandings. This Agreement may not be modified or amended, nor may any right be waived except by a writing signed by the party against whom the modification or waiver is sought to be enforced.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The warranties, representations, and covenants of the Company and the Investor contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The captions and headings contained herein are solely for convenience of reference and do not constitute a part of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Each of the Transaction Documents is hereby incorporated herein as if each of such attachments were fully set forth herein in its entirety. Each of such attachments is hereby expressly made a part of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. The Parties agree that this Agreement may be executed by facsimile signatures and such signatures shall be deemed originals.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) All Parties to this Agreement have been given the opportunity to consult with counsel of their choice regarding their rights under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The term "days," as used in this Agreement and in all documents contained in the Transaction Documents, refers to calendar days unless otherwise clearly indicated.

**[SIGNATURE PAGE FOLLOWS]**

**IN WITNESS WHEREOF**, intending to be legally bound, the Parties hereto have executed this Agreement as of the July 22, 2025.

---

| | |
|:---|:---|
| **COMPANY:** | **COMPANY:** |
| **Alternative Ballistics Corporation,** a Nevada corporation | **Alternative Ballistics Corporation,** a Nevada corporation |
|  | */s/ Steven Luna* |
| By: | Steven Luna |
| Its: | Chief Executive Officer |

---

**PURCHASER:**

**SOLYCO CAC LLC,** 

**a Michigan limited liability company**

A. Has the limited liability company been formed for the specific purpose of investing in the Units?

---

| | |
|:---|:---|
| ☐ YES | ☒ NO |

---

If your answer to question A is "No" CHECK whichever of the following statements (1-5) is applicable to you. If your answer to question A is "Yes" the Purchaser must be able to certify to statement (B) below in order to qualify as an "accredited investor."

The undersigned entity certifies that it is an "accredited investor" because it is:

1. _______ an employee benefit plan within the meaning of Title I of the Employee Retirement Income Security Act of 1974, provided that the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such Act, and the plan fiduciary is a bank, savings and loan association, insurance company or registered investment adviser; or

2. _______ an employee benefit plan within the meaning of Title I of the Employee Retirement Income Security Act of 1974 that has total assets in excess of $5,000,000; or

3. _______ each of its shareholders, partners, or beneficiaries meets at least one of the following conditions described above under Individual Accredited Investor Status. Please also CHECK the appropriate space in that section below; or

4. _______ the plan is a self directed employee benefit plan and the investment decision is made solely by a person that meets at least one of the conditions described above under Individual Accredited Investor Status; or

5. ___X____ an entity with total assets in excess of $5,000,000.

B. If the answer to Question A above is "Yes," please certify the statement below is true and correct:

_______ The undersigned entity certifies that it is an accredited investor because each of its members meets at least one of the following conditions described below under Individual Accredited Investor Status. Please also CHECK the appropriate space in that section.

**ONLY COMPLETE THE FOLLOWING IF YOU CHECKED A.3. OR B:, AND THEN PLEASE COMPLETE THE FOLLOWING FOR *EVERY* MEMBER OF THE LIMITED LIABILITY COMPANY:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Member Name:____________________________________________________________

I certify that I am an individual "accredited investor" because:

_______ I had an individual income of more than $200,000 in each of the two most recent calendar years, and I reasonably expect to have an individual income in excess of $200,000 in the current calendar year; or my spouse and I had joint income in excess of $300,000 in each of the two most recent calendar years, and we reasonably expect to have a joint income in excess of $300,000 in the current calendar year.

**OR**

_______ I have an individual net worth, or my spouse and I have a joint net worth, in excess of $1,000,000 (excluding my (our) primary residence).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Member Name:__________________________________________________________

I certify that I am an individual "accredited investor" because:

_______ I had an individual income of more than $200,000 in each of the two most recent calendar years, and I reasonably expect to have an individual income in excess of $200,000 in the current calendar year; or my spouse and I had joint income in excess of $300,000 in each of the two most recent calendar years, and we reasonably expect to have a joint income in excess of $300,000 in the current calendar year.

**OR**

_______ I have an individual net worth, or my spouse and I have a joint net worth, in excess of $1,000,000 (excluding my (our) primary residence).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Member Name:_____________________________________________________

I certify that I am an individual "accredited investor" because:

_______ I had an individual income of more than $200,000 in each of the two most recent calendar years, and I reasonably expect to have an individual income in excess of $200,000 in the current calendar year; or my spouse and I had joint income in excess of $300,000 in each of the two most recent calendar years, and we reasonably expect to have a joint income in excess of $300,000 in the current calendar year.

**OR**

_______ I have an individual net worth, or my spouse and I have a joint net worth, in excess of $1,000,000 (excluding my (our) primary residence).

[If there are additional members of the LLC, please duplicate this page.]

**SOLYCO CAC LLC, a Michigan limited liability company**

Print Name: John Garcia <br> Its: Managing Director

---

| |
|:---|
| */s/ John Garcia* |
| [Signature] |
| 400 Water Street, Suite 203 |
| Address |
| Rochester, MI 48307 |
| Address |
| jgarcia@solycocapital.com |
| Email Address |
| 85-3182912 |
| Social Security/Tax I.D. Number |

---

**INVESTOR REPRESENTATIONS AND WARRANTIES AGREEMENT**

This INVESTOR REPRESENTATIONS AND WARRANTIES AGREEMENT ("Agreement"), dated as of the date set forth on the signature page of this Agreement, is by and between Alternative Ballistics Corporation, a Nevada corporation (the "Company") and the purchaser set forth on the signature page of this Agreement, or assigns (the "Investor") (the Company and the Investor may be referred to individually as a "Party" and, collectively, as the "Parties").

**RECITALS:**

This Agreement is being made pursuant to an Offering by the Company of the purchase of a Convertible Note (the "Note") and warrants to purchase shares of common stock (the "Warrant" and collectively with the Note, the shares of common stock into which the Note is convertible, and the shares of common stock underlying the Warrant, the "Securities"). The Securities are being issued on the Closing (as defined in the Subscription Agreement) pursuant to a Subscription Agreement of even date herewith between the Company and the Investor which contains representations and warranties and additional covenants of the Company with respect to the sale of the Securities. Capitalized terms not otherwise defined herein shall have the meaning set forth in the Subscription Agreement. THE PROVISIONS OF THE SUBSCRIPTION AGREEMENT ARE INCORPORATED HEREIN BY REFERENCE.

**ARTICLE 1.**

**REPRESENTATIONS AND WARRANTIES OF THE INVESTOR**

The Investor hereby represents and warrants that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Investor acknowledges that the Securities are "restricted securities" (as such term is defined in Rule 144 promulgated under the Securities Act of 1933, as amended ("Rule 144"), that the Securities will include the restrictive legend set forth in Section 1.04 of the Subscription Agreement, and, except as otherwise set forth in the Subscription Agreement, that the Securities cannot be sold unless registered with the United States Securities and Exchange Commission ("SEC") and qualified by appropriate state securities regulators, or unless Investor otherwise complies with an exemption from such registration and qualification (including, without limitation, compliance with Rule 144).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Investor has adequate means of providing for current needs and contingencies, has no need for liquidity in the investment, and is able to bear the economic risk of an investment in the Securities. Investor represents that Investor is able to bear the economic risk of the investment and at the present time could afford a complete loss of such investment. Investor has reviewed the Transaction Documents with care. Additionally, Investor has had a full opportunity to inspect the Disclosure Document and to make any and all inquiries of Company officers and directors regarding the Company and its business as Investor has deemed appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Investor is an "Accredited Investor" as defined in Regulation D of the Act. Investor, either alone or with Investor's professional advisers who are unaffiliated with, have no equity interest in, and are not compensated by the Company or any affiliate or selling agent of the Company, directly or indirectly, has sufficient knowledge and experience in financial and business matters that Investor is capable of evaluating the merits and risks of an investment in the Securities offered by the Company and of making an informed investment decision with respect thereto and has the capacity to protect Investor's own interests in connection with Investor's proposed investment in the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Investor is acquiring the Securities solely for Investor's own account as principal, for investment purposes only and not with a view to the resale or distribution thereof, in whole or in part, and no other person or entity has a direct or indirect beneficial interest in such Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Investor will not sell or otherwise transfer the Securities without registration under the Act or an exemption therefrom and fully understands and agrees that Investor must bear the economic risk of Investor's purchase for an indefinite period of time because, among other reasons, the Securities have not been registered under the Act or under the securities laws of any state and, therefore, cannot be resold, pledged, assigned, or otherwise disposed of unless they are subsequently registered under the Act and under the applicable securities laws of such states or unless an exemption from such registration is available.

**ARTICLE 2.**

**MISCELLANEOUS**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) This Agreement shall be governed by and construed and interpreted in accordance with the laws of the State of California applicable to contracts made and to be performed entirely therein, without giving effect to the rules of conflicts of law. The Parties agree that the courts of the County of Orange, State of California shall have sole and exclusive jurisdiction and venue for the resolution of all disputes arising under the terms of this Agreement and the transactions contemplated herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) This Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective successors and assigns.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The warranties and representations of the Investor contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. The Parties agree that this Agreement may be executed by facsimile signatures and such signatures shall be deemed originals.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) All Parties to this Agreement have been given the opportunity to consult with counsel of their choice regarding their rights under this Agreement.

**IN WITNESS WHEREOF**, intending to be legally bound, the Parties hereto have executed this Agreement as of July 22, 2025.

---

| | |
|:---|:---|
| **COMPANY:** | **COMPANY:** |
| **Alternative Ballistics Corporation,**<br> a Nevada corporation | **Alternative Ballistics Corporation,**<br> a Nevada corporation |
| */s/ Steven Luna* | */s/ Steven Luna* |
| By: | Steven Luna |
| Its: | Chief Executive Officer |

---

---

| | |
|:---|:---|
| **INVESTOR:** | **INVESTOR:** |
| **SOLYCO CAC LLC,** <br> a Michigan limited liability company | **SOLYCO CAC LLC,** <br> a Michigan limited liability company |
| */s/ John Garcia* | */s/ John Garcia* |
| By: | John Garcia |
| Its: | Managing Director |

---

**THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW IS AVAILABLE.**

**ALTERNATIVE BALLISTICS CORPORATION, A NEVADA CORPORATION**

**CONVERTIBLE NOTE**

This Convertible Note (this "Note") has been issued pursuant to a Subscription Agreement dated July 22, 2025 (the "Subscription Agreement") between the Company and the holder of this Note (the "Noteholder"). Capitalized terms not otherwise defined herein shall have the meaning set forth in the Subscription Agreement, the provisions of which are incorporated herein by reference.

---

| | |
|:---|:---|
| **$300000** | **Date: July 22, 2025** |

---

1. <u>The Obligation</u>. FOR VALUE RECEIVED, the undersigned, Alternative Ballistics Corporation, a Nevada corporation (the "Company"), hereby promises to pay to the order of Solyco CAC LLC, a Michigan limited liability company, or its assigns (collectively, the "Noteholder"), in lawful money of the United States of America, and in immediately payable funds, the principal sum of $300,000 (the "Obligation"). The principal amount loaned by Noteholder to the Company shall accrue interest thereon from the date of this Note. Interest shall be paid according to Section 2 below and all amounts due under this Note shall be paid upon the Maturity Date set forth in Section 3 below. The Company has the right to assign this Note upon written notice to the Noteholder. (The Noteholder and the Company may be referred to individually as a "Party" and collectively as the "Parties" in this Note.)

2. <u>Interest</u>. The principal amount of this Note that may be outstanding from time to time shall bear interest at a rate equal to 18% per annum. Interest, if any, shall be computed hereunder based on a 365-day year and paid for the actual number of days elapsed for any whole or partial month in which principal is outstanding, which interest shall then be due and payable on the Maturity Date.

3. <u>Payment Terms</u>. The principal and interest of this Note shall be due and payable to the Noteholder nine months from the date of this Note (the "Maturity Date") unless all principal and interest due under this Note have been prepaid pursuant to Section 4 herein or converted pursuant to Section 5 herein. Payments are to be made to the Noteholder at its address stated in the Subscription Agreement (or such other address as is designated by the Noteholder) in lawful money of the United States of America. Unless otherwise specified, payments received by the Noteholder pursuant to the terms hereof shall be applied, first, to the payment of all expenses, charges, late payment fees, costs, and fees incurred by or payable to the Noteholder and for which the Company is obligated pursuant to the terms of this Note; second, to the payment of interest; and third, to the payment of principal.

4. <u>Prepayment</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1. <u>Prepayment</u>. The Company shall have the right to prepay all or any portion of the Loan outstanding at any time; provided, however, in the event of a prepayment, the Company shall pay 120% of the Principal Balance plus accrued and unpaid interest on the original Principal Balance of the Note. The Company shall deliver a notice of prepayment to Noteholder, which notice shall specify a prepayment date not less than 15 nor more than 30 days from the date of such notice (the "Prepayment Date"); provided, however, that the Investor will continue to have the right to convert the Note until the close of business of the fifth business day prior to the Prepayment Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 <u>Repayment Upon a Qualified Offering</u>. The Company shall immediately notify the Noteholder in the event a Qualified Offering (defined below) closes prior to the Maturity Date. Following such notice, the Noteholder has the option to (a) be repaid from the proceeds of the Qualified Offering within five days from the closing of the Qualified Offering by providing to the Company written notice of its intent to exercise such option for repayment within five days of the notice; or (b) in the event that the Noteholder does not exercise such option for repayment, then the Note shall automatically convert into shares of common stock 30 days following the closing of the Qualified Offering pursuant to the conversion terms set forth in Section 5. A "Qualified Offering" shall mean a public offering in the United States pursuant to a registration statement declared effective by the Securities and Exchange Commission pursuant to the Securities Act of 1933, with minimum gross proceeds of $5,000,000, pursuant to which the common stock is listed for trading on Nasdaq or a similar U.S. nationally-recognized stock exchange

5. <u>Conversion</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1 <u>Conversion Price</u>. The Principal Balance may be converted at any time prior to the Maturity Date at the option of the Company into shares of the Company's common stock at the Conversion Price. The "Conversion Price" shall be such price equal to the lower of (i) a 50% discount to the "Qualified Offering Price," which shall be defined as the price at which the Qualified Offering is consummated and (ii) any conversion price offered to other noteholders on notes issued subsequent to the date of this Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2 <u>Voluntary Conversion</u>. This Note is convertible at the option of the Noteholder, in Noteholder's sole discretion, in whole or in part, at any time prior to the Maturity Date or payment in full of the Note, whichever occurs first, for all or any portion of principal or interest, into shares of Common Stock of the Company at the Conversion Price.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.3 <u>Mechanics of Conversion</u>. To effectuate a Voluntary Conversion, the Noteholder shall deliver to the Company a written Election to Convert, a form of which is attached hereto. Immediately upon receipt of the written Election to Convert, the Company shall issue and cause to be delivered with all reasonable dispatch to or upon the written order of the Noteholder, and in such name or names as the Noteholder may designate, a certificate or other documentary evidence for the full number of shares of common stock ("Common Shares") so purchased upon conversion of the Note. Such certificate or documentary evidence shall be deemed to have been issued and any person so designated to be named therein shall be deemed to have become a holder of record of such securities as of the date of delivery of the Election to Convert, notwithstanding that the certificate or documentary evidence representing such securities shall not actually have been delivered or that the stock transfer books of the Company shall then be closed. The Note shall be convertible, at the election of the Noteholder, either in full or from time to time in part and, in the event that the Note is converted in respect of less than all of the Common Shares specified therein at any time prior to the Maturity Date, a new Note evidencing the remaining portion of the indebtedness shall be issued by the Company to the Noteholder.

6. <u>Representations, Warranties, and Covenants of the Company</u>. In connection with the transactions provided for herein, the Company hereby represents, warrants, and covenants to Noteholder that, as of the date hereof:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1 <u>Organization, Good Standing, and Qualification</u>. The Company is a corporation duly organized and validly existing under the laws of the State of Nevada and has all requisite corporate power and authority to carry on its business as now conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a material adverse effect on its business or properties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2 <u>Authorization</u>. All corporate action has been taken on the part of the Company, its officers, and directors necessary for the authorization, execution, and delivery of this Note. Except as may be limited by applicable bankruptcy, insolvency, reorganization, or similar laws relating to or affecting the enforcement of creditors' rights, the Company has taken all corporate action required to make all of the obligations of the Company reflected in the provisions of this Note the valid and enforceable obligations they purport to be.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3 <u>Compliance with Other Instruments</u>. The Company is not in violation of or in default under its Articles of Incorporation, as amended to date, or in any material respect of any term or provision of any loan, promissory note, mortgage, indebtedness, indenture, contract, agreement, instrument, judgment, order, or decree to which it is party or by which it is bound. The Company is not in violation of any federal or state statute, rule, or regulation applicable to the Company. The execution and delivery of this Note by the Company, the performance by the Company of its obligations pursuant to this Notes, and the issuance of the Common Shares, will not result in any violation of, or conflict with, or constitute a default under, the Company's Articles of Incorporation, as amended to date, or of any of its agreements material to the Company or its business, nor result in the creation of any mortgage, pledge, lien, encumbrance or charge upon any of the properties or assets of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4 <u>Valid Issuance of Common Shares</u>. The Common Shares to be issued, sold, and delivered upon conversion of the Notes will be duly and validly issued, fully paid, and non-assessable and, based in part upon the representations and warranties of the Company in this Note, will be issued in compliance with all applicable federal and state securities laws.

7. <u>Representations and Warranties of Noteholder</u>. In connection with the transactions provided for herein, Noteholder hereby represents and warrants to the Company that, as of the date a Note is issued to such Noteholder:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.1 <u>Authorization</u>. This Note constitutes such Noteholder's valid and legally binding obligation, enforceable in accordance with its terms, except as may be limited by (a) applicable bankruptcy, insolvency, reorganization, or similar laws relating to or affecting the enforcement of creditors' rights and (b) laws relating to the availability of specific performance, injunctive relief, or other equitable remedies. Such Noteholder represents that it has full power and authority to enter into this Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.2 <u>Purchase Entirely for Own Account</u>. Such Noteholder acknowledges that this Note is made with such Noteholder in reliance upon such Noteholder's representation to the Company that this Note and the Common Shares (collectively, the "Securities") will be acquired for investment for such Noteholder's own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that such Noteholder has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Note, such Noteholder further represents that such Noteholder does not have any contract, undertaking, agreement, or arrangement with any person to sell, transfer, or grant participations to such person or to any third person with respect to the Securities. Notwithstanding the foregoing, such Noteholder shall have the right to transfer the Securities, all or in part, to any affiliate of Noteholder. Any such transferees shall execute and deliver appropriate documentation providing that the transferee agrees to be bound by the applicable provisions hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.3 <u>Disclosure of Information</u>. Such Noteholder acknowledges that they have received all the information they consider necessary or appropriate for deciding whether to acquire the Securities. Such Noteholder further represents that they have had an opportunity to ask questions and receive answers from the Company regarding the Company and this Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.4 <u>Investment Experience</u>. Such Noteholder is an investor in securities of companies in the development stage and acknowledges that they able to fend for themselves; can bear the economic risk of this investment; and has such knowledge and experience in financial or business matters that he, she, or it is capable of evaluating the merits and risks of an investment in the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.5 <u>Restricted Securities</u>. Noteholder understands that the Securities are characterized as "restricted securities" under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without registration under the Securities Act, only in certain limited circumstances. Such Noteholder represents that it is familiar with SEC Rule 144, as presently in effect, and understands the resale limitations imposed thereby and by the Securities Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.6 <u>Legends</u>. It is understood that the Securities may bear the following legend:

"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW IS AVAILABLE."

8. <u>Default</u>. The occurrence of any one of the following events shall constitute an Event of Default:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The non-payment, when due, of any principal or interest pursuant to this Note, regardless of whether the Company has received notice of such non-payment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The material breach of any representation or warranty in this Note. In the event the Noteholder becomes aware of a breach of this Section, the Noteholder shall notify the Company in writing of such breach and the Company shall have ten days' notice to effect a cure of such breach;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The material breach of any covenant or undertaking in this Note, not otherwise provided for in this Section. In the event the Noteholder becomes aware of a breach of this Section, the Noteholder shall notify the Company in writing of such breach and the Company shall have ten days' notice to effect a cure of such breach;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) A default shall occur in the payment when due (subject to any applicable grace period), whether by acceleration or otherwise, of any indebtedness of the Company or an event of default or similar event shall occur with respect to such indebtedness, if the effect of such default or event (subject to any required notice and any applicable grace period) would be to accelerate the maturity of any such indebtedness or to permit the holder or holders of such indebtedness to cause such indebtedness to become due and payable prior to its express maturity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The commencement by the Company of any voluntary proceeding under any bankruptcy, reorganization, arrangement, insolvency, readjustment or debt, receivership, dissolution, or liquidation law or statute or any jurisdiction, whether now or hereafter in effect; or the adjudication of the Company as insolvent or bankrupt by a decree of a court of competent jurisdiction; or the petition or application by the Company for, acquiescence in, or consent by the Company to, the appointment of any receiver or trustee for the Company or for all or a substantial part of the property of the Company; or the assignment by the Company for the benefit of creditors; or the written admission of the Company of its inability to pay its debts as they mature; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) The commencement against the Company of any proceeding relating to the Company under any bankruptcy, reorganization, arrangement, insolvency, adjustment of debt, receivership, dissolution or liquidation law or statute or any jurisdiction, whether now or hereafter in effect, provided, however, that the commencement of such a proceeding shall not constitute an Event of Default unless the Company consents to the same or admits in writing the material allegations of same, or said proceeding shall remain undismissed for 30 days; or the issuance of any order, judgment, or decree for the appointment of a receiver or trustee for the Company or for all or a substantial part of the property of the Company, which order, judgment, or decree remains undismissed for 30 days; or a warrant of attachment, execution, or similar process shall be issued against any substantial part of the property of the Company.

Upon the occurrence of any Event of Default, the Noteholder may, by written notice to the Company, declare all or any portion of the unpaid principal amount due to Noteholder, together with all accrued interest thereon, immediately due and payable. The Noteholder may also proceed against any guarantor of this obligation without waiving any rights under the terms of this Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. <u>Notice</u>. Any notice, request, instruction, or other document required by the terms of this Note, or deemed by any of the Parties hereto to be desirable, to be given to any other Party hereto shall be in writing and shall be given by personal delivery, overnight delivery, mailed by registered or certified mail, postage prepaid, with return receipt requested, or sent by electronic transmission to the addresses of the Parties set forth in the Subscription Agreement. The persons and addresses set forth in the Notice provision of the Subscription Agreement may be changed from time to time by a notice sent as aforesaid. If notice is given by mail in accordance with the provisions of this Section, such notice shall be conclusively deemed given upon receipt and delivery or refusal. If notice is given by electronic mail transmission in accordance with the provisions of this Section, such notice shall be conclusively deemed given at the time of delivery if between the hours of 9:00 a.m. and 5:00 p.m. Pacific time on a business day ("business hours") and if not during business hours, at 9:00 a.m. on the next business day following delivery, provided a delivery confirmation is obtained by the sender.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. <u>Choice of Law</u>. This Note and the rights of the Parties hereunder shall be governed by and construed in accordance with the laws of the State of California including all matters of construction, validity, performance, and enforcement and without giving effect to the principles of conflict of laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. <u>Exclusive Jurisdiction and Venue</u>. The Parties agree that the state and federal courts in the County of Orange, State of California shall have sole and exclusive jurisdiction and venue for the resolution of all disputes arising under the terms of this Note and the transactions contemplated herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. <u>Attorneys' Fees</u>. In the event the Noteholder or any assignee thereof shall refer this Note to an attorney for collection, the Company agrees to pay all the costs and expenses incurred in attempting or effecting collection hereunder, including reasonable attorney's fees, whether or not suit is instituted.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. <u>Conformity with Law</u>. It is the intention of the Company and of the Noteholder to conform strictly to applicable usury and similar laws. Accordingly, notwithstanding anything to the contrary in this Note, it is agreed that the aggregate of all charges which constitute interest under applicable usury and similar laws that are contract for, chargeable or receivable under or in respect of this Note, shall under no circumstances exceed the maximum amount of interest permitted by such laws, and any excess, whether occasioned by acceleration or maturity of this Note or otherwise, shall be canceled automatically, and if theretofore paid, shall be either refunded to the Company or credited on the principal amount of this Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. <u>Severability</u>. Every provision of this Note is intended to be severable. In the event any term or provision hereof is declared by a court of competent jurisdiction, to be illegal or invalid for any reason whatsoever, such illegality or invalidity shall not affect the balance of the terms and provisions hereof, which terms and provisions shall remain binding and enforceable.

**[SIGNATURE PAGE FOLLOWS]**

**IN WITNESS WHEREOF**, the Company has signed and sealed this Note and delivered it as of the date first set forth above.

---

| | |
|:---|:---|
| **COMPANY:** | **COMPANY:** |
| **Alternative Ballistics Corporation**<br> a Nevada corporation | **Alternative Ballistics Corporation**<br> a Nevada corporation |
| */s/ Steven Luna* | */s/ Steven Luna* |
| By: | Steven Luna |
| Its: | Chief Executive Officer |

---

---

| | |
|:---|:---|
| **ACKNOWLEDGED AND AGREED:** | **ACKNOWLEDGED AND AGREED:** |
| **SOLYCO CAC LLC,** <br> a Michigan limited liability company | **SOLYCO CAC LLC,** <br> a Michigan limited liability company |
| */s/ John Garcia* | */s/ John Garcia* |
| By: | John Garcia |
| Its: | Managing Director |

---

**FORM OF ELECTION TO CONVERT**

The undersigned, the holder(s) of the attached Note, hereby irrevocably elects to exercise the right to convert $_____________ of the Note into shares of Common Stock of Alternative Ballistics Corporation and request that the certificates for such securities be issued in the name of, and delivered to,_____________________________________.

---

| | |
|:---|:---|
| Dated:______________________ | SIGNATURE: |
|  | (Signature must conform in all respects to name<br> of Noteholder as specified in the Note)<br>|
|  | (Insert Social Security or Federal Tax I.D.<br> Number of Noteholder)<br>|
|  | IF NOTE IS HELD JOINTLY, BOTH PARTIES MUST SIGN:<br>|
|  | (Signature must conform in all respects to name<br> of Noteholder as specified in the Note)<br>|
|  | (Insert Social Security or Federal Tax I.D.<br> Number of Joint Noteholder)<br>|

---

**THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW IS AVAILABLE.**

This Warrant Agreement (this "Warrant") has been issued pursuant to a Subscription Agreement dated July 22, 2025 (the "Subscription Agreement") between the Company and the holder of this Warrant (the "Holder"). Capitalized terms not otherwise defined herein shall have the meaning set forth in the Subscription Agreement, the provisions of which are incorporated herein by reference.

**ALTERNATIVE BALLISTICS CORPORATION**

**a Nevada Corporation**

**WARRANT AGREEMENT**

**To Purchase Shares of Common Stock**

Issue Date: July 22, 2025

THIS CERTIFIES that, for value received, SOLYCO CAC LLC, a Michigan limited liability company, or its assigns (the "Holder"), is entitled, upon the terms and subject to the conditions hereinafter set forth, at any time on or after the date hereof, to subscribe for and purchase from, ALTERNATIVE BALLISTICS CORPORATION, a Nevada corporation (the "Company"), certain fully paid, non-assessable shares of the Company's common stock, par value $0.001 ("Common Stock") set forth in Section 1 below at the Exercise Price (defined below), provided that such right will terminate, if not terminated earlier in accordance with the provisions hereof, at 5:00 p.m. (Pacific time) on the five year anniversary of the Issue Date (the "Expiration Date"). The purchase price and the number of shares for which this warrant (each a "Warrant," and collectively, the "Warrants") is exercisable are subject to adjustment, as provided herein.

As used herein the following terms, unless the context otherwise requires, have the following respective meanings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The term "Company" shall include Alternative Ballistics Corporation and any entity which shall succeed or assume the obligations of Alternative Ballistics Corporation hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The term "Warrant Shares" includes (i) the Company's common stock and (ii) any other securities into which or for which any of the Common Stock may be converted or exchanged pursuant to a plan of recapitalization, reorganization, merger, sale of assets or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The term "Other Securities" refers to any stock (other than Common Stock) and other securities of the Company or any other person (corporate or otherwise) which the holder of the Warrant at any time shall be entitled to receive, or shall have received, on the exercise of the Warrant, in lieu of or in addition to Common Stock, or which at any time shall be issuable or shall have been issued in exchange for or in replacement of Common Stock or Other Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) A "Qualified Offering" shall mean a public offering in the United States pursuant to a registration statement declared effective by the Securities and Exchange Commission pursuant to the Securities Act of 1933, with minimum gross proceeds of $5,000,000, pursuant to which the common stock is listed for trading on Nasdaq or a similar U.S. nationally-recognized stock exchange.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) "Qualified Offering Price" shall be defined as the price at which the Qualified Offering is consummated.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) The term "Conversion Price" shall be such price equal to the lesser of (i) a 50% discount to the Qualified Offering Price and (ii) any conversion price offered to other noteholders on notes issued subsequent to the issue date of the Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) The term "Exercise Price" shall be equal to the lower of (i) $1.00 or (ii) a 50% discount to the Qualified Offering Price.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The "Note" refers to that certain Promissory Note dated on even date herewith issued to the Holder pursuant to the above-referenced Subscription Agreement.

1. <u>Number of Shares Issuable upon Exercise</u>.

Unless sooner terminated in accordance herewith, from and after the date hereof through and including the Expiration Date, the Holder shall be entitled to receive up to three hundred thousand (300,000) Warrant Shares, upon exercise of this Warrant in whole or in part, by delivery of an original or fax copy of the exercise notice attached hereto as A<u>nnex A</u> (the "Notice of Exercise") along with payment to the Company of the Exercise Price.

2. <u>Exercise of Warrant</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The purchase rights represented by this Warrant are exercisable by the registered Holder hereof, in whole at any time or in part from time to time by delivery of the Notice of Exercise duly completed and delivered to the office of the Company, and upon payment of the Exercise Price of the shares thereby purchased (in the manner provided in Section 2(d) hereof); whereupon the Holder of this Warrant shall be entitled to receive a certificate for the number of Warrant Shares so purchased; provided that the Company will place on each certificate a legend substantially the same as that appearing on this Warrant, in addition to any legend required by any applicable state or federal law. If this Warrant is exercised in part, the Company will issue to the Holder hereof a new Warrant upon the same terms as this Warrant but for the balance of Warrant Shares for which this Warrant remains exercisable. The Company agrees that upon exercise of this Warrant the Holder shall be deemed to be the record owner of the Warrant Shares issued upon exercise as of the close of business on the date on which this Warrant shall have been exercised as aforesaid. This Warrant will be surrendered at the time of exercise or if lost, stolen, misplaced, or destroyed, the Holder will comply with Section 11 below.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Certificates for Warrant Shares purchased hereunder shall be delivered to the Holder hereof within a reasonable time after the date on which this Warrant shall have been exercised as aforesaid.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The Company covenants that all Warrant Shares which may be issued upon the exercise of rights represented by this Warrant will, upon exercise of the rights represented by this Warrant, be fully paid and nonassessable and free from all preemptive rights, taxes, liens, and charges in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue which shall be paid by the Company in accordance with Section 6 below).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) In order to exercise this Warrant with respect to all or any part of the Warrant Shares for which this Warrant is at the time exercisable, Holder (or any other person or persons exercising the Warrant) must take the following actions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Execute and deliver to the Company a written notice of exercise stating the number of Warrant Shares being purchased (in whole shares only) and such other information set forth on the form of Notice of Exercise attached hereto as Annex A; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Pay the aggregate Exercise Price for the Warrant Shares by cash, wire transfer, or check made payable to the order of the Company.

3. <u>Leak Out</u>.

During the Leak Out Period (defined below), the Holder's sale of common stock upon exercise of the Warrants shall be limited to 5% of the daily trading volume of the common stock on the immediately prior Trading Day. "Trading Day" shall mean a day on which Nasdaq or a similar U.S. nationally-recognized stock exchange is open for trading. "Leak Out Period" shall mean 12 months following the closing of the Qualified Offering.

4. <u>Mandatory Exercise of Warrants</u>.

At such time, if ever, that the Common Stock is listed on a national securities exchange or quoted in an over-the-counter market, the closing price of the Common Stock equals or exceeds $5.00 per share (which amount may be adjusted for certain capital events, such as stock splits) for ten consecutive trading days (the "Closing Price Measuring Period"), then the Company shall have the right to require the Holder to exercise all or any portion of this Warrant still unexercised, into fully paid, validly issued, and nonassessable shares of Common Stock at the Exercise Price. The Company may exercise its right to require exercise under this Section 4 by delivering within not more than five trading days following the end of such Closing Price Measuring Period a written notice thereof by electronic mail to the Holder (the "Mandatory Exercise Notice"). The Mandatory Exercise Notice shall be irrevocable. Following receipt of the Mandatory Exercise Notice, the Holder will be required to exercise all or any portion of this Warrant still unexercised within 30 calendar days from the date of the Mandatory Exercise Notice (the "Mandatory Exercise Period"). Any unexercised portion of this Warrant on the day immediately following the last day of the Mandatory Exercise Period shall be immediately forfeited.

5. <u>No Fractional Shares</u>.

The Company shall not be required to issue fractional Warrant Shares upon the exercise of this Warrant or to deliver Warrant Certificates which evidence fractional Warrant Shares. In the event that a fraction of a Warrant Share would, except for the provisions of this Section 5, be issuable upon the exercise of this Warrant, the Company shall round the fraction down to the next whole number of the Warrant Share.

6. <u>Charges, Taxes, and Expenses</u>.

Issuance of certificates for Warrant Shares upon the exercise of this Warrant shall be made without charge to the Holder hereof for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Company, and such certificates shall be issued in the name of the Holder of this Warrant, or in such name or names as may be directed by the Holder of this Warrant; provided, however, that in the event certificates for Warrant Shares are to be issued in a name other than the name of the Holder of this Warrant, the Company may require, as a condition thereto, that the transferee execute an appropriate investment representation as may be reasonably required by the Company.

7. <u>No Rights as Shareholders</u>.

This Warrant does not entitle the Holder hereof to any voting rights or other rights as a Shareholder of the Company prior to the exercise hereof.

8. <u>Securities Law Representations</u>.

Holder represents and warrants to Company as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Holder acknowledges that the Warrant Shares will initially be "restricted securities" (as such term is defined in Rule 144 promulgated under the Act) ("Rule 144") and that the certificates evidencing the Warrant Shares will include this legend:

"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW IS AVAILABLE."

Holder further acknowledges that the Warrant Shares cannot be sold unless registered with the United States Securities and Exchange Commission and qualified by appropriate state securities regulators, or unless Holder obtains written consent from Company and otherwise complies with an exemption from such registration and qualification (including, without limitation, compliance with Rule 144).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Holder has adequate means of providing for current needs and contingencies, has no need for liquidity in the investment, and is able to bear the economic risk of an investment in the Warrant and Warrant Shares offered by Company of the size contemplated. Holder represents that Holder is able to bear the economic risk of the investment and at the present time can afford a complete loss of such investment. Holder has had a full opportunity to inspect the books and records of the Company and to make any and all inquiries of Company officers and directors regarding the Company and its business as Holder has deemed appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Holder is an "Accredited Investor" as defined in Regulation D of the Securities Act or Holder, either alone or with Holder's professional advisers who are unaffiliated with, have no equity interest in and are not compensated by Company or any affiliate or selling agent of Company, directly or indirectly, has sufficient knowledge and experience in financial and business matters that Holder is capable of evaluating the merits and risks of an investment in the Warrant and Warrant Shares offered by Company and of making an informed investment decision with respect thereto and has the capacity to protect Holder's own interests in connection with Holder's proposed investment in the Warrant and Warrant Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Holder is acquiring the Warrant and Warrant Shares solely for Holder's own account as principal, for investment purposes only and not with a view to the resale or distribution thereof, in whole or in part, and no other person or entity has a direct or indirect beneficial interest in such Warrant or Warrant Shares.

9. <u>Rule 144 Opinions</u>.

The Company will, at its own expense, provide any and all legal opinions required for the removal of any restrictive legend from any stock certificates representing Warrant Shares under Rule 144. The Company will not unreasonably withhold any legal opinion required for the removal of the restrictive legend from any certificates representing the Warrant Shares pursuant to Rule 144 and will process such request within five business days of receipt of such request.

10. <u>Exchange and Registry of Warrant</u>.

This Warrant is exchangeable, upon the surrender hereof by the registered Holder at the office of the Company, for a new Warrant or Warrants aggregating the total Warrant Shares of the surrendered Warrant of like tenor and dated as of such exchange. The Company shall maintain at its office a registry showing the name and address of the registered Holder of this Warrant. This Warrant may be surrendered for exchange, transfer, or exercise, in accordance with its terms, at such office of the Company, and the Company shall be entitled to rely in all respects, prior to written notice to the contrary, upon such registry.

11. <u>Loss, Theft, Destruction, or Mutilation of Warrant</u>.

Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction, or mutilation of this Warrant, and in case of loss, theft, or destruction, of indemnity reasonably satisfactory to it, and upon reimbursement to the Company of all reasonable expenses incidental thereto, and upon surrender and cancellation of this Warrant, if mutilated, the Company will make and deliver a new Warrant of like tenor (but with no additional rights or obligations) and dated as of such cancellation, in lieu of this Warrant.

12. <u>Saturdays, Sundays, Holidays, etc.</u>

If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall be a Saturday or a Sunday or shall be a legal holiday, then such action may be taken or such right may be exercised on the next succeeding day not a Saturday, Sunday, or legal holiday.

13. <u>Cash Distributions</u>.

If the Company issues cash dividends or interest on the Company's Common Stock or Other Securities that may become purchasable hereunder, the Exercise Price under this Warrant will be adjusted to reflect the diluted value of the Warrant.

14. <u>Consolidation, Merger, or Sale of the Company</u>.

If the Company is a party to a consolidation, merger, or transfer of assets which reclassifies or changes its outstanding Common Stock, the successor corporation (or corporation controlling the successor corporation or the Company, as the case may be) shall by operation of law assume the Company's obligations under this Warrant. Upon consummation of such transaction, the Warrants shall automatically become exercisable for the kind and amount of securities, cash, or other assets which the holder of a Warrant would have owned immediately after the consolidation, merger, or transfer if the holder had exercised the Warrant immediately before the effective date of such transaction. As a condition to the consummation of such transaction, the Company shall arrange for the person or entity obligated to issue securities or deliver cash or other assets upon exercise of the Warrant to, concurrently with the consummation of such transaction, assume the Company's obligations hereunder by executing an instrument so providing and further providing for adjustments which shall be as nearly equivalent as may be practical to the adjustments provided for in this Section 14.

15. <u>Adjustments for Stock Splits, Combinations, etc.</u>

The number of shares and class of capital stock purchasable under this Warrant are subject to adjustment from time to time as set forth in this Section 15.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Adjustment for change in capital stock. If the Company:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) pays a dividend or makes a distribution on its Common Stock, in each case, in shares of its Common Stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) subdivides its outstanding shares of Common Stock into a greater number of shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) combines its outstanding shares of Common Stock into a smaller number of shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) makes a distribution on its Common Stock in shares of its capital stock other than Common Stock; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) issues by reclassification of its shares of Common Stock any shares of its capital stock;

then the number and classes of shares purchasable upon exercise of each Warrant in effect immediately prior to such action shall be adjusted so that the holder of any Warrant thereafter exercised may receive the number and classes of shares of capital stock of the Company which such holder would have owned immediately following such action if such holder had exercised the Warrant immediately prior to such action.

For a dividend or distribution, the adjustment shall become effective immediately after the record date for the dividend or distribution. For a subdivision, combination, or reclassification, the adjustment shall become effective immediately after the effective date of the subdivision, combination, or reclassification.

If after an adjustment the Holder, upon exercise of a Warrant, may receive shares of two or more classes of capital stock of the Company, the Board of Directors of the Company shall in good faith determine the allocation of the adjusted Exercise Price between or among the classes of capital stock. After such allocation, that portion of the Exercise Price applicable to each share of each such class of capital stock shall thereafter be subject to adjustment on terms comparable to those applicable to Common Stock in this Warrant. Notwithstanding the allocation of the Exercise Price between or among shares of capital stock as provided by this Section 15(a), a Warrant may only be exercised in full by payment of the entire Exercise Price currently in effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Company will not, by amendment of its Articles of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue, or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company. The Company shall at all times in good faith assist in the carrying out of all the provisions of this Section 15 and take all necessary or appropriate actions to protect the exercise rights of the Holders of this Warrant against impairment, including but not limited to obtaining a written agreement from any successor or acquiring entity to honor this Warrant in full and recognizing the Holder's right to the same terms and conditions in any new entity.

16. <u>Certificate as to Adjustments</u>.

In each case of any adjustment or readjustment in the shares of Common Stock (or Other Securities) issuable on the exercise of the Warrant, the Company at its expense will promptly cause its Chief Financial Officer or other appropriate designee to compute such adjustment or readjustment in accordance with the terms of the Warrant and prepare a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based, including a statement of (a) the consideration received or receivable by the Company for any additional shares of Common Stock (or Other Securities) issued or sold or deemed to have been issued or sold, (b) the number of shares of Common Stock (or Other Securities) outstanding or deemed to be outstanding, and (c) the Exercise Price and the number of shares of Common Stock to be received upon exercise of this Warrant, in effect immediately prior to such adjustment or readjustment and as adjusted or readjusted as provided in this Warrant. The Company will forthwith mail a copy of each such certificate to the Holder of the Warrant and any Warrant agent of the Company.

17. <u>Reservation of Stock Issuable on Exercise of Warrant</u>.

The Company will at all times reserve and keep available, solely for issuance and delivery on the exercise of the Warrant, shares of Common Stock (or Other Securities) from time to time issuable on the exercise of the Warrant.

18. <u>Assignment; Exchange of Warrant</u>.

This Warrant, and the rights evidenced hereby, may not be transferred to any third party other than an affiliate of the Holder without the prior written consent of the Company which may be withheld in the sole and absolute discretion of the Company and compliance with applicable securities laws. As a condition precedent to the Company considering whether to consent to a transfer, the Holder shall deliver to the Company a legal opinion from the Holder's counsel that such transfer is exempt from the registration requirements of applicable securities laws at the Holder's expense. If the Company consents to the proposed transfer (if applicable), upon surrender for exchange of this Warrant, together with evidence reasonably satisfactory to the Company demonstrating compliance with applicable securities laws and payment by the Holder of any applicable transfer taxes, the Company will issue and deliver to or on the order of the Holder a new Warrant of like tenor, in the name of the Holder and/or the transferee(s) specified (each a "Transferee"), calling in the aggregate on the face or faces thereof for the number of Warrant Shares called for on the face or faces of the Warrant so surrendered by the Holder; and provided further, that upon any such transfer, the Company may require, as a condition thereto, that the Transferee execute an appropriate investment representation as may be reasonably required by the Company.

19. <u>Notices</u>.

Any notice, request, instruction, or other document required by the terms of this Note, or deemed by any of the Parties hereto to be desirable, to be given to any other Party hereto shall be in writing and shall be given by personal delivery, overnight delivery, mailed by registered or certified mail, postage prepaid, with return receipt requested, or sent by electronic transmission to the addresses of the Parties set forth in the Subscription Agreement. The persons and addresses set forth in the Notice provision of the Subscription Agreement may be changed from time to time by a notice sent as aforesaid. If notice is given by mail in accordance with the provisions of this Section, such notice shall be conclusively deemed given upon receipt and delivery or refusal. If notice is given by electronic mail transmission in accordance with the provisions of this Section, such notice shall be conclusively deemed given at the time of delivery if between the hours of 9:00 a.m. and 5:00 p.m. Pacific time on a business day ("business hours") and if not during business hours, at 9:00 a.m. on the next business day following delivery, provided a delivery confirmation is obtained by the sender.

20. <u>Notices of Record Date</u>.

In case,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company takes a record of the holders of its Common Stock for the purpose of entitling them to subscribe for or purchase any shares of stock of any class or to receive a dividend, distribution, or any other rights;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) There is any capital reorganization of the Company, reclassification of the capital stock of the Company (other than a subdivision or combination of its outstanding shares of Common Stock), or consolidation or merger of the Company with or into another corporation which does not constitute a sale of the Company; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) There is a voluntary or involuntary dissolution, liquidation, or winding up of the Company;

then, and in any such case, the Company shall cause to be mailed to the Holder, at least 20 business days prior to the date hereinafter specified, a notice stating the date on which (i) a record is to be taken for the purpose of such dividend, distribution or rights, or (ii) such reclassification, reorganization, consolidation, merger, dissolution, liquidation, or winding up is to take place and the date, if any is to be fixed, as of which holders of Common Stock of record shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such reclassification, reorganization, consolidation, merger, dissolution, liquidation, or winding up.

21. <u>Amendments and Supplements</u>.

The Company may from time to time supplement or amend this Warrant without the approval of any Holders in order to cure any ambiguity or to correct or supplement any provision contained herein which may be defective or inconsistent with any other provision, or to make any other provisions in regard to matters or questions herein arising hereunder which the Company may deem necessary or desirable and which shall not materially adversely affect the interest of the Holder. All other supplements or amendments to this Warrant must be signed by the party against whom such supplement or amendment is to be enforced.

22. <u>Investment Intent</u>.

Holder represents and warrants to the Company that Holder is acquiring the Warrants for investment and with no present intention of distributing or reselling any of the Warrants.

23. <u>Miscellaneous</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) This Warrant shall be governed by and construed in accordance with the laws of the State of California without regard to principles of conflicts of laws. The Company and the Holder hereby submit to the exclusive jurisdiction of the Courts of Orange County, State of California for the resolution of all legal disputes arising under the terms of this Warrant. The Company and the Holder agree to waive trial by jury.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) If any action or proceeding is brought by the Company on the one hand or by the Holder on the other hand to enforce or continue any provision of this Warrant, the prevailing party's costs and expenses, including its reasonable attorneys' fees, in connection with such action or proceeding shall be paid by the other party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) In the event that any provision of this Warrant is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of this Warrant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The headings in this Warrant are for purposes of reference only and shall not limit or otherwise affect any of the terms hereof.

**[SIGNATURE PAGE FOLLOWS]**

**IN WITNESS WHEREOF**, the Company has caused this Warrant to be executed by its officers thereunto duly authorized as of the date first written above.

---

| | |
|:---|:---|
| **COMPANY:** | **COMPANY:** |
| **Alternative Ballistics Corporation,**<br> a Nevada corporation | **Alternative Ballistics Corporation,**<br> a Nevada corporation |
| */s/ Steven Luna* | */s/ Steven Luna* |
| By: | Steven Luna |
| Its: | Chief Executive Officer |

---

---

| | |
|:---|:---|
| **HOLDER:** | **HOLDER:** |
| **SOLYCO CAC LLC,** <br> a Michigan limited liability company | **SOLYCO CAC LLC,** <br> a Michigan limited liability company |
| */s/ John Garcia* | */s/ John Garcia* |
| By: | John Garcia |
| Its: | Managing Director |

---

**ANNEX A**

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF CERTAIN STATES, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW IS AVAILABLE.

NOTICE OF EXERCISE

The undersigned hereby elects irrevocably to exercise the within Warrant and to purchase _______________shares of Common Stock of Alternative Ballistics Corporation and hereby makes payment of $(at the rate of $________________ per share) in payment of the Exercise Price pursuant hereto. Please issue the shares as to which this Warrant is exercised in accordance with the instructions given below.

INSTRUCTIONS FOR REGISTRATION OF SHARES

Name (print) _______________________________________________________

Address (print) _______________________________________________________

Address (print) _______________________________________________________

ASSIGNMENT

FOR VALUE RECEIVED, ________________________ does hereby sell, assign, and transfer unto_____________________________, the right to purchase ______ shares of Common Stock of Alternative Ballistics Corporation, evidenced by the within Warrant, and does hereby irrevocably constitute and appoint _____________________________________ attorney to transfer such right on the books of Alternative Ballistics Corporation, with full power of substitution on the premises.

Dated: ____________, 20___ <br> Signature:____________________________

Notice: The signature of Notice of Exercise or Assignment must correspond with the name as written upon the face of the within Warrant in every particular without alteration or enlargement or any change whatsoever.

**DISCLOSURE DOCUMENT**

Offering Circular on Form 1-A

of

Alternative Ballistics Corporation

dated June 10, 2024

https://www.sec.gov/Archives/edgar/data/1834868/000149315224023306/partiiandiii.htm

## Add

**Exhibit 6.19**

**OMNIBUS AMENDMENT TO BRIDGE LOAN DOCUMENTS**

This Omnibus Amendment (the "Amendment") is entered into as of July 22, 2025, by and among Alternative Ballistics Corporation, a Nevada corporation (the "Company"), and Solyco CAC LLC, a Michigan limited liability company (the "Investor").

**RECITALS**

WHEREAS, the Company and the Investor are parties to that certain Subscription Agreement, Convertible Note, and Warrant Agreement, each dated August 2, 2024, together with all related documents (collectively, the "Transaction Documents");

WHEREAS, the parties desire to amend certain terms of the Transaction Documents as set forth herein.

**AMENDMENT**

---

| | |
|:---|:---|
| 1. | **Interest Rate.** |
|  | All references in the Transaction Documents to an interest rate of "14% per annum" are hereby amended and replaced with "18% per annum." |
| 2. | **Discount on Stock.** |
|  | All references in the Transaction Documents to a "30% discount" to the Qualified Offering Price (or similar language) are hereby amended and replaced with a "50% discount" to the Qualified Offering Price. |
| 3. | **Warrant Exercise Price.** |
|  | All references in the Transaction Documents to a Warrant exercise price of "the lower of (i) $2.00 or (ii) a 50% discount to the Qualified Offering Price" are hereby amended and replaced with "the lower of (i) $1.00 or (ii) a 50% discount to the Qualified Offering Price." |
| 4. | **Conforming Changes.** |
|  | The Transaction Documents are hereby amended to make all conforming changes necessary to give effect to the amendments set forth above. |
| 5. | **No Other Amendments.** |
|  | Except as expressly amended hereby, all terms and conditions of the Transaction Documents remain in full force and effect. |
| 6. | **Counterparts.** |
|  | This Amendment may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. |

---

**IN WITNESS WHEREOF**, the parties have executed this Amendment as of the date first written above.

---

| | |
|:---|:---|
| **Alternative Ballistics Corporation,** | **Alternative Ballistics Corporation,** |
| a Nevada corporation | a Nevada corporation |
| By: | */s/ Steven Luna* |
|  | Steven Luna |
| Its: | Chief Executive Officer |

---

---

| | |
|:---|:---|
| **Solyco CAC LLC,** | **Solyco CAC LLC,** |
| a Michigan limited liability company | a Michigan limited liability company |
| By: | */s/ John Garcia* |
|  | John Garcia |
| Its: | Managing Director |

---

## Add

**Exhibit 6.20**

**OMNIBUS AMENDMENT TO BRIDGE LOAN DOCUMENTS**

This Omnibus Amendment (the "Amendment") is entered into as of July 22, 2025, by and among Alternative Ballistics Corporation, a Nevada corporation (the "Company"), and Solyco CAC LLC, a Michigan limited liability company (the "Investor").

**RECITALS**

WHEREAS, the Company and the Investor are parties to that certain Subscription Agreement, Convertible Note, and Warrant Agreement, each dated January 28, 2025, together with all related documents (collectively, the "Transaction Documents");

WHEREAS, the parties desire to amend certain terms of the Transaction Documents as set forth herein.

**AMENDMENT**

---

| | |
|:---|:---|
| 1. | **Interest Rate.** |
|  | All references in the Transaction Documents to an interest rate of "14% per annum" are hereby amended and replaced with "18% per annum." |
| 2. | **Discount on Stock.** |
|  | All references in the Transaction Documents to a "30% discount" to the Qualified Offering Price (or similar language) are hereby amended and replaced with a "50% discount" to the Qualified Offering Price. |
| 3. | **Warrant Exercise Price.** |
|  | All references in the Transaction Documents to a Warrant exercise price of "the lower of (i) $2.00 or (ii) a 50% discount to the Qualified Offering Price" are hereby amended and replaced with "the lower of (i) $1.00 or (ii) a 50% discount to the Qualified Offering Price." |
| 4. | **Conforming Changes.** |
|  | The Transaction Documents are hereby amended to make all conforming changes necessary to give effect to the amendments set forth above. |
| 5. | **No Other Amendments.** |
|  | Except as expressly amended hereby, all terms and conditions of the Transaction Documents remain in full force and effect. |
| 6. | **Counterparts.** |
|  | This Amendment may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. |

---

**IN WITNESS WHEREOF**, the parties have executed this Amendment as of the date first written above.

---

| | |
|:---|:---|
| **Alternative Ballistics Corporation,** | **Alternative Ballistics Corporation,** |
| a Nevada corporation | a Nevada corporation |
| By: | */s/ Steven Luna* |
|  | Steven Luna |
| Its: | Chief Executive Officer |
| **Solyco CAC LLC,** | **Solyco CAC LLC,** |
| a Michigan limited liability company | a Michigan limited liability company |
| By: | */s/ John Garcia* |
|  | John Garcia |
| Its: | Managing Director |

---

## Add

**Exhibit 6.21**

**OMNIBUS AMENDMENT #2 TO BRIDGE LOAN DOCUMENTS**

This Omnibus Amendment #2 (the "Amendment #2") is entered into as of September 2, 2025, by and among Alternative Ballistics Corporation, a Nevada corporation (the "Company"), and Solyco CAC LLC, a Michigan limited liability company (the "Investor").

**RECITALS**

WHEREAS, the Company and the Investor are parties to that certain Subscription Agreement, Convertible Note, and Warrant Agreement, each dated August 2, 2024, and that certain Amended and Restated Warrant Agreement dated January 21, 2025, together with all related documents (collectively, as amended by Omnibus Amendment to Bridge Loan Documents dated July 22, 2025, the "Transaction Documents");

WHEREAS, the parties desire to amend the Transaction Documents as set forth herein.

**AMENDMENT**

---

| | |
|:---|:---|
| 1. | **Maturity Date.** |
|  | Effective May 1, 2025, the Maturity Date (as defined in the Transaction Documents) is extended to December 31, 2025. |
| 2. | **Conforming Changes.** |
|  | The Transaction Documents are hereby amended to make all conforming changes necessary to give effect to the amendments set forth above. |
| 3. | **No Other Amendments.** |
|  | Except as expressly amended hereby, all terms and conditions of the Transaction Documents remain in full force and effect. |
| 4. | **Counterparts.** |
|  | This Amendment #2 may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. |

---

[signature page follows]

**IN WITNESS WHEREOF**, the parties have executed this Amendment #2 as of the date first written above.

---

| | |
|:---|:---|
| **Alternative Ballistics Corporation,** | **Alternative Ballistics Corporation,** |
| a Nevada corporation | a Nevada corporation |
| By: | */s/ Steven Luna* |
|  | Steven Luna |
| Its: | Chief Executive Officer |
| **Solyco CAC LLC,** | **Solyco CAC LLC,** |
| a Michigan limited liability company | a Michigan limited liability company |
| By: | */s/ John Garcia* |
|  | John Garcia |
| Its: | Managing Director |

---

## Add

**Exhibit 6.22**

**OMNIBUS AMENDMENT #2 TO BRIDGE LOAN DOCUMENTS**

This Omnibus Amendment #2 (the "Amendment #2") is entered into as of September 2, 2025, by and among Alternative Ballistics Corporation, a Nevada corporation (the "Company"), and Solyco CAC LLC, a Michigan limited liability company (the "Investor").

**RECITALS**

WHEREAS, the Company and the Investor are parties to that certain Subscription Agreement, Convertible Note, and Warrant Agreement, each dated August 2, 2024, and that certain Amended and Restated Warrant Agreement dated January 21, 2025, together with all related documents (collectively, as amended by Omnibus Amendment to Bridge Loan Documents dated July 22, 2025, the "Transaction Documents");

WHEREAS, the parties desire to amend the Transaction Documents as set forth herein.

**AMENDMENT**

---

| | |
|:---|:---|
| 1. | **Maturity Date.** |
|  | Effective May 1, 2025, the Maturity Date (as defined in the Transaction Documents) is extended to December 31, 2025. |
| 2. | **Conforming Changes.** |
|  | The Transaction Documents are hereby amended to make all conforming changes necessary to give effect to the amendments set forth above. |
| 3. | **No Other Amendments.** |
|  | Except as expressly amended hereby, all terms and conditions of the Transaction Documents remain in full force and effect. |
| 4. | **Counterparts.** |
|  | This Amendment #2 may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. |

---

**[signature page follows]**

**IN WITNESS WHEREOF**, the parties have executed this Amendment #2 as of the date first written above.

---

| | |
|:---|:---|
| **Alternative Ballistics Corporation,** | **Alternative Ballistics Corporation,** |
| a Nevada corporation | a Nevada corporation |
| By: | */s/ Steven Luna* |
|  | Steven Luna |
| Its: | Chief Executive Officer |
| **Solyco CAC LLC,** | **Solyco CAC LLC,** |
| a Michigan limited liability company | a Michigan limited liability company |
| By: | */s/ John Garcia* |
|  | John Garcia |
| Its: | Managing Director |

---